Infection Control by unknown
Infection Control 
Updates
Edited by Christopher Sudhakar
Edited by Christopher Sudhakar
Health care associated infection is coupled with significant morbidity and mortality. 
Prevention and control of infection is indispensable part of health care delivery system. 
Knowledge of Preventing HAI can help health care providers to make informed and 
therapeutic decisions thereby prevent or reduce these infections. Infection control 
is continuously evolving science that is constantly being updated and enhanced. The 
book will be very useful for all health care professionals to combat with health care 
associated infections.
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Health care associated infection is coupled with significant morbidity and mortality. 
Prevention and control of infection is indispensable part of health care delivery 
system. Knowledge of Preventing HAI can help health care providers to make 
informed and therapeutic decisions thereby prevent or reduce these infections. 
Infection control is continuously evolving science that is constantly being updated and 
enhanced. This book is arranged in various sections like facets of infection control, 
preventive strategies, practice improvement and emerging trends. The authors have 
paid particular attention in their field of expertise. 
I am confident that this book will be very useful for all health care professionals to 
combat with health care associated infections. My sincere thanks to all expert 
contributors from different specialties around the world. 
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Healthcare Associated Infections:  
Nuisance in the Modern Medical Epoch 
Aamer Ikram1 and Luqman Satti2 
1Department of Pathology, Quetta Institute of Medical Sciences 
2Combined Military Hospital, DI Khan 
Pakistan 
1. Introduction 
Rapid advancements in the medical sciences have changed the understanding of the 
diseases down to the molecular level and in turn revolutionized the diagnostics and 
therapeutics. Similarly, architectural and engineering progression has reshaped the outlooks 
of the hospitals with the aim of comforting the patients. Despite all that, hospital 
environments remain a source of infection for the already ailing clientele. The scare of ‘super 
bugs’ has further aggravated the situation requiring more consolidated efforts for protection 
of admitted patients. 
Healthcare associated infections (HAIs) are major cause of increased morbidity and 
mortality (World Health Organization [WHO], 2009). Statistics of various surveys show that 
1 out of 10 patients admitted in hospital invariably acquire HAI (Emmerson, 1995). Data 
from developing countries is sparse, the situation otherwise seems to be much higher as 
compared to the developed world (Allegranzi et al., 2011). Worldwide around 1.4 million 
people are affected by HAIs at any given instance (Pittet & Donaldson, 2005). HAIs account 
for 99,000 deaths in American hospitals according to the Centres for Disease Control & 
Prevention (CDC) estimates (Klevens et al., 2007), and 37,000 deaths in Europe (WHO, 2011). 
HAI or nosocomial infection is defined as localized or systemic infection which reveals itself 
in patient either during stay in hospital or after discharge, and was not incubating at the 
time of admission (WHO, 2002). Hospital infection control (HIC) refers to combination of 
various guidelines, policies and modalities implemented to minimize the risk of spreading 
infections in a health care facility. In the past, HAIs were restricted only to the hospital 
environments but in the recent years, various healthcare settings such as ambulatory care, 
home care have also been included in this category. This chapter essentially focuses on the 
prime aspects of HAIs especially lately documented. 
These unanticipated but otherwise preventable infections have many distressing 
consequences such as increased mortality, prolonging morbidity and hospital stay, 
additional diagnostic and therapeutic interventions adding financial burden not only for the 
patient but also significant economic consequences on the entire healthcare organization. 
HAIs thus have a negative impact on the patients and their families and in turn the system. 
The financial effect is humongous as it has been estimated to reach £ 1,000 million each year 
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in the UK (National Audit Office [NAO], 2000), € 7 billion in Europe (WHO, 2011) and $ 6.65 
billion in the US in 2007 (Scott, 2009).  
In the recent years, duration of patients’ hospital stay has decreased but paradoxically, 
HAIs are increasing at alarming rates (Burke, 2003; Stone et al., 2002). Unfortunately, exact 
incidence of HAIs is not known or undervalued as many patients develop symptoms after 
discharge from the hospitals especially post-surgical infectious cases. Intensive care units 
(ICUs) and surgical units are the main reservoirs for HAIs especially in resource poor 
countries; reason being that most of the patients, especially in ICUs, have meager 
immunity or are critically ill (Ikram et al., 2010). However, the main reason for HAIs 
remains poor adherence to ‘standard infection control guidelines’ and ‘additional 
precautions’ (Siegel, 2007). Any breach in the infection control practices augments the 
transmission of microorganisms. It is, therefore, obligatory for everyone including 
doctors, nurses, paramedics, patients and even visitors to strictly follow the standard 
infection control guidelines. 
The sites involved and the sources could be multiple. Surgical site infections comprise 20% 
of HAIs and around 5% of operated patients develop these infections (de Lissovoy et al., 
2009; Gottrup, 2000). Neonatal nosocomial infection doubles the mortality risk and can only 
be improved by paying comprehensive attention to all aspects of neonatal intensive care 
(Gill et al., 2011).  
Invasive fungal infections in hospitalized patients increase morbidity and mortality. Candida 
spp. is responsible for 15% of HAIs and 72% of nosocomial fungal infections, and invasive 
candidiasis has mortality rate up to 40-50% in hospitalized patients (Gudlaugsson et al., 
2003). Water in the dental units may be contaminated with a variety of organisms which 
may in turn cause infection during dental procedures (Kumar et al., 2011). 
2. Responsibility of infection control team 
Infection control in a health care setting requires a multifaceted approach (CDC, 2007) and is 
responsibility of everyone coming in contact with the patient. The pivotal role is performed 
by a committed Infection Control Team usually comprising: 
 Infection control practitioner or doctor. 
 Administrator. 
 Infection control nurse. 
Infection Control Team is responsible for establishing infection control policies and 
procedures, providing advice and guidance regarding infection control matters, regular audits 
and surveillance, identification and investigation of outbreaks, awareness and education of 
staff (Ayliffe et al., 2000). The team works under Infection Control Committee which chiefly 
carries the responsibilities of making major decisions, problem discussion with the team, 
departmental coordination, educational activities, policy modification and recommendations. 
3. Factors implicated in healthcare associated infections 
Factors predisposing a hospitalized patient to HAI are related to organisms, host and 
environments. 
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3.1 Organism-related factors 
Practically any microorganism in the vicinity can cause HAI; varying for different settings, 
populations and countries (WHO, 2002). The organisms may be endogenous causing auto-
infection or self-infection, or exogenous. The exogenous organisms are usually transferred 
through airborne, percutaneous or direct contact transmission. ‘Cross-infection’ is 
transmission of organism from one person to another. Organisms commonly responsible for 
major HAIs are listed in table 1.  
Type of Infection Common organisms involved 
Surgical site infections 
(SSIs) 
S. aureus, Enterococcus spp, S. pyogenes, E. coli, Pseudomonas 
aeruginosa, Proteus spp and anaerobes 
Blood stream infections 
(BSIs) 
S. aureus including methicillin resistant S. aureus (MRSA), 
coagulase negative staphylococci and Enterococcus spp 
Urinary tract infections 
(UTIs) 
E. coli, Proteus spp, Klebsiella spp, Pseudomonas aeruginosa, 
Serratia spp, Enterococcus spp and less commonly C. albicans 
Ventilator associated 
pneumonia (VAP) 
Acinetobacter baumannii, Pseudomonas aeruginosa, S. aureus, and 
Enterobacteriaceae  
Table 1. Common organisms involved in healthcare associated infections. 
Serratia marcescens has been associated with nosocomial outbreaks mostly with 
contaminated fluids and injections. Recently there has been an outbreak among newborns 
due to usage of contaminated baby shampoo (Madani et al., 2011). Clostridium difficile 
associated diarrhoea (CDAD) is associated with high mortality rate in hospitalized patients 
particularly elderly with multiple co-morbidities (White and Wiselka, 2011). Acinetobacter 
baumannii has rapidly emerged as a nosocomial pathogen and that too with acquisition of 
multidrug resistance. Anti-pseudomonal carbapenems have been utilized against this 
resistant species, however, one-half to two-third of the isolates have been reported as 
resistant to this group as well (Tsakris et al., 2006).  
Viral infections can be transmitted through different routes in the healthcare settings; 
airborne viruses such as influenza virus, respiratory syncytial virus, adenovirus, rhinovirus, 
coronavirus, measles, rubella virus, mumps virus and parvovirus B19 can spread through 
droplets or indirectly by settling on surfaces; faecal-oral route such as norovirus, rotavirus 
and human adenovirus 40 and 41 (Lopman et al., 2004); and blood-borne like hepatitis B and 
C viruses and human immunodeficiency virus (Davanzo et al., 2008).  
3.2 Host-related factors 
The host could either be a patient or staff. There are numerous risk factors which predispose 
a host to acquire HAIs including: 
 Low body resistance as in infancy and old age. 
 Underlying illness gravity – patients with severe diseases /debilitated conditions. 
 Prolonged hospitalization. 
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 Delayed hospital discharge has been associated with increased HAI prevalence. The 
reason for delayed discharge include long term bed care, pending equipment required 
at home or access to other services (McNicholas et al., 2011).  
 Immunosuppression, malignancy, pregnancy. 
 Reduced local tissue resistance. 
 Use of medical devices such as I/V cannula, catheters, shunts and procedures such as 
bronchoscopy, cystoscopy etc. 
3.3 Environment-related factors 
Environment has a very significant impact on the chances of acquiring HAI and it varies for 
different places within a hospital. Clean and healthy environments in wards and sterile 
conditions especially in ICUs, nurseries and operation theatres minimize the risk of HAIs.  
Routine cleaning and disinfection is not sufficient in hospitals with continuous flow of 
patients, healthcare workers (HCWs) and visitors, and more efficient methods may have to 
be adopted to maintain the requisite standards (Wang et al., 2010). 
4. Mode of transmission of microorganisms 
It is important to understand the mode of transmission of microorganisms for putting 
barricades in the chain at healthcare settings. These include (CDC, 1998; 2007): 
4.1 Droplet transmission 
Droplet particles, produced by coughing, sneezing and even talking, can settle either on 
surrounding surfaces or on the body mucosa which can be transferred to others. Examples 
include meningitis and pneumonia. 
4.2 Airborne transmission 
Particles less than 5 micrometers remain suspended in air and may be inhaled causing 
infection in a susceptible host. Examples are tubercle bacilli and varicella virus.  
4.3 Contact transmission  
This is the most common mode of transmission of organisms which can be direct or indirect. 
In direct transmission, organisms are transferred from an infected or colonized person to 
another susceptible host by direct skin contact. In indirect transmission, organisms are first 
transferred from an infected person to a normal host such as a HCW and then to another. 
Most common example of contact transmission seen in surgical settings is the transfer of S. 
aureus from an infected wound or boils. 
4.4 Vector-borne transmission 
This mode is unusual in developed countries but it is not so uncommon in resource poor 
healthcare settings. Organisms are spread by vectors such as flies, mosquitoes and fleas. A 
common example is spread of dysentery caused by Shigella spp. through flies. 
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4.5 Other modes 
There are sometimes incidences where the source of infection in hospital setting is common 
and many persons get infected through the same source like use of contaminated food, 
drinking water, ointments, topical solutions and instruments. This can lead to outbreak in 
hospital setting. 
5. Principles for hospital infection control 
In general, infection control measures particularly revolve around the following: 
 Policies and procedures taken within hospital in different settings such as ICUs, 
operation theatres, other high risk areas, wards, etc. 
 Dedicated infection control teams. 
 Maintaining hospital hygiene. 
 Effective sterilization and disinfection techniques. 
 Proper management of hospital waste. 
 Continuous surveillance. 
 Outbreak investigation and management in hospital. 
 Clinical auditing. 
5.1 Measures taken in hospital 
These include standard infection control measures and transmission based precautions 
(CDC, 2007). Standard infection control measures are universally accepted and followed in 
most healthcare facilities. 
5.1.1 Hand washing and hand hygiene 
Hand hygiene is one of the key measures for preventing HAIs (Pittet & Boyce, 2001). Hand 
washing between patient contact and after surgical/invasive procedures is the most simple, 
economical and easy to perform measure significantly reducing infection transmission. 
However, its practice and compliance has been the core issue worldwide especially in the 
developing countries (Collins, 2008). Poor hand hygiene practices in hospital has led to 
number of outbreaks and adverse outcomes (Jarvis, 2001; Stanton and Rutherford, 2004; 
Hugonnet et al., 2004). It has been well established that simple hand washing with soap and 
water can prevent majority of childhood illnesses causing high mortality (Luby et al., 2005). 
Provision of sinks at various places in hospitals, monitoring of hand hygiene and continued 
education of staff in hospital can increase the level of patient safety. Hand washing and 
hand hygiene practices can be improved and monitored by using guidelines, ‘How-to-Guide: 
Improving Hand Hygiene’ (Institute for Healthcare Improvement, 2008). A versatile approach 
involving HCWs in the form of social marketing or especially directed towards barriers to 
hand hygiene seems to be much more successful (Forrester et al., 2010). 
Preoperative hand scrubbing by surgical team is mandatory to prevent surgical site infection 
along with wearing of gloves, gown, mask and cap. A latest study recommends appropriate 
disinfectant application to forearms for 10 s as part of preoperative hand disinfection 
(Hubner et al., 2011). Another study recommends alcohol-based hand rubs for surgical 
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Hand hygiene is one of the key measures for preventing HAIs (Pittet & Boyce, 2001). Hand 
washing between patient contact and after surgical/invasive procedures is the most simple, 
economical and easy to perform measure significantly reducing infection transmission. 
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developing countries (Collins, 2008). Poor hand hygiene practices in hospital has led to 
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along with wearing of gloves, gown, mask and cap. A latest study recommends appropriate 
disinfectant application to forearms for 10 s as part of preoperative hand disinfection 
(Hubner et al., 2011). Another study recommends alcohol-based hand rubs for surgical 
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preparation because of prompt antimicrobial action, broad spectrum, lesser side effects and 
avoiding the risk of contamination by the rinsing water (Widmer et al., 2010). 
Importance associated with hand hygiene awareness requires national commitment. It is 
mandatory part of national infection control programmes in many countries. A baseline 
survey of activities in improving hand hygiene was conducted by the WHO First Global 
Patient Safety Challenge in 2007. In 2009, it was repeated to evaluate the latest situation. 
Promotion of hand hygiene has become an important initiative with most of the countries; 
however, coordinated efforts are to be strengthened across the world (Mathai et al., 2011). 
WHO message remains – ‘Clean hands are safer hands’. 
Wearing wrist watches augments the bacterial contamination of the wrist but until it is 
manipulated, excess hand contamination does not ensue (Jeans et al., 2010). The wearing of 
watch over the chest pocket is definitely preferable. 
In demanding situations like patient overload or in critical care units, alcohol based hand 
rub may be a more realistic approach as it acts rapidly, takes less time and less irritable 
(Pittet & Boyce, 2001). Goroncy-Bermes et al. (2010) recommended 3 mL of alcohol hand rub 
containing adequate active concentration for contact time of 30 s. In general, sufficient 
amount should be utilized to cover all the surfaces of both the hands. Increased application 
of alcohol hand rub has been associated with noteworthy reduction in MRSA rates in 
hospital settings (Sroka et al., 2010) 
Much valuable time of HIC experts has been spent in the development and implementation 
of audit tools for hand hygiene. Gould et al (2011) recommended a combined approach of 
routine screening from product uptake and utilization of infection control experts. A 
promising consideration adjunct to the safety culture is involvement of patients in the 
design and promotion of hand hygiene at the institutional level (Pittet et al., 2011). 
5.1.2 Physical precautions 
Personal clothing is changed after arriving in the hospital and varies for different 
departments and hospitals. The indication for changing clinical attire is not as intense as 
other infection control measures like hand hygiene but it should be part of measures for 
controlling infections and the concept of ‘bare below elbows’ may be preferred (Shelton et 
al., 2010).  
Personal protective equipment (PPE) is used by healthcare workers for protection against 
infectious organisms as it acts as a barrier between the worker and fluid or material 
containing infectious agents. PPE may comprise of gloves, mask/respirator such as N-95, 
gowns/apron, goggles/face shield, shoe and head covers. Some of the important aspects for 
proper PPE utilization are: 
 Risk assessment is an important aspect before deciding about the sort of PPE to be 
utilized. PPE should be selected according to the risks involved in that particular 
healthcare setting.  
 PPE should not be worn outside the restricted area. There should be properly allocated 
place for every HCW for keeping PPE. 
 Each HCW should have his/her own PPE. 
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 PPE should be changed between patients’ contact followed by proper hand washing. 
 Used or old PPE should be disposed of properly. 
 Double gloving should be done where indicated and punctured gloves should be 
changed immediately.  
Healthcare setting environments can be protected by provision of physical barriers in the 
form of isolation of infected cases. Isolation policy and guidelines for the infectious cases 
thus remain pivotal for curtailing pathogen spread and have to be prepared according to 
requirements considering transmission mode, risk of spread to others, severity of infection, 
effective treatment available, and impact of isolation on patients (Ayliffe et al., 1999). 
Cohorting of the patients infected with same pathogen can be done. 
5.1.3 Environmental safeguards 
Hospital environments hold a diverse group of microorganisms surrounding a patient 
which generally originates from normal flora of patient, HCW, visitor, or from infected 
wounds. In the recent years, much debate is going on the role of environmental cleaning in 
reducing HAIs. The apparent hygiene of hospital cannot be linked with the risk of HAIs. 
With the emergence of fear and public panic due to ‘superbugs’ causing serious HAIs, 
hospital environments have been blamed for such infections. However, the exact role of 
hospital environment in causing these infections remains unknown (Dancer, 2009). Some of 
the superbugs such as Acinetobacter baumannii and Pseudomonas aeruginosa, after gaining 
access to hospital environment especially in ICUs, are extremely difficult to eradicate even 
with the advanced disinfection techniques. Hospital room surfaces and inanimate objects 
such as blood pressure set, stethoscope, utensils, etc can become colonized with resistant 
microorganisms such as MRSA, VRE and Clostridium difficile. Ungloved hands can become 
50% more contaminated with low level pathogenic microorganisms (Bhalla et al., 2004). 
For prevention of health associated infections particularly in immuno-compromised 
patients, special attention should be directed to the quality of air circulating in the hospital 
environments (Leung and Chan, 2006). Total air change rate should be 15 air changes/hr for 
operation theatres and delivery rooms; 6 air changes/hr for intensive care units, isolation 
rooms and laboratories; and 4 air changes/hr for patient rooms. Isolation room, equipment 
sterilization room and laboratory should have negative pressure control while intensive care 
unit, operation theatre and delivery room should have positive pressure control. The flow of 
air has to be from clean towards dirty areas. A latest study by Tang et al. (2011) has nicely 
observed the role of airflow patterns and movement of suspended material in infection 
control of aerosol and airborne transmitted diseases employing different techniques. This 
understanding would be very beneficial in understanding aerosol and airborne infection 
transmission through precise airflow visualization techniques and in turn developing 
modalities for preventing them. 
Among many sources responsible for nosocomial infections, hospital water is a controllable 
but overlooked source. Many pathogens can survive in hospital water supply, transfer 
antibiotic resistance and have been implicated in numerous outbreaks (Anaissie et al., 2002). 
Proper guidelines for the monitoring and prevention of hospital water borne infections are 
still limited. Legionella pneumophila, pathogenic mycobacteria, parasites and viruses have 
been implicated in hospital water borne diseases. In the recent years, pathogenic fungi and 
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 PPE should be changed between patients’ contact followed by proper hand washing. 
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 Double gloving should be done where indicated and punctured gloves should be 
changed immediately.  
Healthcare setting environments can be protected by provision of physical barriers in the 
form of isolation of infected cases. Isolation policy and guidelines for the infectious cases 
thus remain pivotal for curtailing pathogen spread and have to be prepared according to 
requirements considering transmission mode, risk of spread to others, severity of infection, 
effective treatment available, and impact of isolation on patients (Ayliffe et al., 1999). 
Cohorting of the patients infected with same pathogen can be done. 
5.1.3 Environmental safeguards 
Hospital environments hold a diverse group of microorganisms surrounding a patient 
which generally originates from normal flora of patient, HCW, visitor, or from infected 
wounds. In the recent years, much debate is going on the role of environmental cleaning in 
reducing HAIs. The apparent hygiene of hospital cannot be linked with the risk of HAIs. 
With the emergence of fear and public panic due to ‘superbugs’ causing serious HAIs, 
hospital environments have been blamed for such infections. However, the exact role of 
hospital environment in causing these infections remains unknown (Dancer, 2009). Some of 
the superbugs such as Acinetobacter baumannii and Pseudomonas aeruginosa, after gaining 
access to hospital environment especially in ICUs, are extremely difficult to eradicate even 
with the advanced disinfection techniques. Hospital room surfaces and inanimate objects 
such as blood pressure set, stethoscope, utensils, etc can become colonized with resistant 
microorganisms such as MRSA, VRE and Clostridium difficile. Ungloved hands can become 
50% more contaminated with low level pathogenic microorganisms (Bhalla et al., 2004). 
For prevention of health associated infections particularly in immuno-compromised 
patients, special attention should be directed to the quality of air circulating in the hospital 
environments (Leung and Chan, 2006). Total air change rate should be 15 air changes/hr for 
operation theatres and delivery rooms; 6 air changes/hr for intensive care units, isolation 
rooms and laboratories; and 4 air changes/hr for patient rooms. Isolation room, equipment 
sterilization room and laboratory should have negative pressure control while intensive care 
unit, operation theatre and delivery room should have positive pressure control. The flow of 
air has to be from clean towards dirty areas. A latest study by Tang et al. (2011) has nicely 
observed the role of airflow patterns and movement of suspended material in infection 
control of aerosol and airborne transmitted diseases employing different techniques. This 
understanding would be very beneficial in understanding aerosol and airborne infection 
transmission through precise airflow visualization techniques and in turn developing 
modalities for preventing them. 
Among many sources responsible for nosocomial infections, hospital water is a controllable 
but overlooked source. Many pathogens can survive in hospital water supply, transfer 
antibiotic resistance and have been implicated in numerous outbreaks (Anaissie et al., 2002). 
Proper guidelines for the monitoring and prevention of hospital water borne infections are 
still limited. Legionella pneumophila, pathogenic mycobacteria, parasites and viruses have 
been implicated in hospital water borne diseases. In the recent years, pathogenic fungi and 
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molds have been increasingly reported (Falvey & Streifel, 2007; Garner & Machin, 2008) thus 
mounting the need to formulate guidelines for the monitoring of hospital water sources 
(Hayette et al., 2010). Avoidance of hospital tap water, routine and targeted surveillance 
cultures of water sources, and hospital staff and patients education are major measures to 
control water associated nosocomial infections. Marchesi et al. (2011) employed 
hyperchlorination, thermal shock, chlorine dioxide, monochloramine, boilers and point-of-
use filters to control Legionella spp. in hospital water supply.  
The make of surfaces of hospital items does affect the contamination chances. Copper-
containing items tend to reduce the number of microbial surface contamination in hospital 
environments (Casey et al., 2010). The antimicrobial activity of copper-containing surfaces 
has been demonstrated to be far more effectual as it decreases the biodurden to a far 
greater amount as compared to the standard materials (Marias et al., 2010). The routine 
cleaning of these surfaces, however, is mandatory and the make of surfaces act as 
additional factors against HAIs. 
Central venous catheters are justifiably used in the ICUs whereas reverse is true for non-ICU 
settings and even for prolonged periods facilitating infections. There is a dire need to 
prevent infections associated with CVCs and short-term indwelling catheters. Measures 
should be targeted at insertion time with judicious usage of CVCs in these settings as part of 
strategy to reduce HAIs (Zingg et al., 2011).  
5.1.4 Control of multidrug resistant organism 
Multidrug resistant (MDR) organisms in hospital settings add further impetus to the status 
of HAIs. Empirical use of costly and broad spectrum antibiotics against these organisms 
further augments their resistance potential. For example, it is much more difficult to treat 
ventilator associated pneumonia due to MDR Acinetobacter baumannii in an ICU than a 
sensitive strain. A multicentric study showed that bacteremia caused by MRSA strain is 
associated with higher mortality and prolong hospital stay than caused by methicillin 
sensitive strain (Cosgrove et al., 2003). 
During the past decade, MDR organisms have emerged at an alarming level especially in 
intensive care units. In these settings, MRSA infections have been dominant with 60% of all 
the staphylococcal infections followed by VRE, 20% of all the enterococcal infections; while 
31% of the enterobacter infections were caused by third generation cephalosporin resistant 
strains (CDC, 2004). Surveillance data in the USA showed that MRSA accounts for 64% of 
the invasive nosocomial infections due to S. aureus. Various studies have shown that the 
data of frequency of MDR organisms outside the ICUs is almost similar (Loeb et al., 2003; 
Trick et al., 2001). Matenez-Capolino et al. (2010) showed that active surveillance cultures 
with contact precautions augmenting the standard measures could help reducing 
nosocomial MRSA in healthcare settings.  
Strict implementation of HIC guidelines is recommended to prevent the transmission of 
MDR organisms in hospital environments including: 
 Contact precautions, isolation of infected/colonized patients and use of PPE. 
 Active surveillance cultures to identify the persons colonized with resistant organisms 
including HCWs. 
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 Stringently following standard precautions and hand hygiene. 
 Cohorting of patients infected or colonized with MDR organisms. 
Nasal carriage of MRSA by the patients as well as staff remains an important source for 
infection. Many remedies have been tested for nasal elimination of MRSA including local 
2% mupirocin application which has lead to emergence of resistant strains. Polyhexanide, a 
widely used antiseptic, has been shown to be an effective alternate to mupirocin in 
elimination of nasal MRSA especially mupirocin-resistant strains (Madeo, 2010). 
5.1.5 Surveillance 
Surveillance comprises continuing systematic collection, analysis, interpretation and 
dissemination of data pertaining to health related events to be utilized for improving the 
health system (CDC, 2001). It is a vital component in HIC chain for avoidance and early 
detection of outbreaks and in turn prompt response as well as determining the need and 
measuring outcome of actions already adopted (NAO, 2000). Surveillance can be localized 
or targeted such as to see ventilator associated pneumonia in an ICU or generalized such as 
to measure infection rate in a hospital. Financial restraints of a hospital are very important 
to determine the type of surveillance performed. With transformation in healthcare delivery 
system and advancement in more friendly electronic tools, surveillance methods will 
continue progression and facilitate effective infection control measures (CDC, 2007). 
Staff working in hospital environments has to be protected from catching infections from 
patients. There should be a regular health surveillance system, ideally part of occupational 
health services within the setup. The department should address the needs of HCWs 
especially regarding relevant vaccination status and any accidental exposure, maintaining 
proper and timely health records, and requisite guidance and training. 
5.1.6 Hospital antibiotic policy 
Injudicious use of antibiotics especially in hospital settings is a major factor in the 
development of drug resistant organisms. Each hospital must have its own antibiotic policy 
based upon the culture and sensitivity results that should be regularly reviewed. Overuse 
and misuse of antibiotics exerts a selective pressure on bacteria thus resulting in emergence 
of drug resistance. If possible, usage of newer and costly antibiotics should be restricted to 
minimum and prescribed only for serious conditions or non-availability of alternate choice 
in order to prevent the emergence of resistance (Ferguson, 2004). In the recent years, 
attention has been directed to a greater extent towards prevention through immunization 
and HIC steps as substitute to reduce the prescription of antibiotics.  
Many studies have shown that rational use of antibiotics alone can significantly reduce 
emergence of drug resistance (Landman et al., 1999; McNulty et al., 1997; Quale et al., 1996; 
Saurina et al., 2000). In order to reduce emergence of MDR organisms, certain measures 
should be considered while prescribing antibiotics such as: 
 Clinical condition of the patient should be carefully assessed before prescribing any 
antibiotic. 
 Requisite culture and sensitivity results for targeted therapy except in serious 
infections. 
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 Substandard drugs, frequent problem in developing countries, should be prohibited. 
 Truly infecting organisms should be treated, not colonizers or contaminants. 
 Empirical therapy must be advised in the light of existing local susceptibility pattern. 
 Combination therapy should be considered in indicated cases. 
 Appropriate antibiotic, preferably narrow spectrum, should be advised in precise dose 
for proper duration. 
 Measures must be instilled for ensuring awareness regarding hospital antibiotic policy. 
5.1.7 Sterilization and disinfection practices 
Hospital sterilization and disinfection policy is crucial and basic component of infection 
control system. All invasive procedures require direct contact between patient’s skin or 
mucous membrane and medical devices thus carrying a risk of direct transfer of pathogenic 
organisms. Various steps required to reduce infection rate in hospitals by effective 
sterilization and disinfection policy include an efficient and dependable team, assessment 
and implementation of ongoing disinfection policies, adequate staff training and regular 
audits (Coates and Hutchinson, 1994).  
The level of sterilization and disinfection depends on the risk assessment: critical items such 
as surgical instruments for direct tissue contact require sterilization while semi critical items 
such as colonoscope with mucous membrane contact and non critical items such as 
stethoscope with intact skin contact require high level and low level disinfection 
respectively (Dancer, 2009). Failure to strictly comply with these policies can lead to 
outbreaks and transmission of pathogenic organisms such as Mycobacterium tuberculosis 
from one person to another through medical or surgical devices such as contaminated 
endoscopes (CDC, 1998; Garner and Favero, 1986; Uttley and Simpson, 1994).  
Spaulding’s devised compact and effective scheme for sterilization and disinfection is still in 
practice with certain modifications (Weber et al., 2002). Critical items can be purchased as 
sterile or disposable or treated with steam. Heat sensitive instruments can be sterilized by 
ethylene oxide, hydrogen peroxide gas plasma sterilization or by liquid sterilents if other 
methods are not appropriate. One of the disadvantages of liquid sterilents is that the devices 
cannot be wrapped during processing leading to difficulty in maintaining sterilization after 
processing and during storage.  
In case of semi critical items such as endoscope, colonoscope, respiratory therapy 
equipment, devices should be free of all the pathogenic organisms with exception of small 
numbers of bacterial spores. These items require high level disinfection with chemical 
disinfectants such as glutaraldehyde, hydrogen peroxide, ortho-phthalaldehyde, peracetic 
acid with hydrogen peroxide, and chlorine. After disinfection, these items should be 
thoroughly rinsed with sterile water and allowed to dry thus reducing the chances of 
contamination by eliminating the wet environment favourable for bacterial growth 
(Garner and Favero, 1986; Spaulding, 1968). Non critical items such as stethoscope, 
bedpans, bed rails, blood pressure cuff, furniture and floors do not require sterilization or 
high level disinfection as they come in contact with the intact skin. They do not require 
separate processing unit and can be disinfected at the same place. There is no documented 
report of a non critical item causing direct transmission of an infectious agent to patients 
(CDC, 2003). However, they can contribute to secondary transmission mode by 
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contaminating the hands of HCWs and subsequently to the patients. Quaternary 
ammonium compounds, chlorine based compounds and phenols are some of the 
commonly used low level disinfectants.  
As skin antiseptics prior to venous puncture, alcoholic products appear to be better than 
non-alcoholic solutions (Caldeira et al., 2011). Spores of C. difficile can contaminate the 
healthcare settings and require use of appropriate disinfectant. Many available disinfectants 
like alcohol-containing gels, detergents and quaternary ammonium compounds are 
ineffective against C. difficile spores. Chlorine releasing agents are reliable for its control but 
with limitations under dirty conditions (Fraise, 2011).  
The importance of sporicidal disinfectants can never be undervalued especially under the 
present circumstances. Commercially available sporicides have to be evaluated through 
testing standards. Although a number of such standards are available in Europe, these have 
limitations such as prolonged application time and do not involve surface contamination. 
Organization for Economic Cooperation & Development is presently preparing a more 
realistic set of standards (Humphreys, 2011).  
5.1.8 Hospital waste management 
Proper disposal of hospital waste is the last requisite in the chain of an effective HIC system. 
The hospital waste is a threat not only for the patients and the concerned staff but also to 
public health and environment (Singh & Sharma, 1996). It is a bit neglected part in the 
developing countries leading to spread of infectious diseases like hepatitis B, hepatitis C.  
Hospital waste includes all types of waste generated in a healthcare facility including 
laboratories. The infectious waste comprises pathological, isolation, laboratory, surgical, 
autopsy and animal waste, human blood and blood products and contaminated sharps. 
Others include chemical, genotoxic and radioactive waste. Sharps contaminated with blood 
are the major risk factors for infection transmission (WHO, 2002). 
Calculation of infectious waste output is obligatory for each healthcare setting so as to 
streamline the final disposal. Studies have shown that in the US, the rate of average waste 
production is 5.9 to 10.4 kg/bed/day while in Western Europe it is around 3-6 kg/bed/day 
(Brunner, 1986; Halbawach, 1994). Disposal of this infectious waste remains intricate and 
expensive with special concerns like environmental hazards related to incineration. As such, 
infectious waste reduction leads to cost reduction (Daschner, 1991). 
Various components of hospital waste management include: collection of waste by defined 
persons, segregation/sorting of waste, transportation, storage and disposal. 
5.1.8.1 Principles of waste management 
 Dedicated hospital waste management committee is a prerequisite. 
 Suitable waste management plan based on risks and types of waste generated. 
 Waste minimization is an imperative aspect to be highlighted to HCWs. 
 Color coded bags must be utilized according to the type of waste. 
 Waste to be transported in trolleys or carts and stored at specified restricted places. 
 Sharps should be stored in proper boxes with biohazard sign. 
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 Substandard drugs, frequent problem in developing countries, should be prohibited. 
 Truly infecting organisms should be treated, not colonizers or contaminants. 
 Empirical therapy must be advised in the light of existing local susceptibility pattern. 
 Combination therapy should be considered in indicated cases. 
 Appropriate antibiotic, preferably narrow spectrum, should be advised in precise dose 
for proper duration. 
 Measures must be instilled for ensuring awareness regarding hospital antibiotic policy. 
5.1.7 Sterilization and disinfection practices 
Hospital sterilization and disinfection policy is crucial and basic component of infection 
control system. All invasive procedures require direct contact between patient’s skin or 
mucous membrane and medical devices thus carrying a risk of direct transfer of pathogenic 
organisms. Various steps required to reduce infection rate in hospitals by effective 
sterilization and disinfection policy include an efficient and dependable team, assessment 
and implementation of ongoing disinfection policies, adequate staff training and regular 
audits (Coates and Hutchinson, 1994).  
The level of sterilization and disinfection depends on the risk assessment: critical items such 
as surgical instruments for direct tissue contact require sterilization while semi critical items 
such as colonoscope with mucous membrane contact and non critical items such as 
stethoscope with intact skin contact require high level and low level disinfection 
respectively (Dancer, 2009). Failure to strictly comply with these policies can lead to 
outbreaks and transmission of pathogenic organisms such as Mycobacterium tuberculosis 
from one person to another through medical or surgical devices such as contaminated 
endoscopes (CDC, 1998; Garner and Favero, 1986; Uttley and Simpson, 1994).  
Spaulding’s devised compact and effective scheme for sterilization and disinfection is still in 
practice with certain modifications (Weber et al., 2002). Critical items can be purchased as 
sterile or disposable or treated with steam. Heat sensitive instruments can be sterilized by 
ethylene oxide, hydrogen peroxide gas plasma sterilization or by liquid sterilents if other 
methods are not appropriate. One of the disadvantages of liquid sterilents is that the devices 
cannot be wrapped during processing leading to difficulty in maintaining sterilization after 
processing and during storage.  
In case of semi critical items such as endoscope, colonoscope, respiratory therapy 
equipment, devices should be free of all the pathogenic organisms with exception of small 
numbers of bacterial spores. These items require high level disinfection with chemical 
disinfectants such as glutaraldehyde, hydrogen peroxide, ortho-phthalaldehyde, peracetic 
acid with hydrogen peroxide, and chlorine. After disinfection, these items should be 
thoroughly rinsed with sterile water and allowed to dry thus reducing the chances of 
contamination by eliminating the wet environment favourable for bacterial growth 
(Garner and Favero, 1986; Spaulding, 1968). Non critical items such as stethoscope, 
bedpans, bed rails, blood pressure cuff, furniture and floors do not require sterilization or 
high level disinfection as they come in contact with the intact skin. They do not require 
separate processing unit and can be disinfected at the same place. There is no documented 
report of a non critical item causing direct transmission of an infectious agent to patients 
(CDC, 2003). However, they can contribute to secondary transmission mode by 
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contaminating the hands of HCWs and subsequently to the patients. Quaternary 
ammonium compounds, chlorine based compounds and phenols are some of the 
commonly used low level disinfectants.  
As skin antiseptics prior to venous puncture, alcoholic products appear to be better than 
non-alcoholic solutions (Caldeira et al., 2011). Spores of C. difficile can contaminate the 
healthcare settings and require use of appropriate disinfectant. Many available disinfectants 
like alcohol-containing gels, detergents and quaternary ammonium compounds are 
ineffective against C. difficile spores. Chlorine releasing agents are reliable for its control but 
with limitations under dirty conditions (Fraise, 2011).  
The importance of sporicidal disinfectants can never be undervalued especially under the 
present circumstances. Commercially available sporicides have to be evaluated through 
testing standards. Although a number of such standards are available in Europe, these have 
limitations such as prolonged application time and do not involve surface contamination. 
Organization for Economic Cooperation & Development is presently preparing a more 
realistic set of standards (Humphreys, 2011).  
5.1.8 Hospital waste management 
Proper disposal of hospital waste is the last requisite in the chain of an effective HIC system. 
The hospital waste is a threat not only for the patients and the concerned staff but also to 
public health and environment (Singh & Sharma, 1996). It is a bit neglected part in the 
developing countries leading to spread of infectious diseases like hepatitis B, hepatitis C.  
Hospital waste includes all types of waste generated in a healthcare facility including 
laboratories. The infectious waste comprises pathological, isolation, laboratory, surgical, 
autopsy and animal waste, human blood and blood products and contaminated sharps. 
Others include chemical, genotoxic and radioactive waste. Sharps contaminated with blood 
are the major risk factors for infection transmission (WHO, 2002). 
Calculation of infectious waste output is obligatory for each healthcare setting so as to 
streamline the final disposal. Studies have shown that in the US, the rate of average waste 
production is 5.9 to 10.4 kg/bed/day while in Western Europe it is around 3-6 kg/bed/day 
(Brunner, 1986; Halbawach, 1994). Disposal of this infectious waste remains intricate and 
expensive with special concerns like environmental hazards related to incineration. As such, 
infectious waste reduction leads to cost reduction (Daschner, 1991). 
Various components of hospital waste management include: collection of waste by defined 
persons, segregation/sorting of waste, transportation, storage and disposal. 
5.1.8.1 Principles of waste management 
 Dedicated hospital waste management committee is a prerequisite. 
 Suitable waste management plan based on risks and types of waste generated. 
 Waste minimization is an imperative aspect to be highlighted to HCWs. 
 Color coded bags must be utilized according to the type of waste. 
 Waste to be transported in trolleys or carts and stored at specified restricted places. 
 Sharps should be stored in proper boxes with biohazard sign. 
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 Sharps should be first autoclaved and then buried in a secured area after compaction. 
Animal carcasses and anatomical waste should be incinerated while radioactive waste 
should be dealt according to the national laws. 
5.1.9 Education and training 
Awareness of the HCWs has to be ensured and updated in the form of regular educative 
and training activities. Not only that, patients and their relatives have also to be imparted 
awareness regarding infection control measures in order to break the transmission chain. 
Healthcare infection control should be a mandatory component of training at postgraduate 
and undergraduate level for HCWs and also imparted to all others coming in contact with 
patients or medical equipment (CDC, 2007). 
6. International efforts 
Determined efforts and concern for HAI control at the international level especially by the 
WHO have to be acknowledged. The material available at the WHO website provides plenty 
of guidance in this respect. The material can easily be downloaded and utilized in preparing 
local policies. The global involvement in raising awareness about hand hygiene has been 
commendable. Similarly, assistance can be sought through abundant valuable information 
provided by the CDC website. These are truly helpful for the developing world. 
Regular live and archived lectures are available through courtesy of Webber Training Inc 
(www.webbertraining.com). These have ample latest information that can provide guidance 
to the HCWs especially concerned with infection control. 
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1. Introduction 
Health care associated infections are infections that patients acquire, while they are in 
contact with the healthcare system. Contact includes all procedures associated with 
diagnostics, treatment, care, and rehabilitation. Health care associated infections were 
formerly called hospital or nosocomial infections. Hospitals still account for the vast 
majority of cases; however, for practical reasons the concept has been widened to comprise 
infections in all parts of the health care system, because a growing part of disease 
management takes place outside hospitals, e.g. in out patient clinics, nursing homes and 
general practice. The spectrum of health care associated infections ranges from simple 
common colds to life threatening sepsis with multidrug resistant organisms. With the above 
definition, around 10 % of patients on average will become infected while they are in contact 
with the health care system. Health care associated infections also include occupational 
infectious diseases acquired by health care workers. 
Health care associated infections are determined by a number of risk factors related to the 
patients themselves, the procedures they are exposed to, the organisms that cause disease, 
and buildings and rooms where treatment takes place (Fig. 1). Patients have an increased 
susceptibility to infection because they are weakened by disease, and in addition often 
elderly. Old age weakens the immune system and the function of vital organs. Lifestyle 
factors such as poor quality food, lack of exercise, and tobacco and alcohol abuse also play a 
role. Invasive procedures, like surgery and insertion of catheters break down the natural 
barriers of skin and mucous membranes and thereby predispose for health care associated 
infections. Cytostatics and other immunosuppressive agents also enhance the risk of 
infection, and the same applies to broad spectrum antibiotics through their impact on the 
patients’ endogenous microbial flora. Hospital bacteria may have an enhanced potential for 
producing health care associated infections. A high consumption of broad spectrum 
antibiotics selects for multi-drug resistant organisms, which spread in hospitals despite 
infection control measures. Their spread may be favoured by genetic links between 
antibiotic resistance and virulence factors such as adhesion to cell surfaces (Di Martino et al 
1997) and medical devices. Building facilities also play a role. Overcrowding and lack of 
facilities for isolation of contagious patients predispose for health care associated infections. 
Reduction of domestic cleaning leads to accumulation of pathogens on contact surfaces, 
which may subsequently be transmitted to patients. 
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Fig. 1. Factors determining health care associated infections. 
This aim of this paper is to give a comprehensive survey of the more important sources of 
health care associated infections and the way they are spread in the health care setting. The 
source of infection may be the patient’s own microbial flora (self-infection), or organisms 
from other patients, hospital staff, and the hospital environment (cross-infection). 
Transmission may take place by direct or indirect contact, by the airborne route, or through 
a vehicle (e.g. water, food and drugs). Airborne transmission may take place by large 
particle droplets, by small particle droplets (droplet nuclei), and by dust. Table 1 
summarizes the sources and modes of transmission, clarified by examples of risk factors and 
the types of infections they give rise to. A more detailed description of the single elements is 
given in the paragraphs below. 
2. Self-infection 
Patients may acquire health care associated infections from organisms belonging to their 
own normal flora on skin and mucous membranes. This colonizing flora may become 
invasive after break-down of natural barriers following surgery and insertion of catheters. 
The most important organisms are Staphylococcus aureus and Escherichia coli. Treatment with 
broad spectrum antibiotics may destroy the susceptible part of the endogenous flora, and 
instead patients become colonized with more resistant species originating from other 
patients or from the hospital environment. Examples of such resistant organisms are 
methicillin-resistant coagulase-negative staphylococci, ampicillin-resistant enterococci, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. This new 
colonizing flora may eventually give rise to infection. 
 




infection Modes of transmission Examples of risk factors Examples of infections 
Self-infection 
Break of natural barriers 
(skin and mucous 
membranes) 
Surgery. 
Insertion of peripheral or 
central line catheters.  
Staphylococcus aureus carriage
Surgical site infections 
& catheter related 
infections due to 
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colonizing flora may eventually give rise to infection. 
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2.1 Staphylococcus aureus carriage 
About 25 % of the normal population are chronic carriers of Staphylococcus aureus, and the 
carriage rate is even higher – around 50 % - in insulin dependent diabetics, dialysis patients, 
and intravenous drug addicts (Kluytmans et al 1997). The primary carriage sites are nostrils 
and throat, from where the organism is spread to the skin. Persons with a high 
concentration of Staphylococcus aureus in their nostrils have a three to six times higher risk of 
acquiring surgical wound infections, as compared to non carriers or persons with only a low 
concentration (Bode et al 2010). The same applies to catheter related infections in dialysis 
patients and patients with long term indwelling intravenous catheters. The pathogenesis is 
only partly understood, but it probably plays a role that most nasal carriers are at the same 
time skin carriers. Prospective studies have shown that more than 80 % of all Staphylococcus 
aureus blood stream infections are of endogenous origin (von Eiff et al 2001). As to surgical 
site infections the origin of Staphylococcus aureus is less well described; however, it is 
estimated that at least 50 % are due to self-infection (Perl et al 2002). The evidence for a 
causative relationship between Staphylococcus aureus carriage and risk of surgical wound 
infection is proved by the fact that preoperative eradication of Staphylococcus aureus carriage 
leads to a substantial reduction in surgical site infections (Bode et al 2010). 
2.2 Gram-negative bacilli 
Escherichia coli and other intestinal organisms may give rise to ascending urinary tract 
infections in patients with indwelling urinary catheters (Tambyah et al 1999) and to wound 
infections following abdominal surgery. Enterobacteria may also colonize the airways of 
critically ill patients and give rise to ventilator associated pneumonia. In healthy individuals 
the throat flora is dominated by Gram-positive bacteria, which adhere to cell surfaces by 
surface molecules such as fibronectin. However, in critically ill patients throat epithelial cells 
often lose their fibronectin-binding surface molecules and thereby their capacity to bind 
Gram-positive bacteria. This paves the road for colonization with enterobacteria and other 
Gram-negative bacilli (Woods 1987). 
Ventilator associated pneumonia is often due to silent aspiration of bacteria-bearing 
secretions from the upper airways, which leak down along the outer side of the 
endotracheal tube. The aspirated material may also originate from the stomach, which has 
been colonized with intestinal flora following prophylactic treatment with antacids (Safdar 
et al 2005). The role of aspiration in ventilator associated pneumonia is the major rationale 
for using selective decontamination of the oropharynx and digestive tract to prevent such 
cases (Van Saene et al 2003) 
3. Cross infection  
The most important route of transmission of organisms from patient to patient is by 
indirect contact via staff’s hands because hand hygiene is neglected or performed 
inadequately (Fig. 2). Transmission may also occur by direct contact between patients or 
by the airborne route, if they are placed on the same ward.  
Staff is not the only factor involved in cross transmission. It may also occur via the 
environment by contact with surfaces that have been contaminated with organisms from 
other patients (fomites). This will be discussed in a separate paragraph below. Finally, cross 
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transmission may occur via equipment and utensils that have not been decontaminated 
adequately before being reused, and through drugs and blood products. These aspects will 
also be covered in separate paragraphs below.  
   
Fig. 2. The quality of hand hygiene may be visualised with fluorescent alcohol in an 
ultraviolet light box. Studies have shown that even experienced staff may have a low 
technical performance (Kolmos et al 2006). Right-hand persons often miss the back of their 
right hand and fingers, as illustrated on the photo to the right (courtesy: Infection Control 
Team, Odense University Hospital). 
3.1 Cross transmission by health care workers’ hands 
The importance of cross transmission by health care workers’ hands has been documented in a 
large number of studies (Pittet et al 2006). Wearing rings increases the level of skin 
contamination by a factor ten (Trick et al 2003). Artificial nails are also associated with 
increased levels of pathogens on hands (McNeil et al 2001). Pathogens are transmitted to 
health care workers’ hands during contact with patients and their body secretions, and during 
contact with touch sites in the environment that have been contaminated with pathogens 
released from patients (Fig. 3). Hands become progressively contaminated during patient care: 
the longer the duration of care, the higher the level of contamination. Skin contact, diaper 
change, and respiratory care are associated with particularly high levels of transmission 
(Pessoa-Silva et al 2004). Most pathogens from patients can survive for sufficient time on 
health care workers’ hands to be transmitted to other patients in a busy hospital setting. 
Organisms tolerant to desiccation form a particular problem. Examples of such agents are 
Staphylococcus aureus and other staphylococci, enterococci, Clostridium difficile, Acinetobacter 
baumannii and naked viruses such as noro- and rotavirus. However, organisms adapted to 
moist environments are also readily transmissible. Examples of such agents are Escherichia coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, and more fragile viruses such as influenza virus 
and respiratory syncytial virus (RSV). Gloves offer some protection, but do not fully protect 
health care workers’ hands from contamination. Model calculations indicate that they only 
halve skin contamination in connection with heavily contaminated procedures such as 
respiratory care and diaper change (Pessoa-Silva et al 2004).  
The role of health care workers’ hands in cross transmission of organisms is best illustrated 
by the ability of hand hygiene campaigns to reduce health care associated infections. A 
striking example is the study by Pittet and coworkers, where a hospital-wide hygiene 
campaign with emphasis on alcoholic hand rub led to a sustained increase in hand hygiene 
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compliance and a reduction in hospital acquired infections by more than 40 %. Transmission 







Touch sites in the
hospital environment
 
Fig. 3. Interactions between health care workers’ hands and touch sites in the hospital 
environment on transmission of pathogens from one patient to another. 
3.2 The role of airborne transmission 
Many respiratory pathogens are transmitted from patient to patient by the airborne route. 
The large majority are carried by large droplets. This applies particularly to RSV, influenza 
and common cold viruses, and to bacteria like pneumococci, meningococci and haemolytic 
streptococci. Large droplets settle rapidly, and these organisms are therefore only directly 
transmissible within a distance of 1 or 2 metres from the infected patient. However, more 
importantly these organisms can also be transmitted by indirect contact, particularly with 
staff’s hands, if hand hygiene is neglected between patient contacts. Transmission may also 
take place after contact with contaminated surfaces close to an infected patient (fomites). 
This has been clearly documented with RSV (Hall 2000), but probably also applies to the 
other respiratory pathogens mentioned above. Measles, rubella and varicella-zoster virus 
are mainly spread by droplet nuclei, which can keep airborne for long time and therefore be 
transmitted over long distances (Tang et al 2006, Roy & Milton 2004).  
Laboratory studies indicate that Mycobacterium tuberculosis can be transmitted by droplet 
nuclei; however the clinical significance of this remains controversial (Fennelly et al 2004, 
Nardell 2004). Transmission by large droplets plays a much larger role. Furthermore, 
Mycobacterium tuberculosis can survive for long time in dust and dried up secretions, which 
implies that it also has a potential for transmission by fomites. 
The mode of transmission of influenza virus is still controversial. Most clinical studies point to 
transmission by contact and airborne transmission by large droplets; however, airborne 
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transmission by droplet nuclei also seems to play a role. This is particularly the case with 
influenza pneumonitis, which is associated with the generation of droplet nuclei (Brankston et 
al 2007, Tellier 2006). Tracheal suctions and endotracheal intubation give rise the formation of 
aerosols, which may pose a risk to health care workers involved with these procedures.  
4. Health care workers as a source of health care associated infections 
As illustrated above health care workers play a key role in transmitting organisms from one 
patient to another. However, they may also be a source of infection themselves, if they are 
colonized or infected with pathogens which they pass on to patients. This applies 
particularly to Staphylococcus aureus, including MRSA, haemolytic streptococci (Streptococcus 
pyogenes), and to influenza A and hepatitis B viruses.  
4.1 Staphylococcus aureus 
At least 25 % of all staff are permanent carriers of Staphylococcus aureus in their nostrils. 
From here the organism is spread to skin and hands. Special attention has been paid to 
carriers of MRSA, however, ordinary susceptible staphylococci are equally transmissible. As 
a rule the risk of transmitting Staphylococcus aureus from asymptomatic nasal carriers is low, 
provided that they perform proper hand hygiene before contact with patients. However, the 
risk may rise dramatically with sneezing, if they catch a common cold or suffer from a burst 
of hay fever. Rhinorrhoea and sneezing transforms a staphylococcal carrier into a 
staphylococcal disperser (Sherertz et al 2001, Bassetti et al 2005, Bischoff et al 2006). It is 
often referred to as the cloud phenomenon, indicating that the carrier is virtually 
surrounded by a cloud of staphylococci, when sneezing. Bacteria expelled by sneezing are 
usually carried on large droplets that will settle within a distance of 1-2 metres. Thus 
staphylococci from a carrier will not spread airborne over long distances; however, the 
organisms may settle on surfaces and act as fomites, which can be transmitted to patients by 
contact, if surfaces are not properly cleaned (Kramer et al 2006). Staphylococcal carriers with 
scaling skin diseases may also shed large amounts of organisms to the environment.  
4.2 Streptococcus pyogenes 
Haemolytic streptococci (Streptococcus pyogenes) can be contagious with an extremely low 
inoculum. Surgical staff and staff attending wounds may be a source of severe surgical wound 
infections and puerperal fever, if they are carriers of Streptococcus pyogenes . Several outbreaks 
have been reported that could be traced to a carrier (Kolmos et al 1997). Approximately 5 % of 
the normal population are healthy throat carriers. This may involve a risk of transmission, 
particularly in relation to a common cold (cloud phenomenon, see above). However, more 
remarkably vaginal and anal carriage also seems to involve a high risk during surgery. Anal 
carriage may be seen in relation to minor disorders such as haemorrhoids and fissures; vaginal 
carriage is probably secondary to anal carriage. The mode of transmission from anal and 
vaginal carriers during surgery is not fully understood; however, the fact that carriers have 
given rise to outbreaks even without being close to patients in the operating theatre suggests 
that airborne transmission plays a role. Two cases of surgical wound sepsis due to 
Streptococcus pyogenes arising close to each other shortly after surgery is an alarm signal that 
should lead to considerations about a carrier among the surgical staff.  
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4.3 Influenza and other respiratory tract infections 
Health care workers are considered the main source of nosocomial influenza (Salgado et al 
2002). The primary reason is that they meet on work with symptoms that are interpreted as 
a common cold, but are in fact influenza. Half of all cases of influenza A virus infection do 
not give rise to classical flu symptoms, but are subclinical or present with ordinary cold 
symptoms. The role of staff in the transmission of nosocomial influenza was highlighted in a 
Scottish study where vaccination of the staff led to a substantial decrease in mortality among 
residents in long-term care facilities over a winter season (Carman et al 2000). Staff in 
pediatric units may also transmit Bordetella pertussis (whooping cough) and RSV, which 
frequently give rise to re-infections with uncharacteristic cold symptoms in adulthood 
(Sherertz et al 2001, Singh & Lingappan 2006, Hall et al 2001).  
4.4 Blood borne viruses 
Transmission of hepatitis B virus (HBV) to patients by infected surgeons has been reported 
in several studies. Transmission presumably takes place during surgery where the operating 
field is exposed to blood from the surgeon in connection with needle sticks and other skin 
injuries. Clusters of cases have primarily been seen with surgeons, whose serum contained 
hepatitis B e antigen (HBeAg), which is associated with particularly high concentrations of 
circulating virus and therefore great infectivity; however, HBeAg negative surgeons have 
also infected patients (The Incident Investigation Teams and Others 1997). Surgeons may 
also transmit hepatitis C virus and HIV (Heptonstall 2000). 
5. Cross transmission by medical devices 
Instruments and utensils may transmit pathogens if they are not decontaminated properly 
after patient use. The transmitted pathogens may originate from other patients, or from 
sources in the hospital environment. Overall, these problems have been declining over the 
past decades due to the introduction of more single-use equipment and safer and more 
efficient disinfecting techniques for multiple-use equipment. One of the more important 
improvements is the introduction of ward based automatic washing machines with heat 
disinfection programmes, which have replaced older and less safe techniques based on the 
use of chemical disinfectants. However, in recent years new challenges have arisen with the 
introduction of fragile and sophisticated equipment, which cannot be heat sterilized.  
5.1 Fibre-optic endoscopes 
Fibre-optic endoscopes are an example of such heat sensitive equipment. Decontamination 
takes place by a combination of mechanical cleansing with an enzymatic cleaner and 
chemical disinfection with a high level disinfectant, such as peracetic acid or glutaraldehyde 
(Rutala & Weber 2004). The process may be performed manually, but usually takes place in 
an automatic disinfector (Fig. 4). Bronchoscopes are the medical devices that most 
commonly give rise to hygienic problems. Numerous outbreaks and pseudo-outbreaks due 
to the use of contaminated bronchoscopes have been reported, both with person-to-person 
transmission of pathogens (e.g. Mycobacterium tuberculosis), and transmission of pathogens 
from the environment (e.g. Mycobacterium chelonae and Pseudomonas aeruginosa). 
Contamination has been associated with breaches in technique both in the bronchoscopes 
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and the disinfecting machines used for reprocessing (Weber & Rutala 2001, Srinivasan et al 
2003). By contrast, transmission of infection has only been recognized in very few cases with 
endoscopes used in gastrointestinal endoscopy (Nelson & Muscarella 2006).  
The sterility safety of surgical instruments is extremely high, given that they are reprocessed 
and sterilized under well controlled conditions in an autoclave. However, one matter of 
concern is the emergence new prion-related disorders, like variant Creutzfeldt-Jakob disease 
(CJD), since this type of prion protein is not fully inactivated by traditional autoclaving. 
Instruments that have been in contact with brain, spinal cord, eye tissues, lymph nodes, 
spleen, and terminal ileum pose a special risk for transmitting variant CJD (Sutton et al 2006). 
 
Fig. 4. Damaged rubber gasket in a poorly maintained disinfector used for reprocessing 
endoscopes. Formation of biofilm in the disinfector resulted in a pseudo-outbreak of 
Mycobacterium gordonae among patients undergoing bronchoscopy with bronchoscopes 
reprocessed in the disinfector (Courtesy: Infection Control Team, Odense University Hospital). 
6. Infections transmitted through a vehicle  
Transmission of organisms from other patients or from the environment may take place 
through a vehicle, e.g. water, food, drugs, and donor blood.  
6.1 Tap water 
Tap water in most hospitals is colonized with Legionella pneumophila, which may give rise to 
pneumonia and other severe manifestations in immunocompromised patients, such as 
organ transplant recipients. Patients with impaired throat reflexes and intubated patients 
are other important risk groups. The most important mode of transmission is by silent 
aspiration of contaminated secretions from the oral cavity (Sabria & Yu 2002). 
Contamination of the oral cavity may occur with drinks or ice cubes made from tap water, 
or with tap water used for oral hygiene. Thus, transmission of Legionella in hospitals differs 
significantly from transmission outside the health care setting, where transmission usually 
takes place through inhalation of aerosols from contaminated air condition facilities. It is 
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and the disinfecting machines used for reprocessing (Weber & Rutala 2001, Srinivasan et al 
2003). By contrast, transmission of infection has only been recognized in very few cases with 
endoscopes used in gastrointestinal endoscopy (Nelson & Muscarella 2006).  
The sterility safety of surgical instruments is extremely high, given that they are reprocessed 
and sterilized under well controlled conditions in an autoclave. However, one matter of 
concern is the emergence new prion-related disorders, like variant Creutzfeldt-Jakob disease 
(CJD), since this type of prion protein is not fully inactivated by traditional autoclaving. 
Instruments that have been in contact with brain, spinal cord, eye tissues, lymph nodes, 
spleen, and terminal ileum pose a special risk for transmitting variant CJD (Sutton et al 2006). 
 
Fig. 4. Damaged rubber gasket in a poorly maintained disinfector used for reprocessing 
endoscopes. Formation of biofilm in the disinfector resulted in a pseudo-outbreak of 
Mycobacterium gordonae among patients undergoing bronchoscopy with bronchoscopes 
reprocessed in the disinfector (Courtesy: Infection Control Team, Odense University Hospital). 
6. Infections transmitted through a vehicle  
Transmission of organisms from other patients or from the environment may take place 
through a vehicle, e.g. water, food, drugs, and donor blood.  
6.1 Tap water 
Tap water in most hospitals is colonized with Legionella pneumophila, which may give rise to 
pneumonia and other severe manifestations in immunocompromised patients, such as 
organ transplant recipients. Patients with impaired throat reflexes and intubated patients 
are other important risk groups. The most important mode of transmission is by silent 
aspiration of contaminated secretions from the oral cavity (Sabria & Yu 2002). 
Contamination of the oral cavity may occur with drinks or ice cubes made from tap water, 
or with tap water used for oral hygiene. Thus, transmission of Legionella in hospitals differs 
significantly from transmission outside the health care setting, where transmission usually 
takes place through inhalation of aerosols from contaminated air condition facilities. It is 
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often assumed that showering plays a role in transmission of Legionella in hospitals, but 
there is little evidence that this is actually the case (Sabria & Yu 2002). 
Contaminated tap water may give rise to wound infections, if used for cleansing wounds. This 
was for instance the case in an outbreak of Pseudomonas aeruginosa infections in a burns unit, 
where tap water was used for irrigation of burns as part of the first aid treatment, which 
patients received when entering the hospital. Contamination was restricted to the showers and 
plastic tubing, which were permanently connected to the taps. This led to stagnant water 
inside the tubings and heavy contamination due to biofilm formation. Water sampled directly 
from the taps of the metal pipes was not contaminated, and the outbreak stopped, when 
plastic tubings and showers were dismantled and disinfected (Kolmos et al 1993). 
6.2 Food 
Virtually any food pathogen that occurs in the community can give rise to food borne 
infections in the health care setting. Much attention is being paid to zoonotic Salmonella 
enterica, which despite enhanced surveillance strategies still gives rise hospital outbreaks (Sion 
et al 2000, Guallar et al 2004). Outbreaks due to Listeria monocytogenes have also been reported 
(Johnsen et al 2010). A characteristic feature of food borne outbreaks due to these organisms is 
that they predominantly hit debilitated patients, who have a much higher attack rate than 
other patients. A major reason for this is that they develop infection with a lower inoculum 
than other exposed patients, who often stay asymptomatic and therefore go unnoticed. 
Debilitated patients may therefore be regarded as a sentinel population for recognition of food 
borne outbreaks, with symptomatic cases representing only the tip of the iceberg. 
Norovirus is another important pathogen, which may give rise to food borne outbreaks in the 
health care setting, affecting both patients and staff. The virus is extremely contagious, which 
implies that secondary cases often occur (Stevenson et al 1994). A food borne outbreak is 
therefore often a mix of food transmitted cases and secondary cases acquired by patient to 
patient transmission, which makes source identification more difficult.  
Buffets carry a risk of cross transmission, particularly if food is handled by self-service (Fone 
et al 1999). The same applies to ice produced by ward based ice machines (Ravn et al 1991). 
6.3 Intravenous drugs 
Despite efforts to improve safety, transmission of blood borne viruses through intravenous 
drugs is an ongoing problem.  
In recent years there have been reports on transmission of both hepatitis B and C viruses, as 
well as HIV (Fisker et al 2006, Wenzel & Edmond 2005, Katzenstein et al 1999). In the 
majority of cases the sources of infection were capped multi-dose vials used for medication 
of a series of patients. Virus may be spread to the vials by accidental reuse of hypodermic 
needles and syringes contaminated with virus after medication of infected patients. 
Alternatively, the rubber membrane of vials may become contaminated with blood aerosols 
if blood specimens are handled close by, and virus may be introduced by subsequent needle 
perforations, if the membrane is not disinfected properly. This was probably the case in a 
recent outbreak of hepatitis B virus infection in a paediatric oncology ward (Fig. 5). Due to 
crowding and lack of proper room facilities the ward’s preparation room was used for 
collecting blood samples, drying bone marrow smears and occasionally for blood sampling 
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and transfusions, and multi-dose vials in use were placed next to the disposal pot for used 
hypodermic needles and syringes (Fisker et al 2006). Similarly, a large outbreak of hepatitis 
C virus infection among haematology/oncology patients visiting an outpatient clinic could 
be traced back to shared saline bags. Contamination of the saline bags probably occurred 
because the syringe used for collection of blood specimens from the patient was reused to 
withdraw saline to flush the catheter after blood sampling (Macedo de Oliveira et al 2005).  
 
Fig. 5. Snapshot showing the preparation of an infusion with cytostatic agents in the 
preparation room of a paediatric oncology unit. To the right is the infusion line, rolled up on 
the table and connected to the infusion bag (hidden behind the nurse). To the left are several 
multi-dose vials with broken seals, containing drugs for preparation of the infusion. Between 
the infusion line and multi-dose vials is a bowl with a blood sample from a patient and 
disposal pots for hypodermic needles, syringes, and vials. This mingling of sterile procedures 
with handling of blood specimens and disposal of used needles gave rise to a large outbreak of 
hepatitis B (Fisker et al 2006) (Courtesy: Infection Control Team, Odense University Hospital). 
6.4 Donor blood and blood products 
Transfusion blood is not a sterile product. Donors may be silent carriers of blood borne 
viruses, like HBV, HCV, HIV, and HTLV, which may be transmitted to recipients of blood 
and blood products. Transmission of bacteria like Yersinia enterocolitica and protozoa like 
Plasmodium falciparum from apparently healthy donors has also been reported (Leclercq et al 
2005, Bihl et al 2007). Rigorous screening of donors and pathogen inactivation in blood 
components have minimized such cases; however, donor blood may still be contaminated as 
a result of management errors in the blood bank during collection, preparation, and storage 
of blood and blood products. Transfusion related bacteraemia may also arise from 
contaminated blood collection bags. This was the case in a nationwide outbreak of Serratia 
marcescens bacteraemia among transfusion recipients, which could be traced back to 
commercial blood collection bags contaminated at the production plant. Water used for 
cooling the bags upon autoclaving was the source of contamination (Heltberg et al 1993).  
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7. Hospital environment 
7.1 Cross infection from contaminated surfaces (fomites) 
Cross infection may take place by contact with contaminated surfaces (fomites) in the 
health care setting. Examples of contact surfaces are door handles, bed tables, chairs, toilet 
seats, and floors.  
Patients discharge large amounts of organisms to the hospital environment, particularly if 
they suffer from skin, wound, and respiratory tract infections, and from diarrhoea (Fig. 6). 
The discharged organisms settle with skin scales, droplets, and secretions on contact 
surfaces and accumulate in dust. From here they may be passed on to other patients, if they 
touch the contaminated surfaces. Health care workers also play a role in transmission if they 
touch contaminated surfaces and neglect hand hygiene before patient contact.  
Organisms that are tolerant to dessication have a particularly high potential for transmission in 
the health care setting, because they keep viable for long time in the environment after having 
been discharged from patients. Such organisms are Clostridium difficile, Staphylococcus aureus, 
Acinetobacter baumannii, Enterococcus faecium, and Mycobacterium tuberculosis. Yeasts, and naked 
viruses like norovirus can also survive for long time outside the human body. Until recently 
microbial contamination of the hospital environment was considered unimportant in regard to 
transmission of health care associated infections. However, this has changed with the 
emergence of new evidence indicating that cross transmission from the environment is in fact 
a common phenomenon that has to be taken into consideration (Dancer 2008, Dancer 2011). 
One way to illustrate a relationship between contamination of the hospital environment and 
health care associated infections is to study the risk of acquiring a specific pathogen, if a 
patient is admitted into a room that was previously occupied by a patient colonized or infected 
with the same pathogen. With this setup an increased risk of acquisition has been shown with 
Clostridium difficile, methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant 
Enterococcus (VRE), and Acinetobacter baumannii (Carling & Bartley 2010). The excess risk of 
acquiring MRSA and VRE was studied in a large multi-centre cohort study comprising more 
than 10,000 ICU patients, who underwent routine admission and weekly screenings for these 
two agents. The risk increased by 40 %, if patients were admitted into rooms previously 
occupied by patients harbouring MRSA or VRE (Huang et al 2006). A subsequent intervention 
study with focus on adherence to defined cleaning standards, including the use of a 
quaternary ammonium agent, reduced contamination with both organisms, and more 
importantly, it eliminated the excess risk of acquiring MRSA, whereas the risk of acquiring 
VRE remained largely unchanged (Datta et al 2011). This study confirms a previous report, 
where an outbreak of MRSA in a urological ward was contained successfully after intensifying 
domestic cleaning with special focus on dust removal and use of alcohol to disinfect contact 
surfaces (Rampling et al 2001). Similarly, the frequency of Clostridium difficile associated 
diarrhoea was reduced significantly in a number of wards, after the organism had been 
eliminated from the environment by hydrogen peroxide vapour (Boyce et al 2008).  
7.2 Dust from demolition and construction works 
Demolition and construction of buildings are ongoing processes in all big hospitals. Dust 
from building materials contains large amounts of spores of environmental fungi, which 
may pose a threat to heavily immunocompromised patients. (Hansen et al 2008). There are 
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numerous reports of outbreaks of severe fungal respiratory tract infections among 
haematology, oncology and organ transplant patients originationg from inhalation of 
contaminated dust that could be traced back to demolition and renovation works in the 
hospital setting. The fungi most frequently involved were Aspergillus fumigatus and 
Aspergillus flavus (Vonberg & Gastmeier 2006). 
 
Fig. 6. Methicillin resistant Staphylococcus aureus (MRSA) on a sedimentation plate exposed 
for 12 hours on an overbed table of a dermatitis patient colonized with MRSA (Courtesy: 
Infection Control Team, Odense University Hospital). 
8. Discussion 
Sources and transmission routes of health care associated infections are numerous and 
complex. In many cases they are only partly understood, and the hygienic measures taken 
to control transmission are not always ideal. In many areas there is a need for more 
research to clarify the epidemiology and pathogenesis of health care associated infections 
in order to develop and implement more efficient and targeted interventions. This 
research should focus not only on technical and biological aspects, but should also involve 
behavioural sciences, since human behaviour is one of the key factors in transmission of 
infections in the health care setting.  
Failure to perform hand hygiene is probably the single most important factor in 
transmission of health care associated infections. Taking into account the strength of 
evidence for the importance of hand hygiene, it is noteworthy that compliance is still so 
low. Several studies have documented that in daily clinical practice hand hygiene is 
hardly performed in more than half of the cases where it should, and only one third of 
those who perform hand hygiene do it correctly (Kolmos et al 2006). A major reason is 
probably that the complexity of hand hygiene is grossly underestimated. It is often taken 
for granted that everybody masters the technique; however, to clean hands requires in 
fact a systematic and elaborate washing technique, which has to be trained. Furthermore, 
the tools for hand hygiene are far from optimal. A nurse in an intensive care unit with 
seven patient contacts each hour will for instance have to spend nearly one hour a day 
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washing hands with soap and water, if the recommended procedure is to be followed 
(Voss & Widmer 1997). Apart from being time consuming, this may give rise to skin 
problems. Alcoholic hand rub is faster and more gentle to the skin, and even more 
importantly, much more efficient to kill pathogens. It can replace soap and water in most 
cases, provided that hands are not visibly dirty (Pittet et al 2000). However, there are 
important exceptions: spore-forming bacteria, like Clostridium difficile and naked viruses, 
like norovirus (Kampf et al 2005) are not very susceptible to alcohol, which implies that 
health care workers must stick to soap and water, when dealing with patients suffering 
from infections due to these pathogens. It appears from this that what at first glance looks 
simple is in fact a demanding clinical procedure, which requires background knowledge 
and has to be trained in the same systematic manner as e.g. the skills necessary for 
insertion of an i.v. line. Essentially, hand hygiene techniques have not changed very much 
over the past century. With today’s knowledge about the lack of compliance and quality 
with hand hygiene performance and the ability of some organisms to resist alcohol, there 
is a clear need for development of more efficient hand hygiene techniques that are 
universally applicable, and at the same time fast and user-friendly.  
For many years it has been a matter of discussion, whether transmission of pathogens from 
the hospital environment plays a significant role in acquisition and spread of health care 
associated infections. A major reason is lack of well designed studies to document this route 
of transmission, which may be attributed to the fact that cleaning until recently was not 
considered an issue worth investigating (Dancer 2008). From the 1970s and until recently 
cleaning was considered merely an aesthetic issue, and budgets were cut down by hospital 
management in order to meet the demands for resources in other parts of the health care 
system. This was endorsed even by infection control practitioners, partly because of the lack 
of evidence for its importance as an infection control measure, partly because they feared 
that focus on cleaning would draw attention away from more important measures, like 
hand hygiene. This attitude has gradually shifted with the emergence of new well designed 
studies highlighting the role of the environment in transmission of hospital acquired 
infections and the ability of disinfecting cleaning to reduce such cases (Boyce et al 2008, 
Dancer 2008, Datta et al 2011).  
Accumulating evidence suggests that there is a dynamic interaction between the hands of 
health care workers and the environment in transmitting organisms from one patient to 
another (Dancer 2008) (Fig. 3). The question whether focus should be put on hand hygiene 
or cleaning the hospital environment is no longer meaningful. It is not an either or, rather it 
is a both and. If cross transmission is to be controlled there is a need to develop new and 
more efficient methods both for hand hygiene and environmental decontamination. Current 
cleaning methods used in the health care setting are primarily designed to fulfil aesthetic 
purposes, and they do not remove organisms from touch sites in the environment to any 
significant degree (French et al 2004). Cleaning combined with liquid disinfectants, such as 
hypochlorite and quaternary ammonium agents reduces surface contamination with 
pathogens, like Clostridium difficile, MRSA, and VRE (Wilcox et al 2003, Datta et al 2011). 
However, occupational hazards and concern for the environment implies that they are not 
used in daily routine cleaning. Hydrogen peroxide fumigation is an efficient and attractive 
alternative from an environmental point of view (French et al 2004, Boyce et al 2008). However, 
it is not suited for daily routine cleaning either. Clearly there is a need for more user-friendly 
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methods that can be used in daily practice to decontaminate touch sites, without posing any 
risks to humans, materials, and environment. Furthermore, we are in need of universally 
accepted standards to define and monitor microbial cleanliness of surfaces (Dancer 2011). 
Transmission of pathogens by heat sensitive equipment, such as bronchoscopes is still a matter 
of concern. Problems usually relate to breaches in technique, both in the bronchoscopes and 
the disinfectors used for reprocessing. Failures in maintenance are one of the major reasons for 
technical breaches that lead to failing disinfection and eventually to transmission of pathogens 
to patients undergoing examination (Fig. 4). An important reason for failures is that 
responsibilities for maintenance are often shared by different parties, and demands are not 
always clearly defined. Furthermore, when buying this type of equipment there may be a 
tendency to underestimate working expenses for maintenance, which usually requires paid 
expertise from an external supplier. In a situation with need for budget cuts, reduction of 
maintenance may be one way to obtain savings, which may become critical if responsibilities 
and demands are not clearly defined. A clear definition of responsibilities and documentation 
of maintenance in accordance with written guidelines are essential measures to secure a 
satisfactory hygienic standard with this type of fragile equipment. Furthermore, when 
negotiating with a supplier, purchase and maintenance of equipment should be seen as one 
combined package, defining a plan for its maintenance in the years ahead. Finally, producers 
of fibre-optic endoscopes should be encouraged to produce more robust equipment, which can 
tolerate safer sterilization methods, if possible based on heat.  
This review has focused on the sources and routes of transmission seen today and over the 
past few decades. However, it is important to note that the situation is not static. Growing 
age and debilitation of patients predispose for more infections. Furthermore, since health 
care associated infections are in part determined by the procedures used in diagnostics, 
treatment, care and rehabilitation they change with the development of the health care 
system. New sources and transmission routes emerge, while others disappear. The risk of 
new infections can be minimized by making a systematic hygienic risk assessment, when 
introducing new health care procedures and new technology, and by keeping a sharp eye on 
unsuspected findings in the microbiology laboratories (Kolmos 2001). 
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washing hands with soap and water, if the recommended procedure is to be followed 
(Voss & Widmer 1997). Apart from being time consuming, this may give rise to skin 
problems. Alcoholic hand rub is faster and more gentle to the skin, and even more 
importantly, much more efficient to kill pathogens. It can replace soap and water in most 
cases, provided that hands are not visibly dirty (Pittet et al 2000). However, there are 
important exceptions: spore-forming bacteria, like Clostridium difficile and naked viruses, 
like norovirus (Kampf et al 2005) are not very susceptible to alcohol, which implies that 
health care workers must stick to soap and water, when dealing with patients suffering 
from infections due to these pathogens. It appears from this that what at first glance looks 
simple is in fact a demanding clinical procedure, which requires background knowledge 
and has to be trained in the same systematic manner as e.g. the skills necessary for 
insertion of an i.v. line. Essentially, hand hygiene techniques have not changed very much 
over the past century. With today’s knowledge about the lack of compliance and quality 
with hand hygiene performance and the ability of some organisms to resist alcohol, there 
is a clear need for development of more efficient hand hygiene techniques that are 
universally applicable, and at the same time fast and user-friendly.  
For many years it has been a matter of discussion, whether transmission of pathogens from 
the hospital environment plays a significant role in acquisition and spread of health care 
associated infections. A major reason is lack of well designed studies to document this route 
of transmission, which may be attributed to the fact that cleaning until recently was not 
considered an issue worth investigating (Dancer 2008). From the 1970s and until recently 
cleaning was considered merely an aesthetic issue, and budgets were cut down by hospital 
management in order to meet the demands for resources in other parts of the health care 
system. This was endorsed even by infection control practitioners, partly because of the lack 
of evidence for its importance as an infection control measure, partly because they feared 
that focus on cleaning would draw attention away from more important measures, like 
hand hygiene. This attitude has gradually shifted with the emergence of new well designed 
studies highlighting the role of the environment in transmission of hospital acquired 
infections and the ability of disinfecting cleaning to reduce such cases (Boyce et al 2008, 
Dancer 2008, Datta et al 2011).  
Accumulating evidence suggests that there is a dynamic interaction between the hands of 
health care workers and the environment in transmitting organisms from one patient to 
another (Dancer 2008) (Fig. 3). The question whether focus should be put on hand hygiene 
or cleaning the hospital environment is no longer meaningful. It is not an either or, rather it 
is a both and. If cross transmission is to be controlled there is a need to develop new and 
more efficient methods both for hand hygiene and environmental decontamination. Current 
cleaning methods used in the health care setting are primarily designed to fulfil aesthetic 
purposes, and they do not remove organisms from touch sites in the environment to any 
significant degree (French et al 2004). Cleaning combined with liquid disinfectants, such as 
hypochlorite and quaternary ammonium agents reduces surface contamination with 
pathogens, like Clostridium difficile, MRSA, and VRE (Wilcox et al 2003, Datta et al 2011). 
However, occupational hazards and concern for the environment implies that they are not 
used in daily routine cleaning. Hydrogen peroxide fumigation is an efficient and attractive 
alternative from an environmental point of view (French et al 2004, Boyce et al 2008). However, 
it is not suited for daily routine cleaning either. Clearly there is a need for more user-friendly 
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methods that can be used in daily practice to decontaminate touch sites, without posing any 
risks to humans, materials, and environment. Furthermore, we are in need of universally 
accepted standards to define and monitor microbial cleanliness of surfaces (Dancer 2011). 
Transmission of pathogens by heat sensitive equipment, such as bronchoscopes is still a matter 
of concern. Problems usually relate to breaches in technique, both in the bronchoscopes and 
the disinfectors used for reprocessing. Failures in maintenance are one of the major reasons for 
technical breaches that lead to failing disinfection and eventually to transmission of pathogens 
to patients undergoing examination (Fig. 4). An important reason for failures is that 
responsibilities for maintenance are often shared by different parties, and demands are not 
always clearly defined. Furthermore, when buying this type of equipment there may be a 
tendency to underestimate working expenses for maintenance, which usually requires paid 
expertise from an external supplier. In a situation with need for budget cuts, reduction of 
maintenance may be one way to obtain savings, which may become critical if responsibilities 
and demands are not clearly defined. A clear definition of responsibilities and documentation 
of maintenance in accordance with written guidelines are essential measures to secure a 
satisfactory hygienic standard with this type of fragile equipment. Furthermore, when 
negotiating with a supplier, purchase and maintenance of equipment should be seen as one 
combined package, defining a plan for its maintenance in the years ahead. Finally, producers 
of fibre-optic endoscopes should be encouraged to produce more robust equipment, which can 
tolerate safer sterilization methods, if possible based on heat.  
This review has focused on the sources and routes of transmission seen today and over the 
past few decades. However, it is important to note that the situation is not static. Growing 
age and debilitation of patients predispose for more infections. Furthermore, since health 
care associated infections are in part determined by the procedures used in diagnostics, 
treatment, care and rehabilitation they change with the development of the health care 
system. New sources and transmission routes emerge, while others disappear. The risk of 
new infections can be minimized by making a systematic hygienic risk assessment, when 
introducing new health care procedures and new technology, and by keeping a sharp eye on 
unsuspected findings in the microbiology laboratories (Kolmos 2001). 
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1. Introduction 
This chapter will not dwell on how mathematical models are built, better covered elsewhere 
(Bailey, 1975; Renshaw, 1991; Scott & Smith, 1994; Coen, 2007). It will focus on the impact of 
mathematical models on the understanding of infections spread in hospitals and their 
control. Hospital Acquired Infections (HAIs) made their first appearance with the invention 
of hospitals, mostly associated with surgical operations carried out when germ theory and 
hand-hygiene were unheard of and post-surgical mortality could be as high as 90% (La 
Force, 1987). The invention of antibiotics reduced mortality, but subsequently led to the 
emergence of infections adapted to survival in the antimicrobial-rich hospital environment. 
An arms race ensued where the bacterium and the pharmacist are to this day fighting to 
outwit each other (Sneader, 2005). Bacteria like Meticillin-resistant Staphylococcus aureus 
(MRSA) and Vancomycin-resistant Enterococci (VRE) were detected in UK hospitals as early 
as the 1960s (Stewart & Holt, 1962), but it was not until the mid 1990s that they ‘took off’ as a 
significant problem for hospital managers and inpatients (Austin & Anderson, 1999). If only 
10% of adult HAI infections could be prevented, £93 million could be saved in England and 
Wales alone (Plowman et al., 1999). 
Hospital inpatients are difficult subjects for study. They are only ‘available’ for a short time 
window, measured in days; too debilitated to all cooperate to the same degree; an extremely 
heterogeneous population; and major ethical issues are met when it comes to 
experimentation, especially when infection is asymptomatic. Their environment is 
heterogeneous and constantly changing, as technologies improve medical practice change. 
Under these circumstances, HAI models have a distinct advantage over uncontrolled 
observational studies (Cooper et al., 2003). This point is illustrated in section 4.2.  
When designing the structure of a model it is necessary to strike a balance between realism 
and generality (Bonten et al., 2001). A model needs to be complex enough to capture all 
those essential features of the process under study, ensuring realism and providing 
sufficient information so that all questions can be addressed using the model framework. 
Yet models must not be too complex lest conclusions are only generalizable to a small 
number of situations of little interest for much of the health care public. As complexity 
increases, providing information for a model may become prohibitive, less tools for analysis 
may be available for checking errors in formulation, and exact solutions may not exist so 
that numerical approximations are needed. Nevertheless HAIs are complex things, and 
modellers are forced to abandon generality; at worst mathematical models may be too 
simple to be realistic. This chapter explores the nature of this complexity (Section 2), review 
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Hospital inpatients are difficult subjects for study. They are only ‘available’ for a short time 
window, measured in days; too debilitated to all cooperate to the same degree; an extremely 
heterogeneous population; and major ethical issues are met when it comes to 
experimentation, especially when infection is asymptomatic. Their environment is 
heterogeneous and constantly changing, as technologies improve medical practice change. 
Under these circumstances, HAI models have a distinct advantage over uncontrolled 
observational studies (Cooper et al., 2003). This point is illustrated in section 4.2.  
When designing the structure of a model it is necessary to strike a balance between realism 
and generality (Bonten et al., 2001). A model needs to be complex enough to capture all 
those essential features of the process under study, ensuring realism and providing 
sufficient information so that all questions can be addressed using the model framework. 
Yet models must not be too complex lest conclusions are only generalizable to a small 
number of situations of little interest for much of the health care public. As complexity 
increases, providing information for a model may become prohibitive, less tools for analysis 
may be available for checking errors in formulation, and exact solutions may not exist so 
that numerical approximations are needed. Nevertheless HAIs are complex things, and 
modellers are forced to abandon generality; at worst mathematical models may be too 
simple to be realistic. This chapter explores the nature of this complexity (Section 2), review 
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methods used for fitting models to observational data (Section 3), focus on lessons learnt for 
some areas of infection control (Section 4). Finally I give an example of a stochastic model of 
norovirus on a geriatric ward (Section 5). 
2. Essential features of HAI 
This in part depends on the questions addressed and the biological characteristics of the 
HAIs modelled. The general idea is that (susceptible) patients spend time on a ward, they 
have physical contacts with health-care workers ([HCWs] nurses, doctors, cleaners etc.), 
visitors, other patients and with contaminants in the environment. Such exposure can lead 
to colonization with infectious organisms that may sooner or later cause debilitating clinical 
infection. The devil is in the detail. 
2.1 Mechanism of infection 
Some HAIs manifest themselves soon after colonization, regardless of the kind of 
healthcare. This is typical of many viruses, such as varicella, measles, norovirus and 
adenovirus where susceptibles acquire infection and after an incubation period of a few 
days suffer symptoms of infection coincident with infectiousness to others and 
subsequently recover or die (section 5). Such aetiologies are typically associated with 
outbreaks characterized by ‘attack rates’ and outbreak durations.  
In contrast most HAIs are not just about acquiring the organism. Many bacterial infections 
may be carried for months in the absence of clinical symptoms, such as in the nares (MRSA), 
the skin (Coagulase-negative Staphylococci [CNS]), the gastrointestinal tract (Escherichia coli, 
Clostridium difficile). This silent infection may last months to years, makes the patient a 
‘carrier’, more or less infectious to others depending on the organism and other 
circumstances. Only when natural barriers are breached, often as a result of health-care 
intervention (e.g. surgery, line and catheter insertion), bacteria will invade tissues that are 
otherwise sterile, they multiply and cause life-threatening clinical illness. An extreme 
example is Streptococcus pyogenes (or Group A Streptococcus [GAS]), an airborne infection 
that typically causes sore throat, but can be life threatening if allowed to invade 
subcutaneous tissues (necrotizing fasciitis), such as via a stab wound or burn. Untreated it 
can result in multiple organ failure and very high fatality rates (Aziz & Kotb, 2008). 
Hence the epidemiology of most HAIs is the result of a two-step process: the acquisition of 
the organism (acting on susceptibles), and the subsequent invasion of sterile tissues (acting 
on carriers). The slow turn-over of carriage (relative to the average length of stay in hospital) 
means that these HAIs are typically endemic and their burden measured in terms of 
prevalence and incidence. The first step is usually modelled with the rate of infection per 
susceptible-carrier pair, known as the ‘transmission coefficient’, β (Anderson & May, 1991), 
sometimes factorized as β = ab, where a is the contact rate and b is the probability of 
transmission per contact (Austin et al., 1999a). The second step is modelled as a rate per 
carrier. For example, Coello et al., (1997) estimate 0.59% daily probability of MRSA carriers 
developing infection. Cooper and Lipsitch (2004) estimate 35% per day for MRSA in ITU.  
Other HAIs present with mixed aetiologies, such as C difficile, which in one third of 
patients causes life threatening infection of the colon on acquisition, while two thirds 
remain asymptomatic. The latter may yet suffer infection as a result of as poorly understood 
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triggers, such as antimicrobial administration (Johnson et al., 1990). Recent evidence 
suggests that norovirus is carried asymptomatically by 12% of individuals in the community 
(Phillips et al., 2010). Such carriers may well become infectious in hospital when diarrhoea 
sets in, perhaps the result of laxatives and antibiotics. 
2.2 Forms of clinical infection 
At one end of the clinical spectrum organisms enter the bloodstream through a cut in the 
skin, are able to multiply and systemically affect the rest of the body (bacteraemia or 
sepsis). Bacteraemias are relatively rare (1.3% of all HAIs in England; Hospital Infection 
Society & Infection Control Nurses Association, 2007), are expensive to treat and life 
threatening. Other infections are more localized in their effects. Surgical wounds may 
become infected (Surgical Site Infections [SSI]), causing a wide range of problems. Their 
seriousness depends on whether they are peripheral, deep incisional or whether inner 
body spaces and organs are affected (Health Protection Agency [HPA], 2011a). These are 
rarely life threatening, although they make up 16% of all HAIs in England, are expensive 
to treat (Plowman, 1999), may lead to unpleasant consequences (delayed care) and if 
inappropriately treated may lead to bacteraemia, amputation and death. A milder form of 
HAI is the urinary tract infection (UTI) typically caused by insertion of temporary 
indwelling bladder catheters kept long enough for bacteria to move up the urinary tract 
and infect normally sterile sites such as the kidneys. UTIs are very common (21% of all 
HAIs in England), and can lead to pain and distress, general debilitation and occasionally 
bacteraemia (Bryan et al., 1984).  
Many mathematical models distinguish between carriers and clinical infections, but most 
lump all infections into one homogeneous black box, ignoring heterogeneity in frequency 
and consequences. Bacteraemias may be expensive to treat and life threatening, but 
contribute little to infectious spread. SSIs, on the other hand, are not as life-threatening, but 
are more common and more infectious. Treating SSIs and bacteraemias as a uniform entity 
may lead to significant discrepancy between model prediction and reality. 
2.3 The aetiological agent 
Most HAIs are caused by bacteria although viruses and fungi are often involved. Most are 
resistant to some classes of antibiotic. Examples from the Gram-positive bacteria are MRSA 
(penicillins and cephalosporins), VRE (some penicillins and glycopeptides), C difficile 
(fluoroquinolones). Many Gram-negative bacteria cause bacteraemias and UTIs, such as E 
coli, Pseudomonas aeruginosa, Klebsiellas spp., Citrobacter, Enterobacter, and Proteus. Some of 
these produce enzymes known as extended-spectrum beta-lactamases (ESBL), which confer 
resistance to many antibiotic classes (penicillins, cephalosporins, fluoroquinolones and 
aminoglycosides) (Kullik et al., 2010). ESBLs are not a homogeneous group, inheritance may 
be chromosomal or via plasmid, and several genotypes exist (TEM-10, TEM-26, CTX-M etc.; 
Livermore 2001). Resistance to carbapenems, one of the last lines of defence against ESBLs, 
is beginning to emerge (Grundmann et al., 2011). Other bacteria are more sensitive to 
antibiotics but are common enough to cause significant infection (e.g. Meticillin-susceptible 
Staphylococcus aureus [MSSA]). 
The genetic structure of most bacterial populations is clonal (Smith et al., 1993), and 
antibiotic-resistant HAIs are no exception, so that de novo emergence of antibiotic 
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some areas of infection control (Section 4). Finally I give an example of a stochastic model of 
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days suffer symptoms of infection coincident with infectiousness to others and 
subsequently recover or die (section 5). Such aetiologies are typically associated with 
outbreaks characterized by ‘attack rates’ and outbreak durations.  
In contrast most HAIs are not just about acquiring the organism. Many bacterial infections 
may be carried for months in the absence of clinical symptoms, such as in the nares (MRSA), 
the skin (Coagulase-negative Staphylococci [CNS]), the gastrointestinal tract (Escherichia coli, 
Clostridium difficile). This silent infection may last months to years, makes the patient a 
‘carrier’, more or less infectious to others depending on the organism and other 
circumstances. Only when natural barriers are breached, often as a result of health-care 
intervention (e.g. surgery, line and catheter insertion), bacteria will invade tissues that are 
otherwise sterile, they multiply and cause life-threatening clinical illness. An extreme 
example is Streptococcus pyogenes (or Group A Streptococcus [GAS]), an airborne infection 
that typically causes sore throat, but can be life threatening if allowed to invade 
subcutaneous tissues (necrotizing fasciitis), such as via a stab wound or burn. Untreated it 
can result in multiple organ failure and very high fatality rates (Aziz & Kotb, 2008). 
Hence the epidemiology of most HAIs is the result of a two-step process: the acquisition of 
the organism (acting on susceptibles), and the subsequent invasion of sterile tissues (acting 
on carriers). The slow turn-over of carriage (relative to the average length of stay in hospital) 
means that these HAIs are typically endemic and their burden measured in terms of 
prevalence and incidence. The first step is usually modelled with the rate of infection per 
susceptible-carrier pair, known as the ‘transmission coefficient’, β (Anderson & May, 1991), 
sometimes factorized as β = ab, where a is the contact rate and b is the probability of 
transmission per contact (Austin et al., 1999a). The second step is modelled as a rate per 
carrier. For example, Coello et al., (1997) estimate 0.59% daily probability of MRSA carriers 
developing infection. Cooper and Lipsitch (2004) estimate 35% per day for MRSA in ITU.  
Other HAIs present with mixed aetiologies, such as C difficile, which in one third of 
patients causes life threatening infection of the colon on acquisition, while two thirds 
remain asymptomatic. The latter may yet suffer infection as a result of as poorly understood 
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triggers, such as antimicrobial administration (Johnson et al., 1990). Recent evidence 
suggests that norovirus is carried asymptomatically by 12% of individuals in the community 
(Phillips et al., 2010). Such carriers may well become infectious in hospital when diarrhoea 
sets in, perhaps the result of laxatives and antibiotics. 
2.2 Forms of clinical infection 
At one end of the clinical spectrum organisms enter the bloodstream through a cut in the 
skin, are able to multiply and systemically affect the rest of the body (bacteraemia or 
sepsis). Bacteraemias are relatively rare (1.3% of all HAIs in England; Hospital Infection 
Society & Infection Control Nurses Association, 2007), are expensive to treat and life 
threatening. Other infections are more localized in their effects. Surgical wounds may 
become infected (Surgical Site Infections [SSI]), causing a wide range of problems. Their 
seriousness depends on whether they are peripheral, deep incisional or whether inner 
body spaces and organs are affected (Health Protection Agency [HPA], 2011a). These are 
rarely life threatening, although they make up 16% of all HAIs in England, are expensive 
to treat (Plowman, 1999), may lead to unpleasant consequences (delayed care) and if 
inappropriately treated may lead to bacteraemia, amputation and death. A milder form of 
HAI is the urinary tract infection (UTI) typically caused by insertion of temporary 
indwelling bladder catheters kept long enough for bacteria to move up the urinary tract 
and infect normally sterile sites such as the kidneys. UTIs are very common (21% of all 
HAIs in England), and can lead to pain and distress, general debilitation and occasionally 
bacteraemia (Bryan et al., 1984).  
Many mathematical models distinguish between carriers and clinical infections, but most 
lump all infections into one homogeneous black box, ignoring heterogeneity in frequency 
and consequences. Bacteraemias may be expensive to treat and life threatening, but 
contribute little to infectious spread. SSIs, on the other hand, are not as life-threatening, but 
are more common and more infectious. Treating SSIs and bacteraemias as a uniform entity 
may lead to significant discrepancy between model prediction and reality. 
2.3 The aetiological agent 
Most HAIs are caused by bacteria although viruses and fungi are often involved. Most are 
resistant to some classes of antibiotic. Examples from the Gram-positive bacteria are MRSA 
(penicillins and cephalosporins), VRE (some penicillins and glycopeptides), C difficile 
(fluoroquinolones). Many Gram-negative bacteria cause bacteraemias and UTIs, such as E 
coli, Pseudomonas aeruginosa, Klebsiellas spp., Citrobacter, Enterobacter, and Proteus. Some of 
these produce enzymes known as extended-spectrum beta-lactamases (ESBL), which confer 
resistance to many antibiotic classes (penicillins, cephalosporins, fluoroquinolones and 
aminoglycosides) (Kullik et al., 2010). ESBLs are not a homogeneous group, inheritance may 
be chromosomal or via plasmid, and several genotypes exist (TEM-10, TEM-26, CTX-M etc.; 
Livermore 2001). Resistance to carbapenems, one of the last lines of defence against ESBLs, 
is beginning to emerge (Grundmann et al., 2011). Other bacteria are more sensitive to 
antibiotics but are common enough to cause significant infection (e.g. Meticillin-susceptible 
Staphylococcus aureus [MSSA]). 
The genetic structure of most bacterial populations is clonal (Smith et al., 1993), and 
antibiotic-resistant HAIs are no exception, so that de novo emergence of antibiotic 
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resistance is rare on the hospital-admission time-scale, and resistant variants may be 
modelled independently of sensitive counterparts. This is the case of MRSA and MSSA 
(Feil et al., 2003), E coli (Milkman & Bridges, 1990), C difficile (Griffiths et al., 2010). In 
contrast, Enterococci (e.g. VRE) and Gram negatives like the Klebsiella exhibit considerable 
inter-strain genomic diversity, mainly linked to the presence of transposable agents such 
as phages and plasmids – often responsible for the resistance phenotype (van Schaik & 
Willems, 2010; Zhao et al., 2010). It is then possible for sensitive variants to become 
resistant in hosts colonized with both variants. 
Regardless of the genetics, there may be important differences between HAI genotypes. One 
example is C difficile which has hundreds of different ‘ribotypes’. Ribotype 027 can produce 
16 to 23-fold higher concentrations of toxin (Warny et al., 2005) and is associated with twice 
the mortality than other strains (HPA, 2011b). Some S aureus variants, known as 
community-acquired MRSA (CA-MRSA), produce the Panton-Valentine Leukocydin (PVL) 
toxin, are abundant in the community, are much more sensitive to antibiotics and are more 
associated with ‘soft-skin’ infections. But they are also known to cause life-threatening 
necrotizing pneumonia. CA-MRSA is on the increase in North America and is making its 
appearance in the hospital (David & Daum, 2010), although relatively unknown in UK 
hospitals (HPA, 2011c). 
Competition for colonization space is an interesting issue when modelling two or more 
variants. MRSA and MSSA, for example share the same ecologic ‘niche’ as they both 
colonize the nares of human beings, as well as many other aspects of infection aetiology and 
a degree of competition may well exist (Dall’Antonia et al., 2005). The problem is that most 
mathematical models of antibiotic resistance make implicit assumptions regarding 
competition with important implications on model dynamics (see section 4.3). These models 
either include two variants (sensitive and resistant), or only consider the resistant one. One-
strain models are consistent with complete coexistence with other variants (e.g. Austin et al., 
1999a). Two-strain models are consistent with complete competition whenever the ‘co-
carrier’ state is ignored (i.e. a resistant strain may not colonize a host that is already 
colonized with the sensitive strain; e.g. Austin et al. 1999b).  
2.4 The nature of infectious spread 
2.4.1 Transmission routes 
Some modellers (Cooper et al., 1999, 2004a; Smith et al., 2004) followed the implicit approach 
of embedding all possible routes of infection within the value of the transmission coefficient β, 
which measures the effective transmission rate between any susceptible-infected pair, 
regardless of the exact route. Bootsma et al. (2007) estimate transmission coefficients for 3rd 
generation cephalosporin-resistant Enterobacteriaceae (CRE) and consider the addition of the 
‘endogenous’ route, whereby the patient’s already present pathogens grow to detectable 
levels. They find this route to be responsible for more acquisitions than the cross-infection 
route, which brings into doubt the definition of ‘hospital acquired’ as infections detected 48 
hours after admission for Enterobacteriaceae like E coli. 
Other modellers are more explicit and usually make the case for the predominance of a 
single transmission route. Examples are models of VRE and MRSA in ITU where patients 
are not free to move and transmission takes place via the HCW (Austin et al., 1999a; 
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Grundmann et al., 2002). Failure of contact precautions is blamed for any transmission. If P 
is the number of patients and W is the number of HCWs, the total number of infectious 
contacts per day is C = aPW (a as defined in section 2.1). Notice that for a given total number 
of contacts C, the number of contacts per patient (= aW) may not necessarily equal the 
number of contacts per HCW (= aP = aP(W/P)). These are only expected to equal when the 
HCW-patient ratio is 1:1 (as maybe the case on the ITU). This is not realistic when some 
HCWs visit more patients than others.  
In wards where patients are mobile, or where transmission can take the airborne route, 
more transmission coefficients are needed. The airborne route is especially relevant to the 
spread of pulmonary tuberculosis (TB), measles and influenza. Models of the airborne 
route require the measurement of parameters like quantum generation rates (a measure of 
infectious material in the air), room volume, room ventilation rates, pulmonary 
ventilation rates (Beggs et al., 2010). It is common practice to isolate patients susceptible to 
infection (e.g. immunocompromised cases) in isolation rooms with positive pressure (to 
keep infectious quanta out), and infectious cases with negative pressure (to keep 
infectious quanta within the confines of the isolation room). The implicit approach may 
still enable the analysis of the success of isolation, when different transmission coefficients 
are used, for isolated and non-isolated patients (Forrester et al., 2007).  
2.4.2 Quantifying transmission 
It is possible to follow a cohort of inpatients and measure the acquisition rate of infection 
(Jernigan et al., 1996). This is the ‘force of infection’, λ, and is equivalent to β.I, where I is the 
average number of infectious patients per unit time on the ward. It is possible to use this 
number to calculate β from the expected number of daily visits to infectious patients. 
Raboud et al. (2005) estimate βs for patient-HCW contact ranging from 0.017% to 6.7%, 
depending on whether the patient was in isolation and whether HCWs complied with hand-
washing. Forrester et al. (2007) estimated 1.03% acquisitions per day (background rate, β0) 
and transmission coefficients β1 = 1.31% (not isolated), and β2 = 0.45% (isolated). Cooper & 
Lipsitch (2004) estimate transmission coefficients 33% (MRSA), 26% (VRE) for patients in 
ITU. Ong et al. (2008) used transmission coefficients for influenza stratified by 5 categories 
of staff, ambulant and non-ambulant inpatients and visitors. 
Other modellers use the “basic case reproduction number”, R0, as a summary measure of 
infectious spread (Anderson & May, 1991). This is defined as “the average number of 
secondary infections produced when one infectious individual is introduced into [an 
infinite] host population in which every host is susceptible”. It follows that the infection can 
persist in the population only when R0 > 1. Real life populations are finite and seldom 
completely susceptible so that we are more likely to observe effective basic case reproduction 
numbers, Re = R0.s* where R0 is discounted by the proportion of susceptibles in the 
population (s*). Cooper et al. introduced the refinement of having R0 = RA.ξ, where RA is the 
effective basic reproduction number observed within a single admission, and ξ is a constant 
that accounts for the probability of re-admission while still infectious (Cooper et al., 2004a). 
The implication is that even when good infection control practice reduces RA to values less 
than 1, the infection will establish itself as a result of re-admission if ξ is large enough. 
Cooper et al. chose transmission coefficients for MRSA consistent with R0 ranging between 
1.1 (self-limiting clusters of secondary cases) to 1.3 (endemic pattern).  
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resistance is rare on the hospital-admission time-scale, and resistant variants may be 
modelled independently of sensitive counterparts. This is the case of MRSA and MSSA 
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as phages and plasmids – often responsible for the resistance phenotype (van Schaik & 
Willems, 2010; Zhao et al., 2010). It is then possible for sensitive variants to become 
resistant in hosts colonized with both variants. 
Regardless of the genetics, there may be important differences between HAI genotypes. One 
example is C difficile which has hundreds of different ‘ribotypes’. Ribotype 027 can produce 
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colonized with the sensitive strain; e.g. Austin et al. 1999b).  
2.4 The nature of infectious spread 
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of embedding all possible routes of infection within the value of the transmission coefficient β, 
which measures the effective transmission rate between any susceptible-infected pair, 
regardless of the exact route. Bootsma et al. (2007) estimate transmission coefficients for 3rd 
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Grundmann et al., 2002). Failure of contact precautions is blamed for any transmission. If P 
is the number of patients and W is the number of HCWs, the total number of infectious 
contacts per day is C = aPW (a as defined in section 2.1). Notice that for a given total number 
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(Jernigan et al., 1996). This is the ‘force of infection’, λ, and is equivalent to β.I, where I is the 
average number of infectious patients per unit time on the ward. It is possible to use this 
number to calculate β from the expected number of daily visits to infectious patients. 
Raboud et al. (2005) estimate βs for patient-HCW contact ranging from 0.017% to 6.7%, 
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completely susceptible so that we are more likely to observe effective basic case reproduction 
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population (s*). Cooper et al. introduced the refinement of having R0 = RA.ξ, where RA is the 
effective basic reproduction number observed within a single admission, and ξ is a constant 
that accounts for the probability of re-admission while still infectious (Cooper et al., 2004a). 
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Cooper et al. chose transmission coefficients for MRSA consistent with R0 ranging between 
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2.4.3 The role of the environment 
The hospital environment, as a source of infection, is an extremely complex entity and difficult 
to model explicitly. Hospital surfaces can harbour live HAI agents (e.g. Staphylococci, 
Enterobacteriaceae, C difficile spores etc). The problem is that even where it is possible to 
establish associations between bacterial flora on patients and their immediate environment 
(Asoh et al., 2005), the direction of the causal arrow is not known. Wards are also extremely 
heterogeneous places. Bacterial counts sampled from sites most likely associated with direct 
patient contact (e.g. hand-rails, soap dispensers, bedding, curtains) are much lower than other 
sites (e.g. floor) (Hamilton et al., 2010), and porous surfaces are more difficult to clean (Oie et 
al., 2005). To explicitly model these environmental sites it is necessary to choose the 
appropriate site, sample for organisms at appropriate intervals, and follow up patients for 
contact rates with the site as well as their carriage status. An alternative is to model the 
environment as a black box and set its ‘colonization’ and ‘turnover’ rates, tweaking them so as 
to obtain a model output close to observation (Kouyos et al., 2011). 
2.5 The patient 
Many inpatients have co-morbidities that put them at special risk of infection: HIV cases, 
diabetics, bone-marrow transplant patients, those on chemotherapy, in elderly care wards, 
those undergoing surgery, to mention a few. There are behavioural differences: some 
patients are more likely to be re-hospitalized, and those with a history of hospitalization 
are more likely to carry HAIs. Cooper et al. (2004a) stratified patients into two categories 
of re-admission frequency (see section 2.7), while Bootsma et al. (2006) allowed 1% of 
inpatients colonized with MRSA to be ‘super-spreaders’ (10 times more infectious than 
other carriers). 
In the UK patients rarely stay on the same ward for the duration of their admission. There are 
at least two distinct patterns of patient flow (Figure 1): elective admissions, planned weeks or  
 
 
Fig. 1. Schematic description of patient flow in a UK hospital. 
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months in advance, are usually taken directly to specialist wards. In contrast, emergency 
admissions present to A&E and are subsequently moved to a temporary unit, known in the 
UK as the Acute Admissions Unit (AAU) and stay there for 1-3 days prior to being admitted 
to specialist wards. Patients may also be taken to ITU, infectious diseases wards, or may be 
moved to theatre to undergo surgery, to then recover in a different ward. The role of ITU is 
thought to be important in the seeding and spread of certain antimicrobial resistant HAIs to 
other wards (Edgeworth, 2011). Bootsma et al. (2006) and Hubben et al. (2011) modelled 
patients admitted to one of three hospitals with 36 wards each and 5 ITUs, whose inpatient 
population had differing lengths of ward stay depending on whether patients were in ITU 
(mean of 3 days) or other wards (7 days). 
2.6 The staff 
Some modellers assume all transmission between inpatients to take place via the medium of 
the ward environment – HCWs being part of it (Cooper et al., 2004a). Others explicitly 
model HCWs and are seen as the most responsible transmission component (Austin et al., 
1999a). Because staff members work on on the ward for much longer than the average 
patient length of stay, they have a huge potential to spread infection. Hence they cannot 
play as large a role in transmission as inpatients lest we expect every inpatient to become 
infected (Beggs et al., 2008). HCWs are a heterogeneous group. Ong et al. (2008) stratified 
HCWs into cleaners, clerks, doctors, health-attendants, and nurses for an influenza model. 
Their “Who-Acquires-Infection-From-Whom” (WAIFW) matrix suggest heterogeneous 
contact rates with patients and each other: cleaners, health-care attendants and clerks mostly 
contacted nurses; doctors had them mostly with nurses, patients and their visitors; nurses 
had them mostly with other nurses, patients and visitors. Bootsma et al. (2006) stratified 
staff into those that have contact with patients on a single ward (1:1 staff patient ratios in 
ITU, and 5:18 ratios on other wards), and staff with unrestricted contact across wards and 
hospitals. Some have greater hand-hygiene compliance than others (Pittet et al., 1999). 
Raboud et al. (2005) stratified them into daytime and night-time staff and went as far as 
including the detail of staff looking after the patients of other staff during coffee breaks! 
2.7 The community 
Early HAI models ignored the impact of the population outside hospital walls (the 
“extramural” population), and patients admitted into hospital were either assumed 
uncolonized or came with a fixed probability of acquiring infection (Austin et al., 1999a; 
Lipsitch et al., 2000). Cooper et al. (2004a) broke this tradition and modelled the 
extramural population, stratifying it into those with a high vs. low rate of readmission 
(0.57% vs. 0.06% readmissions per day). Hubben et al. (2011) stratify patients by ward 
within three hospitals and by risk of readmission with 22,000 ‘high-risk’ patients who are 
10 times more likely to be readmitted, out of a catchment population of 220,000 – resulting 
in 50% high risk patients within the hospital population. This kind of HAI model predicts 
low extramural MRSA prevalence, which matches observation (Lu et al., 2005). Austin & 
Anderson (1999) modelled the spread of MRSA across 400 NHS hospitals in England and 
conclude that the largest hospitals are responsible for most ‘transmission’ events, and 
make the case in favour of active surveillance.  
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moved to theatre to undergo surgery, to then recover in a different ward. The role of ITU is 
thought to be important in the seeding and spread of certain antimicrobial resistant HAIs to 
other wards (Edgeworth, 2011). Bootsma et al. (2006) and Hubben et al. (2011) modelled 
patients admitted to one of three hospitals with 36 wards each and 5 ITUs, whose inpatient 
population had differing lengths of ward stay depending on whether patients were in ITU 
(mean of 3 days) or other wards (7 days). 
2.6 The staff 
Some modellers assume all transmission between inpatients to take place via the medium of 
the ward environment – HCWs being part of it (Cooper et al., 2004a). Others explicitly 
model HCWs and are seen as the most responsible transmission component (Austin et al., 
1999a). Because staff members work on on the ward for much longer than the average 
patient length of stay, they have a huge potential to spread infection. Hence they cannot 
play as large a role in transmission as inpatients lest we expect every inpatient to become 
infected (Beggs et al., 2008). HCWs are a heterogeneous group. Ong et al. (2008) stratified 
HCWs into cleaners, clerks, doctors, health-attendants, and nurses for an influenza model. 
Their “Who-Acquires-Infection-From-Whom” (WAIFW) matrix suggest heterogeneous 
contact rates with patients and each other: cleaners, health-care attendants and clerks mostly 
contacted nurses; doctors had them mostly with nurses, patients and their visitors; nurses 
had them mostly with other nurses, patients and visitors. Bootsma et al. (2006) stratified 
staff into those that have contact with patients on a single ward (1:1 staff patient ratios in 
ITU, and 5:18 ratios on other wards), and staff with unrestricted contact across wards and 
hospitals. Some have greater hand-hygiene compliance than others (Pittet et al., 1999). 
Raboud et al. (2005) stratified them into daytime and night-time staff and went as far as 
including the detail of staff looking after the patients of other staff during coffee breaks! 
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“extramural” population), and patients admitted into hospital were either assumed 
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10 times more likely to be readmitted, out of a catchment population of 220,000 – resulting 
in 50% high risk patients within the hospital population. This kind of HAI model predicts 
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Anderson (1999) modelled the spread of MRSA across 400 NHS hospitals in England and 
conclude that the largest hospitals are responsible for most ‘transmission’ events, and 
make the case in favour of active surveillance.  
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2.8 Infection control 
No hospital applies exactly the same infection control strategy as any another at any one 
time. Several interventions are invariably applied simultaneously. Many of the decisions 
taken by hospital managers are based on quasi-experimental and observational data at best. 
This point is illustrated in the review of the evidence in favour of inpatient isolation for the 
control of MRSA infection (Cooper et al., 2003; Cooper et al., 2004b). This is an area where 
mathematical models can contribute. As it is not possible to manipulate the real world of 
patients in hospitals, we can resort to manipulating a simulated hypothesis of it, and draw 
some conclusions, aware of all the assumptions made in its design. One approach is to fit the 
model to infection data and estimate unknown parameters (see section 3), and subsequently 
to use it to run simulations and test infection control strategies (Section 4). 
Some infection control methods are easier to model because they directly affect the 
transmission cycle: cohorting (Austin et al., 1999a), hand-hygiene (Austin et al., 1999a; Beggs 
et al., 2008, 2009), isolation (Cooper et al., 1999, 2003). Cohorting, the neutralization of 
transmission routes into 1:1 HCW:patient contacts, is only possible in settings where staff 
numbers exceed patient numbers, such as on the ITU. On other wards patients can exceed 
staff numbers by at least 5:1, and only degrees of cohorting are possible, especially when 
patients are mobile (see section 5; Raboud et al., 2005). Hand-hygiene, the cleaning of staff 
hands before and after patient contact, has two dimensions (Beggs et al., 2008): compliance 
(the proportion of staff that actually clean their hands) and effectiveness (the probability of 
effective removal of contaminants during hand-cleaning). The problem with most hand-
hygiene models is their assumption of a linear relationship between hand-washing 
compliance and the reduction of the transmission coefficient, β – for which there is no 
evidence. If effectiveness is inversely proportional to compliance non linear effects are 
expected (Coen, 2007). Isolation, the removal of patients into secluded areas so as to prevent 
contacts with other patients, does not eliminate transmission completely (Forrester et al., 
2007; Cepeda et al., 2005), and moving patients to isolation facilities comes with a risk of 
death on the ITU (section 4.2). Modelling isolation is achieved by adding isolated 
‘categories’ of patients in the model structure (e.g. Cooper et al., 1999). More difficult is to 
include the realism of true isolation which is the result of competition with a range of other 
priorities, such as privacy, dignity, avoiding disturbance from difficult patients, and 
infections caused by other organisms (Jeanes et al., 2011). 
Other interventions are the control of hospital demography (closing wards to admissions; 
sending affected staff home; Section 5), environmental cleaning whose effectiveness is 
difficult to measure; surveillance and feedback, such as the health-care bundle audits and 
screening of patients on admission (Raboud et al., 2005; Hubben et al., 2011; section 4.1); 
antibiotic usage (section 4.3). The practice of training staff to minimize infection risk, such as 
in the safe taking of blood, the insertion of central lines and catheters, has never been 
modelled and requires the colonization vs. infection stratification (section 2.1). Rare are the 
models where several infection control method are compared simultaneously (Austin et al., 
1999a; Raboud et al., 2005; Hubben et al., 2011). 
2.9 Small population sizes and the role of chance 
Even the largest hospitals are broken up into wards which are small enough to make chance 
events of significant importance. Observing zero cases in a particular month does not mean 
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absence of transmission, and in doing surveillance it is necessary to gather infection data 
over a wide time period in order to obtain a reliable average incidence rate. For this reason 
stochastic models (which approximate the probability distribution of model behaviour) are 
preferable to deterministic models (which approximate average model behaviour). The 
advantage of stochastic models – also known as Markov Chain Monte Carlo (MCMC) 
models – is that they give an indication of the variability in the expected trends (Renshaw, 
1991). This variability can be so significant that control measures expected to be successful 
on average can fail “catastrophically” as a result of chance alone (Cooper et al., 2004a). Their 
disadvantage is that when parameters are unknown, computer-intensive statistical methods 
are needed to obtain estimates (section 3). There are many examples of HAI stochastic 
models: MRSA (Cooper et al., 2004a; Raboud et al., 2005; Hubben et al., 2011), VRE (Austin 
et al., 1999a), influenza (Ong et al., 2008), Severe Acute Respiratory Syndrome ([SARS]; 
Fukutome et al., 2007) and norovirus (section 5). 
2.10 The finance 
Treating infections costs money, so that spending money to implement infection control can 
save money. Hence, it is important to show that infection control interventions are cost 
effective. Mathematical models can help provide estimates of the number of cases 
prevented, N, as a result of intervention. This was done for MRSA screening (Raboud et al., 
2005; Hubben et al., 2011). If CT is the cost of treating one infection, CI the overall cost of 
intervention then the cost per case averted (or the ‘average Cost Effectiveness Ratio’ 
[aCER]), is CI / N. The net benefit of an intervention is given by (N x CT) - CI. The aCER is an 
indication of the return to the health-care system for each £ spent. A positive net benefit 
indicates that the intervention will save money. It follows that it does not pay to prevent a 
rare infection (low N) unless treatment costs are sufficiently high (large CT), and 
intervention costs, CI, are low. Estimates of CT for MRSA infections are $10,000-$16,000 
(Raboud et al., 2005). In the mid 1990s Plowman et al. (1999) estimated CTs of £5397 
(bloodstream infections), £2398 (lower respiratory tract infections), £1618 (SSIs), £1237 
(UTIs) and £9152 (multiple infections). Lopman et al. (2004) estimate costs per norovirus 
inpatient bed-day of £145 (elderly care ward). 
3. Dealing with unknown parameters 
The design of a mathematical model should be informed by observation. There are 
numerous ways to achieve this. Some parameters can be ‘fixed’ by using estimates from 
direct measurement possibly from the literature (e.g. the mean duration of infection). 
WAIFW matrices were estimated from conversations (surrogates of infectious contacts) for 
varicella (Zagheni et al., 2008), and from direct observations of HCW and patients the wards 
(Ong et al., 2008). Overlapping stay on the same ward (available from hospital computer 
records) can be used as surrogate measures of exposure to HAI cases. Alternatively 
sensitivity analysis uses a range of plausible values and the outcomes compared. Examples 
are screening costs (Hubben et al., 2011), contact rates (Beggs et al., 2008), days from 
detection of the index case to isolation of SARS cases (Fukutome et al., 2007).  
Another approach is to identify the range of parameter values that minimize the 
discrepancy between model and data. This is usually done via numerical minimization 
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algorithms such as Powell’s direction set methods (Press et al., 1994; Chapter 10). Maximum 
likelihood uses the probability of observing some body of data, y, when the model θ is ‘true’, 
and is usually presented as l = p(y|θ), where y are the data and θ the unknown model 
parameters (Edwards, 1972). Confidence intervals may be achieved by means of profile 
likelihood methods (Aitkin, 1998; Press et al., 1994; Chapter 15). This was applied to time-
series data of the inpatient ‘admission experience’ (dates of admission and discharge, swab 
test dates and results, dates of isolation). The unknown part of the model was kept to a 
minimum (e.g. transmission coefficients and dates of acquisition of carriage) (Pelupessy et 
al., 2002; Cooper & Lipsitch, 2004; Bootsma et al., 2007). Cooper and Lipsitch (2004) applied 
a hidden MCMC model to time-series of MRSA, VRE and resistant Gram-negative rods (R-
GNR) clinical infection in order to estimate parameters such as the patient-patient 
transmission coefficient (β) and the probability of colonization on admission (υ). A ‘hidden’ 
MCMC model (based on β and υ) described colonization and a Poisson process of rate λ 
described infection rates per carrier. Their model gave superior fits to HAI data compared 
with quality control processes based on the Poisson distribution (Grigg et al., 2003). The 
latter are nevertheless useful to the local ward manager as null models, the lack of fit 
indicating the existence of infectious spread (and infection control breakdown), than the 
estimate of transmission parameters whose confidence intervals may be wide. 
Bayesian methods have been applied to iterative MCMC models (Forrester et al., 2007; 
Kypraios et al., 2010). These are based on sampling algorithms known as the Gibbs’ sampler 
and Hastings-Metropolis, which are based on Bayes’ Theorem (Carlin & Louis, 2000). This 
states that the probability of the model is proportional to the likelihood multiplied by the 
‘prior’ probability of the model, π(θ), or 
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where D is the marginal probability of the data, across all possible models: D = 
∫p(y|θ)π(θ)dθ. The probability density function p(θ|y) is the ‘posterior’ density of the 
unknowns. It is the weighted average of the ‘prior’ probability and the weights are the 
likelihoods. When prior knowledge is unavailable, π(θ) is set equal for the entire parameter 
space θ (a ‘non-informative’ prior). 
When D is known the posterior probability density is said to be available in ‘closed form’ 
and the Gibbs sampler makes use of standard density functions (e.g. Gamma, Beta etc.) 
where the same algebraic form exists for the prior, the likelihood and the posterior. An 
example is the Beta distribution for proportion data y/n, used by Forrester et al. (2007) to 
estimate MRSA test sensitivity. The Gamma distribution is used for count data, the Inverse 
Gamma for variances (Carlin & Louis, 2000). 
For more complex models D may be impossible to compute, and the Hastings-Metropolis 
approach can be used instead (Metropolis et al., 1953). A likelihood function is considered 
for each unknown parameter in turn, conditional on the data and the other unknown 
parameters. This is equivalent to the full likelihood with all other unknown parameters 
fixed, e.g. p(y,θ1|θ2, θ3). The algorithm works by iteratively sampling a ‘candidate’ 
parameter value, say θ1*, from a ‘proposal distribution’ which may be the prior density 
function, π(θ), or a multivariate normal density with means μ = (θ1, θ2, θ3) and some 
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variance-covariance matrix Σ (Carlin & Louis, 2000). The candidate density is then 
accepted with probability r where 
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The list of accepted parameter values makes up the Markov chain. No matter what starting 
values for θ, the chain converges to the posterior distribution. When discarding the first 500 
iterates or so we obtain an ‘ergodic’ chain whose distribution can be used to measure 
confidence intervals for the estimates. 
Forrester et al. (2007) applied a mixture of MCMC approaches to MRSA carriage data from a 
patient cohort admitted to a 12-bed ITU with 2 isolation rooms. Their parameter space, θ = 
(β0, β1, β2, φ, ρ) is represented by a background infection rate (β0) and transmission 
coefficients β1 (from other patients) and β2 (from patients in isolation rooms), as well as the 
probability of colonization on admission to the ITU (φ) the sensitivity of the MRSA 
screening test (ρ), the time of MRSA colonization, ci, for patient i. The data were dates of 
admission (ai), first positive swab (vi), isolation (qi) and discharge (ri). For a discussion of 
results see Section 4. Similar approaches have been used for Stapylococcus aureus (McBryde et 
al., 2007), VRE (Cooper et al., 2008) and swine flu (Hohle et al., 2005). 
There is a philosophical problem with more realistic (and complex) models. The model may 
never fit the precise circumstances of the data, and estimated parameters may not be truly 
representative of the target situation. This is the case of norovirus outbreaks (section 5), with 
rare epidemics involving small numbers of cases, each on different wards with their own 
idiosyncratic sets of infection control approaches and patient management. Even when 
epidemic data are available for such a specific settings it is by no means certain that they are 
representative of a common ‘true’ underlying model. A pragmatic approach is to illustrate a 
point by using a set of parameter values vaguely consistent with observation. 
4. Some conclusions from the literature 
4.1 Screening and surveillance 
The advantage of screening is three-fold: 1) detection protects the positive case when 
measures are taken to clear carriage; 2) isolation of positives prevents transmission to other 
inpatients; 3) removal of carriage from the community means less imported cases in future 
re-admissions. Bootsma et al. (2006) used a stochastic model to compare six infection control 
components that are part of what is known as the “search and destroy” approach, including 
the passive treatment and isolation of known MRSA carriers, the screening of all patients 
and health-care staff in affected wards, and the eradication of colonization at discharge. 
They find that treatment of known carriers and screening of contact patients can bring down 
prevalence from 15% and maintain low endemicity (<1%), but additional screening (such as 
of staff in affected wards) does not offer additional benefit. 
The paradox is that when HAI screening is successful it becomes less cost effective (Raboud 
et al., 2005; Hubben et al., 2011). Raboud et al. modelled a Canadian hospital ward with 1.3% 
MRSA prevalence and showed that culture-based MRSA screening is cost-effective so long 
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algorithms such as Powell’s direction set methods (Press et al., 1994; Chapter 10). Maximum 
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as there is at least 1 case for every 2 to 3 years, but MRSA infection is too infrequent to 
justify a more expensive molecular test. Hubben et al. compared two settings: high 
prevalence (15%) vs. medium prevalence (5%) of MRSA carriage. The molecular test was 
more cost effective at high prevalence, whereas the culture based chromatogenic test was 
more cost effective at medium prevalence, in spite of the advantages of molecular tests (high 
sensitivity, result in hours). 
Robotham et al. (2007) use a stochastic model and find random screening (at rate φ per 
patient per day) more effective at detecting MRSA carriers than screening a proportion ω of 
all admissions. While this is a more realistic model as it assumes limited isolation capacity 
(20 rooms), the bizarre result is more likely the result of the unrealistic assumption of a 
homogeneous inpatient population and randomly distributed MRSA carriers within it. Their 
baseline 40% prevalence is an extreme exaggeration (5 to 10% would be more likely) and the 
assumption of no infection control other than isolation is unrealistic. Ultimately admission 
screening is reputed successful, partly because it targets prevalence in the fraction of the 
catchment population re-admission risk and partly because it targets patients in ITU, an 
important reservoir “for generating and then seeding the rest of the hospital with MRSA-
colonized patients” (Edgeworth, 2011). 
4.2 Isolation 
The practice of isolation originates at least from the 1600s, when those affected by the plague 
were isolated in secluded buildings (Cipolla, 1973). The evidence in favour of isolation on 
the hospital ward may depend on the type of ward. Cooper et al. (2003, 2004b) carried out a 
Cochrane review and identified 46 studies that addressed the issue. Not one study was fully 
clear of methodological shortcomings. The authors subsequently designed and carried out a 
new study to address such study design problems (Cepeda et al., 2005). They chose ITU 
inpatients, a study population with special issues around the act of switching off life 
support machinery in order to move patients to isolation facilities and measured acquisition 
of MRSA carriage and infection over a period of 12 months as outcome. They applied a 
quasi-experimental cross-over design comparing isolation with no isolation, and controlled 
for numerous potential confounders such as nursing hours per patient, severity of 
underlying disease and antibiotic usage. No beneficial effect of isolation was detected 
(multivariate relative risk of infection for non-isolation: 0.73, 95% confidence intervals: 0.49-
1.10). Unfortunately their design lacked adequate temporal controls leaving conclusions 
open to uncertainty. Hand-hygiene compliance in staff was also low (21%) and isolation was 
not expected to work anyway (Huskins & Goldmann, 2005). 
By contrast, Cooper et al. (2004a) used a stochastic model of MRSA in a homogeneous 1000 
bed-hospital and showed that 20-bed isolation units are successful in controlling and 
eradicating MRSA from hospital inpatients, so long as R0 < 1.3, although this can take as 
much as 15 years to achieve. This is consistent with “search and destroy” being effective 
only in low-prevalence situations such as in Denmark and the Netherlands (Wertheim et al., 
2004). In high endemic countries (e.g. USA and UK), isolation alone is not sufficient, 
especially if isolation is not 100% efficient. Forrester et al. (2007), estimate non-zero 
transmission rates from isolated inpatients (β2=0.0045), although smaller than for non-
isolated patients (β1 = 0.0131). 
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4.3 Antimicrobial resistance 
Early models of antibiotic resistance were deterministic and concerned large host 
populations (Levin, 2002). Austin et al. (1999b) modelled bacterial carriage, where 
individuals may be colonized with one of two possible variants (one susceptible and one 
resistant to antibiotics) and may or not be treated with antibiotics. The absence of a co-
carrier state means the two variants compete for colonization space. In the absence of 
antibiotics the sensitive variant has a selective advantage (greater transmission coefficient). 
They fitted the model to β-lactam resistance in Moraxella catarrhalis from Finland (where 
cephalosporin usage increased), and to penicillin-resistance in pneumococci from Iceland 
(where antibiotic usage declined) and found that significant reductions in resistance require 
equally significant reductions in drug consumption.  
Lipsitch et al. (2000) used a similar deterministic model for antibiotic resistance in the 
hospital, with the addition of categories of ‘history of past usage’. They found that when 
reductions in antibiotic usage are implemented, the response is rapid—weeks to months—
the dynamics being driven by replacement of resistant variants by sensitive admissions. 
Unfortunately this prediction is not always consistent with observation (Enne et al., 2001; 
Sundqvist et al., 2010; Cook et al., 2004), possibly due to compensatory mutations that 
counter genetic costs of resistance (Wijngaarden et al., 2004; Besier et al., 2005) or because 
resistance to one antibiotic is genetically linked to resistance to other antibiotics that are still 
in use (Enne et al., 2004; Fraser et al., 2005). The expectation of a ‘rapid’ response may also 
be explained by the implicit assumption of 100% competition for ‘susceptible space’ between 
variants. The inclusion of a co-carrier state in the model would allow for milder forms of 
competition, and slower responses to changes in antibiotic usage. 
Similar work focused on optimal empirical treatment strategy, when sensitivity knowledge 
is absent or delayed. Haber et al. (2010) used a stochastic, model and concluded that 
antimicrobial resistance should drop within months (rather than years) when a switch to 
second-line drugs is made. Kouyos et al. (2011) modelled MRSA carriers and infections on a 
20-bed ward assuming clinicians can choose between two broad spectrum antibiotics (A and 
B) while they wait for antibiotic sensitivity results from the laboratory (so that a narrow-
spectrum drug can be given). They compared the performance of a number of empirical 
treatment strategies: mixing (simultaneous use of different drugs in different patients), 
cycling (sequential use of different drugs), and informed switching strategies (ISS) which 
can take many forms. Sensitivity analyses showed the optimal strategy to be ISS with 
deployment of drugs at frequencies inversely proportional to their respective resistance 
frequencies, especially if historical data are used (their ISS7). 
4.4 Barrier precautions and cohorting 
Sebillé et al. (1997) used a deterministic model of S aureus, and showed that it takes >60% 
hand hygiene compliance to reduce prevalence from 30% to below 20%. Austin et al. (1999a) 
used a deterministic model of VRE where patients and staff infect each other by direct 
contact. They find the role of barrier precautions (gowns, gloves and hand-hygiene) and 
cohorting of major importance in controlling VRE infection. This is probably because they 
ignore the effect of environmental contamination on transmission, a choice based on pulse 
field gel electrophoresis of bacteria isolated from patients, HCWs and the environment 
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as there is at least 1 case for every 2 to 3 years, but MRSA infection is too infrequent to 
justify a more expensive molecular test. Hubben et al. compared two settings: high 
prevalence (15%) vs. medium prevalence (5%) of MRSA carriage. The molecular test was 
more cost effective at high prevalence, whereas the culture based chromatogenic test was 
more cost effective at medium prevalence, in spite of the advantages of molecular tests (high 
sensitivity, result in hours). 
Robotham et al. (2007) use a stochastic model and find random screening (at rate φ per 
patient per day) more effective at detecting MRSA carriers than screening a proportion ω of 
all admissions. While this is a more realistic model as it assumes limited isolation capacity 
(20 rooms), the bizarre result is more likely the result of the unrealistic assumption of a 
homogeneous inpatient population and randomly distributed MRSA carriers within it. Their 
baseline 40% prevalence is an extreme exaggeration (5 to 10% would be more likely) and the 
assumption of no infection control other than isolation is unrealistic. Ultimately admission 
screening is reputed successful, partly because it targets prevalence in the fraction of the 
catchment population re-admission risk and partly because it targets patients in ITU, an 
important reservoir “for generating and then seeding the rest of the hospital with MRSA-
colonized patients” (Edgeworth, 2011). 
4.2 Isolation 
The practice of isolation originates at least from the 1600s, when those affected by the plague 
were isolated in secluded buildings (Cipolla, 1973). The evidence in favour of isolation on 
the hospital ward may depend on the type of ward. Cooper et al. (2003, 2004b) carried out a 
Cochrane review and identified 46 studies that addressed the issue. Not one study was fully 
clear of methodological shortcomings. The authors subsequently designed and carried out a 
new study to address such study design problems (Cepeda et al., 2005). They chose ITU 
inpatients, a study population with special issues around the act of switching off life 
support machinery in order to move patients to isolation facilities and measured acquisition 
of MRSA carriage and infection over a period of 12 months as outcome. They applied a 
quasi-experimental cross-over design comparing isolation with no isolation, and controlled 
for numerous potential confounders such as nursing hours per patient, severity of 
underlying disease and antibiotic usage. No beneficial effect of isolation was detected 
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(Bonten et al., 1996). Raboud et al. (2005) used a similar model and made compliance 
dependent on the type of contact: with non-isolated patients (low-risk visits, 34% vs. high-
risk visits, 74%), and isolated patients (low-risk visits, 75% vs. high-risk visits, 85%). They 
show that increasing hand-hygiene compliance by just 10% can result in a 50% reduction in 
the number of MRSA cases. Grundmann et al. (2002) applied the same model of Austin et al. 
to MRSA, and conclude that a 10% increase in hand-hygiene compliance might compensate 
the ill effects of staff shortage, though very difficult to achieve because above a certain level 
of compliance hand-hygiene gets in the way of life-saving action. 
Beggs et al. (2008) use a modified version of an earlier model used by Cooper et al. (1999) 
where the patient-staff contact structure is explicitly modelled (as in Austin et al. 1999a), 
except that they distinguish between hand-hygiene compliance from hand-hygiene efficacy. 
They argue that a low hand-hygiene rate (20-40%) is enough to control S aureus infections, 
and additional improvements in compliance yield diminishing returns. Their 
deterministic model is however not ideal for a population of 20 inpatients and 3 staff 
members. The assumption of equal patient-staff and staff-patient contact rates is 
unrealistic (Ong et al., 2008). Beggs et al. (2009) reach similar conclusions with a stochastic 
approach. In each simulation the HCW makes 100 journeys from patient A (the source of 
MRSA) to patient B. MRSA is transmitted from A to HCW (with probability p’) and from 
HCW to patient B (with probability p). The integer of a normally distributed random 
number gives the number of hand hygiene events out of 100 journeys. Each batch of 
journeys is repeated 1000 times. Should transmission occur between A and B, the risk of 
infection is 1 if no hand hygiene event takes place, and 1-λ otherwise (λ is hand-hygiene 
efficacy). They use p’ = 0.4 and p = 0.1 as estimated for VRE in the intensive care unit 
(Austin et al., 1999a), an odd choice given that it is meant for MRSA (supposedly 0.15 and 
0.01 respectively; Grundmann et al., 2002). The hand-hygiene efficacy was either λ = 0.58 
(antibacterial soap) or λ = 0.83 (alcohol-based solution). No indication is given as to how 
the standard deviations were chosen. They suggest that when hand hygiene compliance is 
low the alcohol-based solution confers little advantage. Their model seems unrealistic as 
infection is only allowed in one direction, there are only 4 patients at most, and the HCW 
is not allowed to infect multiple patients. 
5. Norovirus on a UCLH elderly care ward 
In January 2009 a 63-bed ward in a UCLH hospital had an outbreak of norovirus affecting 
39 cases (only 19 of which were laboratory confirmed). The time-line of the outbreak is 
shown in Figure 2. 
5.1 The model 
In collaboration with the HPA work began to gather data to inform a MCMC model of 
norovirus spread among inpatients and staff on a ward stratified into bays. The idea was to 
build an outbreak simulator flexible enough to help members of the infection control office 
make decisions during an outbreak. On a day-to-day basis, they would alter the settings so 
as to match the ward ‘state’, as well as specifying the infection control strategy of interest. 
Figure 3 illustrates in more detail the spatial structure of the ward affected by the outbreak: 
13 bays (3-4 beds each), and 7 isolation rooms. Users could then run batches of simulations 
and learn from the outcome.  
 




Fig. 2. Time-line of UCLH outbreak. IR = isolation room, each column represents one bay 
(beds numbered in brackets); numbers are cases (laboratory confirmed if in a bold square). 
Bays were closed to admission (grey squares), turned into isolation wards (blue squares) 
and deep cleaned (black squares). 
The model concerns the infectious status of individuals (inpatients and staff) and inpatients 
are mapped on beds nested within bays. Patient and HCW movements are implicitly 
modelled via transmission coefficients stratified so as to distinguish between contacts within 
a bay (β0), across bays (β1) and with HCWs (β2). Transmission from isolation rooms is 
assumed nil. The βs were chosen so as to match the known distribution of outbreak sizes, 
and attack rates in inpatients and staff from UK hospitals (Lopman et al., 2004; Harris et al., 
2010), matching interquartile ranges for outbreak sizes (6 to 92 days) and attack rates (6% to 
65% for inpatients and 18% to 43% for staff). Each Member of staff is assigned a selection of 
bays. Bed occupancy may be under 100% and discharged patients are immediately replaced 
with a new admission (not necessarily to the same bed as the dischargee). Cases may not be 
discharged until they have recovered. Staff members ‘rotate’ shifts of 5 working days each 
and 2 days leave in between. Diarrhoea caused by agents other than norovirus (e.g. 
antibiotics, other viruses) affects 5% of inpatients.  
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Fig. 2. Time-line of UCLH outbreak. IR = isolation room, each column represents one bay 
(beds numbered in brackets); numbers are cases (laboratory confirmed if in a bold square). 
Bays were closed to admission (grey squares), turned into isolation wards (blue squares) 
and deep cleaned (black squares). 
The model concerns the infectious status of individuals (inpatients and staff) and inpatients 
are mapped on beds nested within bays. Patient and HCW movements are implicitly 
modelled via transmission coefficients stratified so as to distinguish between contacts within 
a bay (β0), across bays (β1) and with HCWs (β2). Transmission from isolation rooms is 
assumed nil. The βs were chosen so as to match the known distribution of outbreak sizes, 
and attack rates in inpatients and staff from UK hospitals (Lopman et al., 2004; Harris et al., 
2010), matching interquartile ranges for outbreak sizes (6 to 92 days) and attack rates (6% to 
65% for inpatients and 18% to 43% for staff). Each Member of staff is assigned a selection of 
bays. Bed occupancy may be under 100% and discharged patients are immediately replaced 
with a new admission (not necessarily to the same bed as the dischargee). Cases may not be 
discharged until they have recovered. Staff members ‘rotate’ shifts of 5 working days each 
and 2 days leave in between. Diarrhoea caused by agents other than norovirus (e.g. 
antibiotics, other viruses) affects 5% of inpatients.  
 




Fig. 3. Layout of the UCLH geriatric ward affected by the norovirus outbreak (blue squares 
indicate bays, and red rectangles are isolation rooms). 
A 60 day simulation period is split into ‘time steps’ of width Δt (starting with Δt = 3 hours). 
For some events (acquisition of norovirus, detection of norovirus in the laboratory, 
acquisition and recovery of norovirus-unrelated diarrhoea) we used exponentially 
distributed waiting-time probability methods, equivalent to Poisson distributed numbers of 
events per time step (Ross, 2006). When the probability of two or more events per time step 
exceeded 0.01, we halved Δt. For other events, we sampled from exact distributions. Times 
to discharge are sampled from the observed distribution of length of stay on this ward for 
January 2008 (mean 7.2 days), in the absence of an outbreak. Times to onset of symptoms 
come from experimental studies on US convicts (mean 36 hours, Wyatt et al., 1974) and 
times to recovery come from observational work from the Avon region, UK (Lopman et al., 
2004). Immunity to norovirus was initially set to 30% in patients and 60% in staff members. 
Each simulation begins with the introduction of an infectious individual admitted to a 
random bed. Not all seeding events result in an outbreak. Most outcome measures (attack 
rates, outbreak durations, bed days lost to closing bays or wards to new admissions) are 
obtained from the subset of 200 simulations where an outbreak did take place. On 
acquisition individuals incubate norovirus, then become infectious and finally recover into 
the immune category. Two definitions of a norovirus ‘case’ were investigated: a) laboratory 
confirmed positives with 50% sensitivity (Vinjé et al., 2003; de Bruin et al., 2006) and a 1 day 
average delay to laboratory result, or b) acquisition symptoms (diarrhoea and/or vomiting).  
Infection control measures take place 3 days after an outbreak is declared (two cases within 
seven days of each other) and include i) isolation of ‘cases’ into one of the isolation rooms, 
depending on availability (initially assumed fully occupied); ii) closure of affected bays to 
admissions until the last bay patient has recovered; iii) closure of the whole ward to 
readmission until the last case of the outbreak has recovered; iv) affected staff are sent home 
and may not return to work until 48 hours after recovery; v) restriction of patient-staff 
 
Models of Hospital Acquired Infections 
 
55 
assortment (baseline: 6 staff members look after beds 1-31, the other 6 look after beds 32-63, 
as observed on the UCLH ward). 
5.2 Results and discussion 
The outcomes of three control strategies are shown in Fig. 4. In comparing strategies, 
medians are not as meaningful as ranges. Waiting for laboratory confirmation is equivalent 
to no control, because of the delay to the laboratory results, and low test sensitivity (half the 
cases missed). Acting on symptoms works best, except that in wards with non-specific 
symptoms it leads to unnecessary bay closures (Fig. 4b). Closing the ward leads to short 
term losses in patient-days, but control is swift and the outbreak is soon over, with little 
variability in outbreak sizes. These strategies are extremes and serve only for illustration. In 
real life managers are more likely to adopt mixed strategies: closing the ward for a few days 
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Fig. 4. Output of the stochastic model. Lines and error bars represent the median, 10th and 
90th centiles. 
bays (Fig. 2). The model could be made more realistic, allowing for mixed strategies. 
Transmission could be made dependent on actual distance between bays. This may not be 
necessary when patients do not move (e.g. ITU) and when they move ‘too much’ (physical 
distance being no distance). Environmental contamination could be added, allowing 
 




Fig. 3. Layout of the UCLH geriatric ward affected by the norovirus outbreak (blue squares 
indicate bays, and red rectangles are isolation rooms). 
A 60 day simulation period is split into ‘time steps’ of width Δt (starting with Δt = 3 hours). 
For some events (acquisition of norovirus, detection of norovirus in the laboratory, 
acquisition and recovery of norovirus-unrelated diarrhoea) we used exponentially 
distributed waiting-time probability methods, equivalent to Poisson distributed numbers of 
events per time step (Ross, 2006). When the probability of two or more events per time step 
exceeded 0.01, we halved Δt. For other events, we sampled from exact distributions. Times 
to discharge are sampled from the observed distribution of length of stay on this ward for 
January 2008 (mean 7.2 days), in the absence of an outbreak. Times to onset of symptoms 
come from experimental studies on US convicts (mean 36 hours, Wyatt et al., 1974) and 
times to recovery come from observational work from the Avon region, UK (Lopman et al., 
2004). Immunity to norovirus was initially set to 30% in patients and 60% in staff members. 
Each simulation begins with the introduction of an infectious individual admitted to a 
random bed. Not all seeding events result in an outbreak. Most outcome measures (attack 
rates, outbreak durations, bed days lost to closing bays or wards to new admissions) are 
obtained from the subset of 200 simulations where an outbreak did take place. On 
acquisition individuals incubate norovirus, then become infectious and finally recover into 
the immune category. Two definitions of a norovirus ‘case’ were investigated: a) laboratory 
confirmed positives with 50% sensitivity (Vinjé et al., 2003; de Bruin et al., 2006) and a 1 day 
average delay to laboratory result, or b) acquisition symptoms (diarrhoea and/or vomiting).  
Infection control measures take place 3 days after an outbreak is declared (two cases within 
seven days of each other) and include i) isolation of ‘cases’ into one of the isolation rooms, 
depending on availability (initially assumed fully occupied); ii) closure of affected bays to 
admissions until the last bay patient has recovered; iii) closure of the whole ward to 
readmission until the last case of the outbreak has recovered; iv) affected staff are sent home 
and may not return to work until 48 hours after recovery; v) restriction of patient-staff 
 
Models of Hospital Acquired Infections 
 
55 
assortment (baseline: 6 staff members look after beds 1-31, the other 6 look after beds 32-63, 
as observed on the UCLH ward). 
5.2 Results and discussion 
The outcomes of three control strategies are shown in Fig. 4. In comparing strategies, 
medians are not as meaningful as ranges. Waiting for laboratory confirmation is equivalent 
to no control, because of the delay to the laboratory results, and low test sensitivity (half the 
cases missed). Acting on symptoms works best, except that in wards with non-specific 
symptoms it leads to unnecessary bay closures (Fig. 4b). Closing the ward leads to short 
term losses in patient-days, but control is swift and the outbreak is soon over, with little 
variability in outbreak sizes. These strategies are extremes and serve only for illustration. In 
real life managers are more likely to adopt mixed strategies: closing the ward for a few days 






0 5 10 15 20 25 30 35 40 45 50










C lose bays  with confirmed norovirus
C lose the whole ward







0 5 10 15 20 25 30 35 40 45 50














s C los e bays  with confirmed norovirusC los e the whole ward
C los e bays  with symptoms
 




















C los e only bays  with lab c onfirmed norovirus
C los e bays  with jus t c linic al s ymptoms
C los e the whole ward
Day before c ontrol beg ins






















C los e only bays  with lab c onfirmed norovirus
C los e bays  with jus t c linic al s ymptoms
C los e the whole ward
Day before c ontrol beg ins
0 1 2 3 4 5 6 no 
c ontrol
 
  c) Outbreak duration (days)   d) Attack rates (% patients) 
Fig. 4. Output of the stochastic model. Lines and error bars represent the median, 10th and 
90th centiles. 
bays (Fig. 2). The model could be made more realistic, allowing for mixed strategies. 
Transmission could be made dependent on actual distance between bays. This may not be 
necessary when patients do not move (e.g. ITU) and when they move ‘too much’ (physical 
distance being no distance). Environmental contamination could be added, allowing 
 
Infection Control – Updates 
 
56
investigation of the impact of deep cleaning. Another aspect is building design. In our case 
we had an open ward where patients could infect other patients (β0 > β1 > 0). Some wards 
have physical barriers (rooms rather than bays), and HCWs become the main transmission 
vectors, allowing barrier precautions as well as relative cohorting to be much more effective. 
6. Conclusions 
The ideal HAI model is stochastic, simulates patient movement between wards of a set of 
hospitals, stratifies model parameters according to ward location (ITU, AAU, surgical, 
geriatric, infectious diseases wards etc.), stratifies the extramural population by re-
admission rate, stratifies by different categories of HCW, accounts for surveillance and 
delays in diagnosis, includes antibiotic usage, contaminated environment, and allows for all 
possible forms of infection control. In reality this level of complexity is not necessary to 
address questions for a specific setting. Most HAI models deal with MRSA in ITU, a mere 
fraction of all HAIs. The main lesson is there is no universal answer. Success depends on 
local conditions (e.g. epidemic/endemic setting, patient mobility, aetiological agent, 
treatment and intervention costs). 
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1. Introduction 
Infectious diseases are a global concern and the second commonest cause of death in the 
world. Of the annual 15 million deaths, 95% occur in the developing world, with 
predominance of acute respiratory infections, diarrhoeal diseases, measles, AIDS, malaria and 
tuberculosis (World Health Organization, 2008). More than 1 billion inhabitants in this part of 
the world do not have access to safe water and basic sanitation (Moe & Rheingans, 2006). 
Health care-associated infections (HCAIs) constitute an important health challenge 
worldwide and pose a major threat to patient safety. Risks for acquiring infections during 
health care delivery have increased dramatically with advances in diagnostic and treatment 
procedures. In developing world this challenge is more highlighted because infection 
prevention and control policies are either nonexistent, poorly adapted or insufficiently 
funded by governments (Ponce-de-Leon & Macias, 2003). Therefore, infections are between 
2-6 times higher than those in developed world. 
Hospitals are main facilities for the risk of acquiring an infection during the delivery of 
care. Therefore infection control and prevention activities are focused mainly at the 
hospital level. The rates of HCAIs within a hospital represent the best indicator for the 
quality of services offered, where a high frequency of HCAIs is evidence of a poor quality 
of health service delivery. But, nowadays their occurrence is increasing in outpatient 
clinics and in nursing homes as well.  
HCAIs impact on the population in many ways. They affect patients directly, causing 
increased morbidity and mortality; they may lead to disability and may reduce quality of 
life (Pittet et al., 2008). They also impact on the healthcare system by extending 
hospitalization of affected patients and driving up the costs of diagnosis and treatment. 
HCAIs may be transmitted from healthcare settings into the community. They also may be a 
subject of indictment by the treated patients in hospitals, decreasing the reputation of 
healthcare institutions in the eyes of the public. 
The endemic burden of HCAIs is significantly higher in developing countries, in particular 
in patients admitted to intensive care units and in neonates (Raka, 2008). Most developing 
countries lack surveillance systems for HCAI. They usually have limited and low quality 
data (Allegranzi et al., 2011). In developing world there are many determinants, which are 
specific to settings with limited resources described below. 
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2. Challenges of infection control in developing countries 
2.1 Health care and hospitals in developing world - Constraints and outcomes 
2.1.1 Resources and incomes  
Resources and incomes are unequally distributed throughout the world. Country economies 
are divided among income groups according to 2008 gross national income (GNI) per capita, 
calculated using the World Bank Atlas method. Countries with low income ( $975 or less) 
and lower middle income ( $976–3,855) are referred to as developing countries and they 
represent more than 75% of the world population. Prevention and control in low and middle 
income countries differs substantially from that in the developed world with high income. 
Limited resources represent the main challenge for governments in developing countries 
(Lynch et al., 2007). There may be a lack of commitment to healthcare by policy-makers in 
the developing world and allocation of funds is often disproportionate to the priorities set 
by providers. Priority in the allocation of funds is often directed to visible targets within 
society such as schools, infrastructure and security. Healthcare frequently is far behind. 
Even in countries where the healthcare budget is given high priority, the proportion 
devoted to prevention of HCAIs is usually insufficient.  
2.1.2 Health care system and society 
Health systems in developing countries are hospital-dominated, with 50-80% of resources 
allocated to hospitals in urban centres, which often have tertiary academic affiliations. On 
the other hand a large number of people present to the other regional hospitals, which have 
inadequate resources, staff training, and motivation with an impact on the health of millions 
of people (Duke et al., 2006). 
Corruption and nonformal payments are frequent in developing countries. Inadequate 
salaries lower the healthcare workers’ motivation for quality care. Information systems are 
not fully developed. There are limited grants available for research and no legislation 
mandating accreditation of hospitals and infection control programmes. In-service training 
for employees is highly variable and often minimal. Patients and their families may be 
required to provide care materials such as syringes, surgical gowns, and drugs. Frequent 
movement of patients and staff between hospitals wards results in an increased risk of 
transmission of multidrug-resistant microorganisms (Clements et al., 2008). Such 
transmission is often exacerbated by overcrowding, with patients sometimes sharing beds 
and supplies.  
During the last few decades, infection control activities in developing countries have 
increased, particularly in South America, South East Europe and countries of the former 
Soviet Union (Morris, 2008). Public pressure to improve the quality of hospital care, the 
increased cost of HCAIs in healthcare systems, the emergence of multiresistant 
microorganisms, the approach of occupational hazards have played an important role in this 
development. 
In many hospitals of developing countries adequate supplies to control and prevent 
infections are not available. Compliance with hand hygiene is often very low. Many other 
problems abound; for example, sterilisation departments are not centralised and there is 
lack of quality control in disinfection and sterilisation. Although many hospitals in the 
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developing countries may have infection control programmes and committees on paper, in 
practice they barely exist. Inadequate numbers of trained personnel work in infection 
control, and face continual resistance from clinical staff. This litany of problems means that 
the response to common outbreaks of disease in high risk units by management and staff is 
mainly reactive rather than proactive. Lack of ongoing surveillance results in delays in 
detecting outbreaks, with increasing costs and mortality. 
Baseline endemic infection rates are not established by the hospital authorities in vast 
majority of developing countries and usually there is no anticipation of the possible risks of 
acquiring a HCAI. Infection control does not exist as a medical or nursing speciality, and 
formal training programmes on infection control are not available in medical schools of 
developing world. In addition to mentioned constraints, frequent malnutrition and other 
types of infection and diseases contribute to increase the risk of HCAIs in developing 
countries. Poverty, war, economic and political disturbances all significantly increases 
HCAIs (Lynch et al., 2007). As a result of the weakness and problems outlined above, 
developing countries face the challenge of high rates of HCAIs and frequent outbreaks.  
2.2 Blood and injection safety 
Transfusion and injections may pose a risk for transmission of HIV and hepatitis in 
developing world. Between 5% and 10% of human immunodeficiency virus (HIV) infections 
worldwide are transmitted through transfusion of contaminated blood and blood products. 
Over 16 billion injections are administered each year in developing countries and the 
proportion of injections given by syringes and needles that are reused without sterilization 
ranges from 1.5 to 69.4% (Simonsen et al., 1999). Improper waste disposal is present in 18- 
64% of health care facilities of developing countries (World Health Organization, 2005). The 
2000 Global Burden of Disease study, death and disability from injection-associated 
infections by hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV revealed that 
patients received an average of 3.4 injections per year, 39.3% of which were given with 
reused equipment. Contaminated injections caused an estimated 21 million HBV infections, 
2 million HCV infections and 260 000 HIV infections, accounting for 32%, 40% and 5%, 
respectively, of new infections (Hauri et al., 2004).  
2.3 The burden and impact of health care-associated infections 
HCAIs represent one of the commonest adverse event during delivery of health care, 
complicating 5-10% of admissions to acute care hospitals in industrialised countries. Pooled 
prevalence of HCAI in Europe is 7.1% with range 3.5– 11.3% (ECDC, 2008). More than 4 
million patients are affected by HCAI every year in Europe and 1.7 million in USA. In 
developed countries, approximately 25-30% of patients admitted to Intensive Care Unit 
(ICU) are affected by HCAI. Urinary tract infections constitute a predominant portion of 
HCAIs with 30-40% of the overall infections. 
In developing countries the global picture of the burden of HCAI is unknown due to lack of 
reliable data and the use of different definitions and methodologies. Many developing 
countries have not conducted any surveillance studies regarding HCAIs and few studies 
provide information on etiology and risk factors for HCAIs (Allegranzi et al., 2011). Only 23 
developing countries of 147 (15.6%) reported a functioning HCAI national surveillance 
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developing countries may have infection control programmes and committees on paper, in 
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developing countries face the challenge of high rates of HCAIs and frequent outbreaks.  
2.2 Blood and injection safety 
Transfusion and injections may pose a risk for transmission of HIV and hepatitis in 
developing world. Between 5% and 10% of human immunodeficiency virus (HIV) infections 
worldwide are transmitted through transfusion of contaminated blood and blood products. 
Over 16 billion injections are administered each year in developing countries and the 
proportion of injections given by syringes and needles that are reused without sterilization 
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system in 2010. Hospital-wide prevalence of HCAI in developing countries varied from 
5.7% to 19.1%. A review of several studies in developing world showed that increased 
length of stay associated with HCAI varied between 5 and 29.5 days. 
Surgical site infection (SSI) is the most surveyed and most frequent type of infection in 
developing countries with incidence rates ranging from 1.2 to 23.6 per 100 surgical 
procedures and a pooled incidence of 11.8%. By contrast, SSI rates vary between 1.2% and 
5.2% in developed countries (Allegranzi et al., 2011). Incidence of ICU-acquired infection is 
at least 2–3 fold higher than in high-income countries; device-associated infection densities 
up to 13 times higher than in the USA were reported in some studies. 
Ventilator-associated pneumonia (VAP) is a leading cause of death in hospitalised patients. 
A meta-analysis of articles concerning VAP in developing countries in MEDLINE (January 
1966 to April 2007) showed rates from 10 to 41.7 per 1000 ventilator-days; crude mortality 
ranged from 16% to 94% and with increased length of stay in intensive care (Arabi et al., 
2008). VAP attributable costs was US$ 10 000–25 000 per case. 
Many studies have shown the importance of HCAI among neonates in developing 
countries, where an average of 4384 children die every day of these infections (WHO, 2007). 
In a major review, reported rates of neonatal infections were 3-20 fold higher than those 
reported in industrialised countries (Zaidi et al., 2005). Neonatal infections are estimated to 
cause 1.6 million deaths annually, 40% of all neonatal deaths in developing countries (Lawn, 
2004). From microbiological prospective of HCAI in developing world the most frequent 
microbial pathogens were S. aureus in mixed patient populations, and Acinetobacter spp. in 
high-risk patients. 
The costs of HCAIs are substantial everywhere, although they varies between countries due 
to different health care systems. In countries with prospective payment systems based on 
diagnosis- related groups, hospitals lose from $583 to $4,886 for each HCAI. Annual 
economic impact of HCAIs in Europe is about 7 billion euro per year and 16 million extra-
days of hospital stay(ECDC, 2008). In the USA, associated costs are approximately US$ 6.5 
billion (Klevens et al., 2007). The cost to the government of Trinidad and Tobago for HCAIs 
was estimated at $697,000 annually. In Mexico, the annual cost approaches $1.5 billion; in 
Mexican ICUs, overall average cost of a HCAI episode was calculated at US$ 12 155 
(Higuera et al., 2007). In Thailand 10% of the annual hospital budget is spent on HCAIs 
(WHO, 2005). Some investigators have attempted to measure costs related to hospital 
outbreaks of HCAIs caused by multiresistant organisms. In a study of infections caused by 
MRSA it was estimated that average cost was $4000 per infection, whereas costs of C. 
difficile-associated diarrhea was approximately $4500 per patient (Stone, 2009). In an 
university hospital in Malaysia the cost of antibiotics prescribed to treat HCAI was 
estimated at US$ 521 000 per year (Hughes et al., 2005).  
2.4 Antimicrobial resistance 
Resistance to antimicrobial agents is a global challenge in all healthcare facilities. In 
developing countries inappropriate and uncontrolled use of antibiotics is very common 
and antimicrobials are frequently available over the counter in pharmacies. In many 
developing countries resistance among common pathogens to cheap antimicrobials has 
already increased drastically, resulting in limited effectiveness. The quality and potency 
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of antibiotics are often suspected, with unregulated import, registration and distribution. 
Another factor contributing to resistance is lack of antibiotic policies or basic 
recommendations at governmental level or within hospitals. Between 20% and 50% of a 
hospital budget is spent on antimicrobials, which are used to treat more than half of all 
patients. Even in developed countries >50% of antimicrobials are prescribed incorrectly, 
either administered in suboptimal doses or for incorrect duration (Wenzel, 2000). Misuse 
has been identified as an important factor in the emergence of antimicrobial resistance 
(Kollef, 2001). In turn, this resistance makes the clinical management of the patients more 
difficult. 
The use of antimicrobials in the veterinary area had an important impact on increase of 
antimicrobial resistance. Other factors contributing to increase of antimicrobial resistance 
are: limited number of new classes of antibiotics in pipeline by pharmaceutical companies 
and globalization, which enabled the rapid spread of multiresistant microorganisms 
worldwide (Okeke, 2005). 
 




(interquantile range,  
25-75%) 
Antibiotic resistant pathogen INICC 2002-2007 US NNIS 1992-2004 
Methicillin-resistant Staphylococcus 
aureus (MRSA) 80.8 (50.0-100.0) 52.9 (32.7-603) 
Methicillin-resistant coagulase-negative 
staphylococci 75.2 (64.0-100.0) 76.6 (69.4-83.8) 
Vancomycin-resistant enterococcus 
species 9.4 (0.0-6.3) 13.9 (5-24.3) 
Ciprofloxacin/ofloxacin-resistant 
Pseudomonas aeruginosa 52.4 (40.0-75.0) 34.8 (17.4-41.3) 
Imipenem-resistant P aeruginosa 36.6 (0.0-52.4) 19.1 (8.3-25.5) 
Ceftazidime-resistant P aeruginosa 51.7 (33.3-72.7) 13.9 (5-16.9) 
Piperacillin-resistant P aeruginosa 50.8 (36.4-75.0) 17.50 (7.5-19.5) 
Ceph3-resistant Enterobacter species 56.8 (30.8-80.0) 27.70 (17.4-36.4) 
Carbapenem-resistant Enterobacter 
species 8.5 (0.0-0.0) 0.70 (0.0-0.0) 
Ceph3-resistant Klebsiella pneumoniae 68.2 (33.3-85.7) 6.20 (0.0-8.0) 
Ceph3-resistant Escherichia coli 53.9 (11.1-80.0) 1.3 (0.0-2.6) 
Ciprofloxacin/ofloxacin-resistant E coli 42.6 (12.7-78.9) 7.30 (0.0-8.2) 
Table 1. Comparison of antimicrobial resistance rates (%) in the ICUs of the International 
Nosocomial Infection Control Consortium (INICCC) and the U.S. National Nosocomial 
Surveillance System (NNIS) (Rosenthal et al., 2010). 
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developing countries resistance among common pathogens to cheap antimicrobials has 
already increased drastically, resulting in limited effectiveness. The quality and potency 
 
Infection Control in Developing World 
 
69 
of antibiotics are often suspected, with unregulated import, registration and distribution. 
Another factor contributing to resistance is lack of antibiotic policies or basic 
recommendations at governmental level or within hospitals. Between 20% and 50% of a 
hospital budget is spent on antimicrobials, which are used to treat more than half of all 
patients. Even in developed countries >50% of antimicrobials are prescribed incorrectly, 
either administered in suboptimal doses or for incorrect duration (Wenzel, 2000). Misuse 
has been identified as an important factor in the emergence of antimicrobial resistance 
(Kollef, 2001). In turn, this resistance makes the clinical management of the patients more 
difficult. 
The use of antimicrobials in the veterinary area had an important impact on increase of 
antimicrobial resistance. Other factors contributing to increase of antimicrobial resistance 
are: limited number of new classes of antibiotics in pipeline by pharmaceutical companies 
and globalization, which enabled the rapid spread of multiresistant microorganisms 
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Table 1 presents overview of antimicrobial reisistance rates in ICU between INICC and 
NNIS system. The frequencies of resistance of Staphylococcus aureus isolates to methicillin 
(MRSA) (80.8% vs 52.9%), Enterobacter species to ceftriaxone (50.8% vs 17.8%), and 
Pseudomonas aeruginosa to fluoroquinolones (52.4% vs 34.8%) were also far higher in the 
Consortium’s ICUs. 
2.5 Consequences 
As a result of the weakness and problems outlined above, developing countries face the 
challenge of high rates of HCAI and frequent hospital outbreaks. Another consequence of 
insufficient infection control infrastructure is the spread of multidrug-resistant organisms, 
such are meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant 
Enterococcus spp. (VRE), extended-spectrum b-lactamase-producing Gram-negative bacilli, 
multidrug-resistant Mycobacterium tuberculosis and fluconazole-resistant Candida spp.  
3. Solutions and perspectives for prevention and control 
In order to improve the effectiveness of infection control in developing countries, a 
multifactorial initiatives needs to be implemented (Borg, 2010). Some of these initiatives are 
cheap and cost-effective, whereas others have a budget implications for governments. 
3.1 Prevention comes first 
Most countries address the problem of HCAI differently. As healthcare systems vary 
widely, so preventive strategies must be designed accordingly. The key component of 
solution is infection prevention. The prevention and control of HCAIs requires a triangle 
partnership between health care workers (HCW), government and community. Most HCAIs 
can be prevented with readily available and relatively inexpensive strategies. The Study on 
the Efficacy of Nosocomial Infection Control in 1974 showed that effective infection control 
programmes could reduce infection rates by as much as 32% and be cost-effective (Haley, 
1980). In an overview of published reports on the effect of infection control programmes 
from 1990 to 2002, Harbarth et al. found that between 10% and 70% of HCAIs were 
preventable (Harbarth, 2003). In the Hospital Sao Paulo in Brazil, there was a 71% decline in 
all HCAIs in the ICU when an infection control programme was implemented, saving about 
US $2 million (Cavalcante, 2001). Many other successful strategies have been documented. 
3.2 Political commitment and support 
In developing countries, the risk of patients and HCWs acquiring HCAIs could be 
significantly reduced if governments make infection control a high priority. Administrative 
controls are amongst the most important steps in prevention and control of HCAIs. 
Therefore a political support and commitment is essential in effectiveness of all other 
measures. National authorities must understand that without the proper resources, 
hospitals can be high risk areas. Therefore health care authorities must establish and 
support a comprehensive, effective national programme. Such a programme should set 
national objectives, and develop strategies, guidelines and policies for specific infection 
control issues, which are regularly updated. Many countries already have such 
 
Infection Control in Developing World 
 
71 
programmes. If these programmes are not available, those from the developed world should 
be adopted. Since developing countries have their own characteristic problems, these must 
be taken into account when formulating recommendations and policies (Raza et al.,2004). 
Due to their contact with patients or infected material from patients, many health care 
workers are at risk for exposure and possible transmission of infectious agents. Therefore 
occupational health and immunisation of HCWs is an essential part of prevention and 
infection control programmes (Randle, 2006). Moreover, education of HCWs and 
behavioural models complete the mosaic for prevention and control of HCAIs. 
3.3 Hand hygiene 
Hand hygiene remains the simplest and the primary measure to prevent HCAI and reduce 
spread of multidrug resistant organisms. Although hand hygiene is a simple measure, the 
lack of compliance among healthcare workers is problematic worldwide, averaging <40% 
(Boyce & Pittet 2002). In 2002, the CDC recommended the use of alcoholic hand rubs which 
have the advantage that they can be placed at the bedside (Hugonet et al., 2003). Also, where 
hand-washing facilities are primitive or scarce, it is often easier to provide a hand rub than 
sinks with running water and a functioning sewage system. Introduction of alcohol- based 
hand rub has led to increased hand hygiene compliance among healthcare workers and 
fewer HCAIs (Rosenthal et al., 2005). Today, many developing countries use WHO based 
formulation for alcoholic hand rub. In some developing countries, implementation of 
education, process surveillance, and performance feedback has considerably enhanced hand 
hygiene compliance (Damani, 2008).  
3.4 Surveillance 
Surveillance is an essential component in HCAIs prevention, with the aims of outbreak 
identification, establishment of endemic baseline rates of infection and the evaluation of 
control measures. Surveillance data can be used to identify preventable infections in high 
risk areas, so that resources are targeted to high priority areas. Surveillance of most 
important HCAIs should be accompanied by surveillance of antimicrobial use and 
resistance pattern. There is good evidence that antibiotic stewardship programmes have 
been successful in modifying antimicrobial prescribing practices, resulting in most instances 
in reduction of use (Gould, 1999). Unfortunately, such programmes are often lacking in 
developing countries, and antimicrobial resistance problems emphasise the importance of 
clinical microbiology laboratory services (Pfaller & Herwalt, 1997). 
3.5 The bundle approach 
In order to meet the required level of prevention, multiple strategies must be implemented 
simultaneously. Care bundles are part of a set of multiple intervention strategies to improve 
patient outcomes. They have been introduced in the USA by Institute for Healthcare 
Improvement and through the Saving Lives initiative produced by the UK Department of 
Health as hight impact interventions. Bundles are directed generally at aseptic procedures 
that carry a high risk of HCAI if not done properly (Westwell, 2008). These usually represent 
a set of three to five practices that, when performed collectively, reliably, and continuously 
have been proven to improve patient outcomes. Bundles also incorporate a simple audit tool 
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to check that they are being implemented. The bundles are focused on the most important 
HCAIs: catheter-associated bloodstream infection, catheter-associated UTI, ventilator-
associated pneumonia and SSI.  
Bundled interventions using systems quality improvement approaches for improved 
infection control in developing countries face many obstacles. Limited resources, poor 
infrastructure, insufficient equipment, lack of national guidelines, policies and evidence are 
key difficulties in successful implementation of bundle approach. 
3.6 Global initiatives: World alliance for patient safety  
Improving the safety of patient care is now a global issue. A growing awareness of HCAIs 
and patient safety prompted the World Health Organization (WHO) to promote the creation 
of the World Alliance for Patient Safety to coordinate, spread and accelerate improvements 
in patient safety (Allegranzi et al., 2007). Prevention of HCAI is the target of the Alliance’s 
First Global Patient Safety Challenge, ‘Clean Care is Safer Care’, launched in October 2005. 
Implementation strategies include the integration of multiple interventions in the areas of 
blood safety, injection safety, clinical procedure safety, and water, sanitation and waste 
management, with the promotion of hand hygiene in healthcare as the cornerstone. The 
main target of the campaign is 'Five Moments for Hand Hygiene' approach. It defines the 
key moments for hand hygiene with united vision. Various tools and resources have been 
developed to complement the Five Moments approach including localized country specific 
tool (Allegranzi & Pittet, 2009). 
3.7 Research 
One measure to improve the knowledge base of infection control is through research and 
development. Research resources for addressing infection control problems of developing 
countries remain disproportionately low compared with the disease burdens borne by these 
countries. National economies in developing countries remains too weak to support 
research and development. Research activities are sporadic and marginal, based mainly on 
individual initiatives in the university sector and with almost no support from governments. 
There is a need to focus these limited resources on research that will optimize health benefits 
with cost-effective interventions. Research priorities of developing countries in the field of 
HCAI are different compared to developed world. Research infrastructure should be 
focused on evaluating costs of HCAIs, risk factors for developing HCAI, hand hygiene, 
gather surveillance data on HCAI, study on antibiotic consumption and resistance 
patterns and monitor impact of infection control programmes. Publications from 
developing countries are increasing daily. An important window for research in 
developing countries arose through the International Nosocomial Infection Control 
Consortium (INICC). The INICC is the first multinational research network established to 
control HCAIs in hospitals in limited-resource countries. It has developed from South 
American hospitals in 1998 to a dynamic network of 450 healthcare centers in 108 cities, 
from 36 countries of 4 continents. It is the only source of aggregate standardized 
international data on HCAIs epidemiology in intensive care. 
INICC published a surveillance study from January 2003 through December 2008 in 173 
ICUs in Latin America, Asia, Africa, and Europe. During the 6- year study, using CDC 
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NNIS/NHSN definitions for device-associated healthcare-associated infection, 
prospective data were collected from 313,008 patients hospitalized in the consortium’s 
hospital ICUs for an aggregate of 2,194,897 days (Rosenthal et al., 2011). Despite the fact 
that the use of devices in the developing countries' ICUs was remarkably similar to that 
reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection 
were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-
associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was 
more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US 
ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 
per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 
vs. 3.3 per 1,000 catheter-days) and the crude unadjusted excess mortalities of device-related 





Pooled Mean (95% CI) 
U.S. NHSN 
2006-2008 
Pooled Mean (95% CI) 
Medical Cardiac ICU 
CLAB 6.2 (5.6 – 6.9) 2.0 (1.8 – 2.1) 
CAUTI 3.7 (3.2 – 4.3) 4.8 (4.6 – 5.1) 
VAP 10.8 (9.5 – 12.3) 2.1 (1.9 – 2.3) 
   
Medical-surgical ICU 
CLAB 6.8 (6.6 – 7.1) 1.5 (1.4 – 1.6) 
CAUTI 7.1 (6.9 – 7.4) 3.1 (3.0 – 3.3) 
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Newborn ICU (1501-2500 g) 
CLAB  11.9 (10.2 – 13.9) 1.5 (1.2 – 1.9) 
VAP 10.1 (7.9 – 12.8) 0.8 (0.04 – 1.5) 
   
CI, confidence interval; ICU, intensive care unit; DA-HAI, device associated health care associated 
infection; INICC, International Nosocomial Infection Control Consortium; NHSN, National Healthcare 
Safety Network; CAUTI, catheter-associated urinary tract infections; CLAB, central line-associated 
blood stream infection; VAP, ventilator-associated pneumonia. 
Table 2. Device associated infections (DAI) rates (per 1000 device-days) in the ICUs of the 
low income countries participating in International Nosocomial Infection Control 
Consortium (INICC) and the U.S. National Healthcare Safety Network(NHSN)(Rosenthal 
et al., 2011). 
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Isolation precautions with disinfection and sterilization comprise another important brick in 
the wall of infection control. Isolation precautions are important step in preventing 
transmission of infectious agents within the hospital wards. Isolation systems enable health 
care workers to identify patients who need to be isolated and undertake appropriate 
precautions. In developing world there is a lack of isolation rooms and usually patients with 
infections caused by same microorganisms are cohorted in same rooms. Personal protective 
equipment support achievement of this objective. Education of healthcare workers 
regarding standard precautions and safe and appropriate use of injections are important for 
prevention and control of HCAI. Important steps in prevention of HCAI are introduction of 
validated processes for decontamination, cleaning and sterilisation or high level disinfection 
of soiled instruments and other items; and improving safety in operating rooms and other 
high risk areas (Rutala & Webber, 2004). 
3.9 Infection control societies 
Many countries have not yet established infection control societies or associations, and 
general professional societies of physicians, nurses, and laboratory staff are not effectively 
engaged in infection control and prevention activities. The International Federation of 
Infection Control (IFIC) is an umbrella organisation of societies and associations of 
healthcare professionals in infection control and related fields worldwide including majority 
of them coming from developing countries. Currently IFIC has 66 members from 51 
countries, and provides guidelines and educational material. Many regional and 
international networks throughout the world also participate in IFIC.  
3.10 Microbiology laboratory support for infection control  
Clinical microbiology laboratory plays a pivotal role in patient care providing information 
on a variety of microorganisms with clinical significance and is an essential component of an 
effective infection control program (Kalenic & Budimir, 2009). Laboratory plays important 
duties in prevention of HCAIs, which include: surveillance of HCAIs and antimicrobial 
resistance, rapid communication of laboratory data relevant to infection control, 
epidemiology typing of isolated pathogens, storing laboratory data and isolates, outbreak 
investigation and management. A variety of methods can be used to identify 
microorganisms in clinical specimens, although in developing countries diagnostic 
capabilities are insufficient. Partnership between the infection preventionist and the clinical 
microbiology laboratory staff is crucial in combating against HCAIs.  
3.11 Combating antibiotic resistance 
There is good evidence that antibiotic stewardship programmes have been successful in 
modifying antimicrobial prescribing practices, resulting in most instances in reduction of 
use. Unfortunately, such programmes are often lacking in developing countries, and 
antimicrobial resistance problems emphasise the importance of clinical microbiology 
laboratory services(Sosa et al.,2010) . Key actions in prevention and control of antimicrobial 
resistance are: empower the surveillance systems of antibiotic use and antibiotic resistance, 
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prudent use in clinical practice (governmental measures, increase awareness of the public 
and health care workers, upgrading diagnostic capabilities), prudent use in veterinary, 
infection control in hospitals and community, implementation of Information technology, 
applied research and international cooperation. 
4. Conclusion 
HCAIs represent a major threat to patient safety and quality healthcare in developing 
countries. In many hospitals of developing world infection control activities are limited by 
many constraints in all levels of health care. As a consequence, these countries are facing the 
challenges of higher rates of hospital infections, frequent outbreaks, unsafe care and spread 
of infections in acute care facilities and community. The best solution for this challenge 
entail a multifactorial initiatives, which have to be sustainable in order to have a great 
impact on outcomes. Through focusing on infection control, countries with limited resources 
can improve the quality of healthcare in the future. 
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1. Introduction 
Fourteen percent of deaths among patients with endstage kidney disease (ESKD) are due to 
infections, preceded only by cardiovascular diseases (USRDS,2006). According to The 
United States Renal Data System (USRDS), the number of patients receiving hemodialysis in 
the United States of America (USA) was 328,000 in 2006(USRDS,2008). Secondary to 
multiple defects in the ability to kill bacteria, infectious complications are more frequent in 
the Chronic Kidney Disease (CKD) and dialysis populations. (USRDS,2010). 
Data from Brazilian Society of Nephrology reported that the number of patients on dialysis 
treatment in Brazil was 77.589 in 2009 and 90.8% of those patients were receiving 
hemodialysis (SBN,2010). The estimated prevalence and incidence rates of chronic renal 
failure on maintenance dialysis were 405 and 144 patients per million population, 
respectively. The estimated number of new patients starting dialysis program in 2010 was 
49,077. The annual gross mortality rate was 17.1%. For prevalent patients, 39.9% were aged 
60 years or older, 89.6% were on hemodialysis and 10.4% on peritoneal dialysis, 30,419 
(39.2%) were on a waiting list of  renal transplant, 27% were diabetics, 37.9% had serum 
phosphorus > 5.5 mg/dL and 42.8% hemoglobin < 11 g/dL. A venous catheter was the 
vascular access for 12.4% of the hemodialysis patients. 
CVC (CVC) as vascular access are considered inferior to other means of vascular access with 
2006 K/DOQI guidelines recommending less than 10% prevalence rate. However, despite 
these recommendations the Dialysis Outcomes and Practice Patterns Study (DOPPS II), 
reports that 46% to 70% of European and Canadian ESKD patients commencing 
maintenance haemodialysis do so via a CVC. This dependence on CVC is also reflected in 
the prevalence rates which range from 18% (Europe) to 34% (Canada) (Mendelssohn DC 
2006 ). This over reliance on catheters may be attributed to late referrals to nephrologists, 
delay in access formation, lack of sufficient time for an AVF to mature or an ever increasing 
older ESKD population who experience higher rates of vascular disease and diabetes 
resulting in an inadequate vasculature for AVF formation (Butterly DW 2001 ; Letourneau I 
2003 ; Mendelssohn DC 2006 ). 
Data from the USA National Healthcare Safety Network demonstrated that bloodstream 
infection rates in 2006 varied according to the site of vascular access: 0.5% arteriovenous 
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fistula (AVF), 0.9% AV grafts, 4.2% long-term central venous catheter and 27.1% short-term 
central venous catheter per month, respectively.  
Chronic kidney disease (CKD) is a syndrome caused by many diseases that have in 
common the progressive reduction of glomerular filtration. Regardless of the initial insult 
caused by the underlying disease, the lesion progresses to glomerulosclerosis and 
interstitial fibrosis, resulting in established chronic kidney disease (ECKD). The ECKD 
treatment depends on the evolution of the disease and may be conservative with 
medication use, diet and fluid restriction, when such treatment becomes insufficient, you 
need to start dialysis to replace, in part, the kidney's function, or even apply to a kidney 
transplant (Mason J et al, 2008). 
Conservative treatment aims to help reduce the rate of progression of the renal disease, 
using the dietary guidelines that aim to promote adequate nutritional status, metabolic 
control and uremic symptoms (20), with the improvement in organ dysfunction and 
comorbid conditions such as infection, contributing to better outcomes related to dialysis 
and transplantation (Klevens RM et al, 2008). 
Despite advances in dialysis mortality remains high in ECKD. The infection continues to be 
a major cause of morbidity and the second most frequent cause of mortality (14%), preceded 
only by cardiovascular events as the first cause of death (Klevens RM et al, 2008).  
Most microorganisms detected in the blood culture were considered to be a skin 
contaminant coagulase-negative Staphylococcus. Forty two percent (42%) of Staphylococcus 
aureus were resistant to methicillin and 39% of Enterococcus spp were resistant to 
vancomycin (Klevens et al,2008). Patients receiving hemodialysis have high risk for infection 
due to immunosuppression caused by ESKD, comorbidities, inadequate diet and the need 
for maintaining the venous access for long periods. In dialysis clinics many patients are 
submitted to this procedure at the same time, leading to the dissemination of 
microorganisms through direct or indirect contact with the devices, equipment, 
contaminated surfaces or the hands of health professionals. 
In a study conducted at the Federal University of São Paulo (UNIFESP) it was found an 
incidence of infection of the bloodstream of 61% among patients with ESKD in use of central 
venous catheter associated with a mortality rate of 29% ( Grothe C et al, 2009). 
American data show that the main agents of bloodstream infections in hemodialysis patients 
were methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus coagulase negative 
(SCN) and vancomycin-resistant Enterococcus spp (VRE) (Klevens RM, 2008). 
S. aureus is an important etiologic agent of both community-acquired infections and 
healthcare associated infections (HAI). In community-acquired infections are responsible 
for infections of skin and soft tissues, but is also responsible for invasive infections such as 
pyomyositis, osteomyelitis, necrotizing fasciitis, pneumonia and severe sepsis (King MD 
et al, 2006; Bocchini CE et al 2006; PV Adem et al , 2005). This agent is an important 
colonizer of the skin and mucous membranes. Although many sites of the human body 
can be colonized, nasal colonization is the most common. Studies show that 
approximately 20% of health professionals have persistent colonization and 80% 
intermittent colonization by this microorganism, nasal colonization is the biggest risk 
 
Prevention of Catheter-Related Bloodstream Infections in Patients on Hemodialysis 
 
83 
factor for the development of most endogenous infections (Van Belkum A et al, 2009 ; 
Wertheim HF et al, 2004; Von Eiff C et al, 2001). 
Following the acquisition of MRSA colonization during hospitalization, patients with 
chronic renal failure on conservative treatment may persist as carriers for prolonged periods 
even after discharge from hospital and readmittance, may reintroduce the bacteria in the 
hospital (Roberts S et al, 2004) 
The risk of transmission occurs most often because the patient is not identified as a carrier. A 
retrospective analysis that used information from hospital patients for eight years evaluated 
the risk of acquiring MRSA in patients who shared the same room with other hospital patients 
colonized with MRSA, unidentified. The study found a 13% incidence of infection by the same 
strain of MRSA among colonized patients (Moore C et al, 2008). Another study that evaluated 
the prevalence of MRSA on admission identified that 49% of patients would not have been 
identified without screening on admission (VCC Cheng et al, 2008). 
Faced with complications that occurred due to infection in patients on dialysis treatment, 
Barbosa et al (D Barbosa et al, 2004; MCS Freitas et al, 2006) assessed the prevalence of 
colonization by vancomycin-resistant Enterococcus (VRE) in 300 patients in program 
dialysis and 280 transplant recipients treated in this service. It was found a prevalence 
rate of 14.5% in dialysis patients and 14% in renal transplanted patients, which proves to 
be quite high in relation to the rate documented in American services, which is around 
7% (Tokars JI et al, 2000). The molecular typing of these samples was recently performed 
and it made possible the important detection of cross-transmission of VRE among 
patients treated at the Department of Dialysis and Transplantation of UNIFESP, and  
Fram et al observed the occurrence of vancomycin-resistant Enterococcus (VRE) cross-
transmission between two patient groups (long-term dialysis and kidney transplant 
patients) Fram D et al, 2010.  
In Europe and the United States the increase in infections caused by VRE in patients with 
ESKD have contributed to an increased morbidity and mortality in this patients population, 
which has generated a great concern in the nephrology services (Perencevich EM et al, 2004). 
Data from the National Healthcare Safety Network show that VRE was isolated in 26% of 
dialisys patients' blood cultures (Rom Klevens, 2008). 
In the 90s, there was a significant increase in the prevalence of VRE infection in hospitals, 
particularly among immunosuppressed patients, such as those with chronic diseases, 
infectious diseases and renal transplants (Brady JP et al, 1998). Currently, VRE is between 
the second and third most frequent cause in the IRAS, due to its rapid spread, high 
associated mortality and limited treatment options, besides the possibility of transfer of the 
vanA resistance gene to other virulent organisms and more prevalent as the S . aureus 
(Chang S et al, 2003; & Salgado CD Farr BM, 2003). 
The glycopeptide resistance may be mediated by several genes, vanA, vanB, vanC, vanD, 
vanE, vanG and vanL. Resistance mediated by mobile elements, called plasmids, may be 
transferred from one strain of VRE to another (Werner G et al, 2008; Arthur M, 1993) 
The increased risk of VRE colonization and infection has been associated with the 
indiscriminate use of antibiotics, prolonged hospital stay, underlying diseases, 
transplantation, invasive treatments such as intra-abdominal surgery, presence of central 
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venous catheterization and proximity to colonized patients. Studies done in the UNIFESP's 
nephrology service demonstrated the presence of VRE in dialysis patients and kidney 
transplantation. Among dialysis patients, the colonization prevalence was 14.5% and the 
identified risk factors were: dialysis type (hemodialysis), number of hospitalizations and 
length of hospital stay. Similar rate was found among patients undergoing renal 
transplantation, where the prevalence was 14%, although no risk factor was identified 
(Barbosa D et al, 2004; MCS Freitas et al, 2006). 
Considering the emergence of new microorganisms, Klebsiella pneumoniae producing 
carbapenemases (KPC) has been highlighted as an important pathogen in healthcare 
related infections. Due to the great ability to spread and limited therapeutic options, the 
introduction of surveillance of this pathogen in the study group is necessary. According to 
a recent study by Ji-Young Rhee (2010),  the isolation of bacteria K. pneumoniae producing 
carbapenemases (KPC) in hemodialysis patients with chronic renal failure demonstrated 
that the infection caused by multidrug-resistant pathogen that affected the patient's 
prognosis. Another study in Chicago showed that the implementation of a bundle that 
includes: surveillance cultures, team education, contact precautions, chlorhexidine 
bathing and environment cleaning greatly reduced the horizontal transmission of this 
pathogen (Mimoz O, 2007). 
Microbial resistance should be considered because patients on dialysis treatment are often 
hospitalized and exposed to multi-resistant microorganisms and to broadspectrum 
antimicrobial therapy. (Klevens et al, 2008; Fram et al, 2010; Horl Wh 1999;Descamps-
Latscha B & Herbelin A, 1993; MMWR,2001). On the one hand, the quality of dialysis and 
thus patients. well being and survival depend on the venous access; on the other hand, this 
is considered the major risk factor for infection and especially bacteremia in this group of 
patients(Mangini et al, 2005). In a study performed at Universidade Federal de São Paulo, 
61% of patients with ESKD using central venous catheter presented bacteremia. Risk factors 
for bacteremia were: catheter insertion in the subclavian vein, duration of catheter use and 
the hospitalization period. The mortality rate in these patients was 29% and for patients who 
developed endocarditis it was 55.5%(Groethe C et al, 2010). As this population is exposed to 
a high infection risk which can be prevented in most cases by health professionals, a 
systematic review of literature was performed to establish standard measures to prevent 
catheter associated infections in hemodialysis patients. 
1.2 Epidemiology 
Twenty months of epidemiological surveillance data in the USA demonstrated that the risk 
for bacteremia was 32 times higher when short-term venous catheter was used, and 19 times 
higher when long-term venous catheter was used compared to the use of arteriovenous 
fistula (AVF). Similar data were observed in a study conducted in 11 dialysis centers in 
Canada (George A et al, 2006). A prospective survey with 35,000 randomized patients 
between the years of 1996 and 2007 treated in about 300 dialysis units in 12 countries 
demonstrated a great variation on AVF utilization. AVF use declined in elderly, obese, 
diabetic and patients with cardiovascular diseases or recurrent cellulitis. Considering the 
high mortality caused by the use of catheters, the best option for these patients is AV graft. 
However, in some countries there was an increase in catheter use and a proportional 
decrease in the use of AV grafts in patients with the characteristics mentioned (LoboRD et 
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al, 2005). Measures to prevent catheter associated infections in hemodialysis patients must 
be considered taking into account the reduction in the use of central venous catheter (CVC), 
giving priority to the use of AVF whenever possible. However, in patients with impaired 
vessels, obesity and diabetes, where access through AVF or graft can be difficult, long-term 
CVC use is recommended(MMWR, 2001). 
2. Methods 
The present study was carried out through a review of the literature encompassing the 
issue of preventing catheter-associated bloodstream infections in hemodialysis patients. 
Studies published from 1990 to 2011 have been selected through electronic search in the 
following databases: Cochrane Library,CINAHL, WEB OF SCIENCE, Medline, SciELO, 
Embase, Lilacs, works presented in congresses, reviews and guidelines. The search strategy 
used for Medline presented the following steps: .Catheterization, Central Venous. [Mesh] 
AND .Infection. [Mesh]) AND .Renal Dialysis. [Mesh]) AND .Renal Dialysis/education. 
[Mesh] AND .Infection Control. [Mesh]. To select articles, two independent reviewers 
assessed the titles and abstracts of the publications found. All studies in the issue meeting 
the criteria for review have been included regardless of the language or design. 
Photocopies of the articles have been obtained and a standard form has been used to 
extract data. 
3. Results 
Two hundred and ninety three articles were found according to the used descriptors, 50 of 
them were literature reviews. After a previous selection, we included some studies that met 
the inclusion criteria were selected according to the assessment of the two independent 
reviewers. Among the studies analyzed we included (chart 1) systematic reviews, 
prospective cohorts, experimental study, meta-analysis review, controlled randomized 
clinical essays, cross-sectional randomized clinical trial and guidelines.  
It was clear that surveillance is the essential issue for an infection control program and also 
for improving quality of care. A prospective study carried out in London between 2002 and 
2004 with 112 patients (3418 patients per month) demonstrated reduction in bacteremia rate 
from 6.2% to 2.0% per month, reduction in hospitalizations due to bacteremia from 4.0% to 
1.4% per month and also a significant downward trend was seen in bacteremia rates and 
antibiotic usage after the introduction of a surveillance scheme with patients. risk 
stratification, definition of denominators, type of access performed by physicians and nurses 
from the service, team training, preventive measures of infections, dissemination of data and 
use of results to optimize the actions introduced (George A et al, 2006). The training and 
education of health professionals, patients and care givers is recommended by the Center 
for Disease Control and Prevention (CDC) to prevent dialysis infections and must be 
compatible with the available knowledge from the personnel involved(9). A study conducted 
in a university hospital from São Paulo demonstrated 40% reduction in catheter-associated 
bloodstream infections (CABSI) after the implementation of an educational intervention 
with staff members (Lobo RD et al, 2005) 
There are some standard precautions based on strategies to prevent transmission of 
infections that health professionals must use in patients. care: hand washing before and after  
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infections that health professionals must use in patients. care: hand washing before and after  
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the contact, use of gloves, masks, protection glasses and laboratory coats when there is risk 
of contact with biological material, be careful with sharp-edged and hollow-pointed devices, 
environmental cleaning, adequate use of materials and equipments and health professionals 
immunization. When patients present suspicion or confirmation of a more severe infection, 
additional measures must be taken in addition to those mentioned above (Ethier J et al 
2008). According to national and international recommendations, catheter insertion has to be 
conducted under sterile conditions and maximum barrier: masks, laboratory coats, gloves 
and sterile drapes (Descamps-Latscha B & Herbelin A, 1993; MMWR 2001; O.Grady NP et 
al, 2002). Alcoholic chlorhexidine 2% (drug of choice) or polyvinylpyrrolidone-iodine 
solution (PVP-I) 10% has to be used for skin antisepsis before catheter insertion and before 
dressing changes (MMWR, 2001; Mimoz O et al, 2007). 
A CVC can be non-tunnelled or tunnelled. A non-tunnelled catheter - sometimes referred 
to in the literature as non-cuffed, temporary, short-term or acute - is intended for short-
term haemodialysis use. On the other hand tunnelled catheters - also known as cuffed, 
chronic, long-term or permanent catheters - are generally used when patients require 
more than two to three weeks haemodialysis (Frankel, 2006). However, the reported use 
of these different catheters suggest that tunnelled catheters have been used for periods of 
short duration and, although not recommended, non-tunnelled catheters have been used 
for periods of long duration (months or years) (Ash SR, 2001; KDOQI 2006; Oliver MJ 
2001; Ponikvar R, 2005). 
A Cochrane systematic review with meta-analysis, published in 2003 compared the use of 
gauze and micropore film versus sterile transparent semipermeable polyurethane (Opsite ® 
(Smith & Nephew Healthcare Ltd), Tegaderm ® (3M) and Opsite IV3000 ®) to cover the 
catheter central venous . The transparent film covers so classified as highly permeable and 
permeable polyurethane polyurethane. The outcomes analyzed in this review were: 
catheter-related sepsis, infection at the catheter insertion site and colonization of catheter 
between the different types of coverage, but there was no statistical difference in any 
outcome analysis. One of the observations made by the plaintiff was an insufficient number 
of randomized clinical trials that could be included in the study ( Gillies D et al, 2003) 
A randomized study(Sesso R et al, 1998) highlighted that use of chlorhexidine before 
catheter insertion and during dressing changes is associated with less colonization and 
occurrence of CABSI when compared to the use of alcoholic PVP-I. Gauze or sterile 
transparent film are recommended to dress the site of catheter insertion. After bathing or 
showering it is important to inspect the insertion site, protecting it and replacing the 
catheter-site dressing when it becomes damp, loosened, or soiled (Descmaps-Latscha B & 
Herbelin A,1993; MMWR 2001; Ethier et al, 2008). A study (Sesso R et al 1998) demonstrated 
that mupirocin use in the catheter insertion site reduces significantly the risk of S aureus 
colonization and bacteremia. The same result was obtained in a study carried out in 
Australia ( Johnson DW et al 2.002).  
The meta-analysis of a profhylatic use of Mupirocin in central venous catheter for 
hemodialysis indicates that the use of topical mupirocin has been effective to reduce 
episodes of infections among patients increasing the usage time of the catheter in addition to 
significantly reducing the infections by S aureus, the most prevalent in this population 
(Taminato M et al, 2011).  
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Other systematic review ( McCann M & Moore ZEH, 2008) shws that topical antimicrobial 
ointments compared to no ointment or placebo had a significant favourable effect on 
catheter removal due to infection caused by all types of organisms ( RR 0.35, 95% CI 0.25 to 
0.50). Catheter removal due to S. aureus was significantly reduced by topical antimicrobial.  
However, the emergence of resistant strains must be considered as demonstrated in a 
Spanish study where pandemia of methicillin-resistant Staphylococcus aureus was associated 
to high-level mupirocin resistance (Johnson et al, 2002; Perez-Roth E et al, 2006).  
Another prevention strategy is the use of gentamicin, cephalosporin or vancomycin lock 
solution, taking into account the possibility of the emergence of resistant microorganisms 
when vancomycin is used (Bleyer AJ, 2007; Safdar N & Maki DG, 2006).   
The study Al-Kwiesh & Abdulla Khalaf, showed that the administration of vancomycin 
catheter lock via intralumenal was superior compared to the peripheral intravenous 
administration, where the results showed that the experimental group of 28 patients that 
used the vancomycin catheter lock had only one (3%) catheter removal, in contrast, the 
control group of 39 patients that had peripheral intravenous antibiotics had 22 (56%) 
catheter removals. 
In a meta-analysis, authors demonstrated that in highrisk patients treated with long-term 
catheters the use of vancomycin lock solution reduces the risk of bacteremia(Safdar N & 
Maki DG, 2006). CDC does not recommend the regular use of antimicrobial lock solution to 
prevent bloodstream infection. The use is recommended only in special circumstances (e.g. 
patient with a long-term catheter or patients with clinical data of recurrent infections despite 
optimal maximal adherence to aseptic technique (O´Grady et al, 2002). 
4. Conclusion 
The authors conducted extensive review to suggest that catheter-associated bloodstream 
infection can be reduced when prevention measures are adequately taken they are: proper 
choice of insertion site, local antisepsis, personnel appropriate attire, infection surveillance, 
care and maintenance of the catheter or remove as well as the use of new technologies. 
Topical mupirocin ointment significantly reduced the risk of S. aureus exit site infection and 
catheter-related bacteraemia. The risk of catheter removal and episodes of hospitalisation 
due to S. aureus were also significantly reduced in those patients who used topical 
mupirocin ointment. Taking into account that this is a population at high risk for infection, 
the emergence of multi-resistant microorganisms must be considered, and if a severe case 
occurs, additional prevention measures must be taken to avoid an outbreak in this 
population.  All personnel involved in the process of catheter insertion, maintenance and 
removal must be aware of the importance of excellent care for infection prevention therefore 
this chapter may contribute to infection control book. 
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What Works in Practice? 
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Center for eHealth Research and Disease Management 
University of Twente 
The Netherlands 
1. Introduction 
There have been increasing numbers of  media reports about careless behaviour by 
healthcare workers, mainly involving insufficient cleaning practices and the absence of hand 
hygiene measures (Boyce, 2009). Although adherence to infection prevention and control 
measures has received a lot of attention in the media and in scientific literature, surprisingly 
little attention has been given to the implementation of the infection prevention and control 
strategies in healthcare practices. In the medical literature the focus is on the availability of 
national or regional MRSA surveillance data and guidelines for prevention and control. To 
date hardly any data has been made available about the kinds of interventions that have 
been successful in implementing infection prevention and control.  
Research has shown that an intensive infection prevention programme could prevent 
about one-quarter to one-third of all hospital infections (Sengers et al., 2000). An example 
of such a successful policy is the ‘search-and-destroy’ strategy that has been introduced in 
the Netherlands, to prevent the spread and outbreak of infections caused by multi-
resistant bacteria such as Methicillin Resistant Staphylococcus Aureus (MRSA). However, 
adherence to this policy still remains a problem. It is known from prior research (van 
Gemert et al., 2005; Verhoeven et al., 2009) that healthcare workers are insufficiently 
aware of infection control measures; they do not understand the rationale behind these 
measures and think that infection control is not their problem, that it is mainly an issue 
for hygiene experts.  
Research in the social sciences has shown that improving safety in hospitals requires a 
tailored strategy to persuade people to change their attitudes and behaviours (Fogg, 
2003). Furthermore, changing routines and habits in healthcare is not easy: it requires an 
integral approach, with activities addressing human behaviour, culture, incentives and 
other managerial reinforcement activities, and of course adequate information about 
safety regulations (Foy et al., 2001; Van Gemert et al., 2005; Verhoeven et al., 2009). A 
multifaceted implementation strategy might be a solution (Foy et al., 2001, Pittet et al., 
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2000). Such a strategy should include interventions aimed at different levels: the 
management of healthcare institutions, the behaviour of healthcare workers and the 
quality of the infection control guidelines. However, what empirical evidence exists for a 
multi-faceted implementation strategy? And how successful are these strategies? To 
investigate this, we conducted a systematic literature review. This review will be used to 
develop an implementation strategy that fits the habits and culture of hospital-based 
healthcare workers (HCWs) in hospital care settings. In this review, we searched for 
empirical studies to investigate and identify effective implementation strategies for 
improving adherence to MRSA prevention and control measures. The following questions 
guided our review of the literature: 
- What implementation strategies are used? 
- What is the foundation of these strategies (theories, experience, etc.)?  
- What research designs were used to measure the effects of the implementation 
strategies? 
- What effects are reported? 
- On adherence to the measures? 
- On the reduction of costs?  
- On the reduction of MRSA? 
2. Method of the systematic review 
The York protocol for systematic reviews (Centre for Reviews and Dissemination, 2001) was 
used to guide the review process. Literature searches were carried out in the online 
databases Scopus, ISI Web of Knowledge and the Cochrane Library. In addition, we hand-
searched the indexes of the Journal of Hospital Infection (JHI), the American Journal of Infection 
Control (AJIC) and Clinical Microbiology and Infection (CMI) for relevant publications. We 
searched for studies describing the implementation of MRSA prevention or control 
measures. The publications were included in the review if they met the inclusion criteria 
listed in Table 1. Most important was that the publications described an implementation 
strategy and implementation outcomes. Two independent reviewers (NdJ, JW) applied 
the inclusion criteria to the publications in a title screening round, followed by an abstract 
and a full-text screening round. After each round, the reviewers compared their 
judgments and resolved discrepancies through discussion. The included studies are 
summarized in a data table, and the study features and results are summarized and 
compared. Due to the heterogeneity of the data and the limited number of included 
studies, no meta-analysis was performed. 
3. Results of the systematic review 
3.1 Article screening 
The search strategy resulted in 661 potentially relevant publications (after duplicates were 
removed). The screening process and outcomes are shown in Figure 1; 29 publications were 
included in the review. The characteristics of these publications are summarized in Table 2. 
The characteristics and outcomes of the included studies are discussed in the following 
sections. The numbers we cite correspond to the publications summarized in Table 2.   
 





(Scientific) Journal article, published between 2005-2010 
Scope of Studies 
Implementation of an evidence-based MRSA prevention or control measure. The 
implementation strategy must be described. 
Study Settings 
Primary-/secondary-care facilities, long-term care facilities, nursing homes 
Outcome measure
Implementation outcomes (mostly behavioural) must be given. 
 Behavioural (e.g. adherence to implemented measure, knowledge) 
 Clinical (e.g. prevalence rates, infection rates, deaths) 
 Organizational (e.g. changes in Length of Stay (LoS), expenditures, costs)  
Table 1. Inclusion Criteria 
 
 
A: Insufficient implementation strategy information. B: No Compliance rates; no implementation results 
described. C: Article is a Viewpoint/Review. D: Article was not written in English. E: Article is a report 
of Conference Proceedings. F: Other. 
Fig. 1. Results of the screening process 
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3.2 Study design 
Among the included studies, there was one randomized controlled trial (RCT) (1). In eight 
studies, a time series design was used (2, 9, 14, 15, 17, 22, 23, 25), and in fourteen studies a 
before and after design was used (3, 4, 5, 7, 10-12, 18, 19, 21, 26-29). Five studies applied a 
combination of time series and before and after design (6, 8, 13, 16, 20).  
3.3 MRSA prevention and control measures 
Different measures were implemented to prevent or control MRSA. In some studies a 
single MRSA prevention or control measure was implemented, in others a bundle of 
measures was implemented. Hand hygiene was implemented as a stand-alone measure in 
seven studies (4, 5, 7, 10, 13, 20, 29) and as part of a bundle of measures in eleven studies 
(1, 3, 6, 8, 11, 14, 16, 17, 19, 21, 24). Environmental hygiene was implemented as a stand-
alone measure in one study (12) and as part of a bundle of measures in two studies (1, 17). 
The use of personal protective equipment such as gloves or gowns was implemented as part 
of a bundle of measures in four studies (1, 3, 16, 21); it was implemented as a stand-alone 
measure in none of the studies. Medication, or the correct use of antibiotics, was 
implemented as a stand-alone measure in six studies (2, 9, 15, 22, 23, 25); in none of the 
included studies was it part of a bundle of measures. In two studies (26, 27), patient 
screening was implemented as a stand-alone measure, and in six studies (3, 8, 11, 16, 17, 
19) it formed part of a bundle of measures that was implemented. HCW screening was 
implemented only as part of a bundle of measures, in one study (17). Patient isolation was 
implemented as stand-alone measure in one study (28), and was part of a bundle of 
measures in five studies (3, 6, 16, 18, 19).  
3.4 Implementation strategies and their foundation 
Various strategies were used to implement the MRSA prevention and control measures. 
Most implementation strategies are set up because of the empirical observation of non-
adherence to clinical guidelines, thus creating an impediment to successful MRSA control. 
The theoretical foundation of the chosen strategies is often unclear, or not specified.  
Most studies, 24 out of 29, combined different elements (1-17, 19, 20, 22, 24, 25, 26, 27). In 
five studies the implementation strategy consisted of one component (18, 21, 23, 28, 29). The 
strategies used are summarized below: 
- Audit and feedback was performed and given by trained nurses or auditors, infection 
control specialists, or multidisciplinary teams (nineteen studies: 1, 2, 4-6, 8, 9, 11-17, 19, 
20, 22, 24, 27). 
- Reminders were used in eighteen studies (3-9, 11, 16-20, 23, 26, 27, 28, 29), for example 
pop-ups, fluorescent tape drawing attention to hand-cleaning facilities, posters or 
messages clipped to patient charts.  
- Educational meetings were held, for example to inform HCWs about the measure or to 
demonstrate new working methods or hygienic practices (seventeen studies: 1, 3-6, 8, 
12-16, 19, 21, 22, 26, 27).  
- Mass media were used in fourteen studies (3, 5-8, 10, 11, 13, 17, 19, 20, 24, 28, 29); 
posters, and to a lesser extent brochures or flyers, were used to remind or instruct 
HCWs about the implemented measures. Role models (hospital management or 
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leaders) were sometimes depicted, or HCWs were involved in the creation of the 
poster (11, 17, 29).  
- Technology was used in ten studies (1, 3, 5, 13, 17, 18, 21, 23, 26, 27), in the context of 
education (PowerPoint presentations, training via DVD), electronic order forms, pop-
ups assisting medication choice or screening of patients. 
- Changes in physical structure, facilities and equipment were applied in eight studies (4, 5, 6, 
8, 11, 12, 16, 27). These changes included strategically placed hand disinfectant 
dispensers, equipping HCWs with pocket bottles of hand disinfectant, or new cleaning 
materials (cloths), the bundling of protective gear and the availability of a test kit for 
screening. 
- Educational materials were distributed in eight studies (4, 5, 8, 10, 13, 17, 20, 27). 
Brochures, newsletters or instructional pocket cards were given to HCWs, often focused 
on applying correct (hand) hygiene.  
- Local opinion leaders guided the implementation process in six studies (1, 4, 5, 15, 24, 27), 
sometimes by reinforcing good infection control, or acting as a link worker between the 
professions and management.  
- Clinical multidisciplinary teams were used in five studies (2, 6, 20, 22, 25) to guide the 
implementation of a MRSA control measure. Via cooperation or consultation these 
teams supported the measures taken, for example by approving antibiotic 
prescriptions. 
- Educational outreach was carried out in five studies (6, 10, 15, 25, 27) to teach HCWs on-
site and sometimes on demand how to apply the implemented measure.  
- Rewards for correctly performing the implemented measures were given in two studies 
(4, 16), either to individuals directly after observing correct behaviour, or to groups 
based on periodic adherence results. 
- A patient-mediated intervention was implemented in one study (10); patients and visitors 
were actively addressed to perform the desired hand hygiene behaviour and motivate 
adherence among staff.  
- AB permission/formulary was applied in one study (2) where permission to use a certain 
antibiotic was required.  
3.5 Outcomes 
We classified the reported effects into three categories: adherence to the measures, reduction 
of costs and reduction of MRSA. 
In twelve studies (1-3, 7, 9, 12, 13, 17, 18, 24, 28) significant improvements (e.g. fewer 
prescriptions for antibiotics, more correctly executed hand hygiene, reduced expenditure on 
materials) in adherence to the MRSA control measures were observed. Similar positive results 
were observed in fourteen studies (4-6, 8, 10, 14-16, 20, 22, 23, 25, 27, 29), although these results 
were not statistically tested. In one of the studies (16), negative effects were observed: 
adherence to the measures increased in the first year but decreased thereafter. 
Acquiring a hospital-associated infection (HAI) results in a longer length of stay for the 
patient and poses many additional costs. Therefore, reductions in length of stay are an 
important outcome associated with decreased MRSA infection rates. Cost savings, or at least 
cost-neutral intervention effects, were observed in four studies (5, 10, 15, 27). On the other 
hand, increased isolation and increased expenditure also posed costs, as described in one 
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study (18). However, in this study, these increased costs were not compared to possible 
savings due to prevented infections. In another study (19), improved screening led to 
increased lengths of stay (pre-ICU and ICU), because MRSA detection increased. 
In nine studies (8, 12-14, 16, 17, 21, 25, 26), significant clinical improvements were reported, 
including MRSA prevalence, MRSA infection rates and susceptibility rates. Positive effects 
were also observed in eleven other studies (2, 5, 7, 10, 11, 15, 20, 22-24, 27), although these 
results were not statistically tested. 
4. Conclusion and discussion 
The results of our review show that in most cases hygiene experts or an infection control team 
(nurse, infectologist, microbiologist) are the developers of implementation strategies. These 
strategies are driven by empirical observations and audits. The theoretical foundation of the 
chosen strategies is often unclear. No references to theories and models of human behaviour 
are made. However, some articles indicated that a literature search was carried out.  
When looking at the implementation strategies, we can conclude that in most cases a multi-
faceted strategy was carried out. This strategy entails a combination of several activities: 
- Education or training modules for HCWs,  sometimes mandatory, taking various forms 
(DVDs, PowerPoint presentations, posters, meetings, brochures) to improve hand 
hygiene and compliance with protocols. 
- Inspections of the adherence to the safety programme and of hand washing 
behaviour via audits, on-site instructions, and observations by hygiene experts or 
trained auditors. Results were communicated to management and demonstrated via 
feedback meetings. 
- Environmental interventions (red lines at the entrance to high-risk wards, talking walls) 
to remind HCWs to behave safely in that particular area and to provide antibiotic policy 
support via guidelines and cards.  
The implementation pathway consists of education-inspection-feedback rounds; unfortunately 
it is unclear who is responsible for the management of the intervention strategies and who 
invests in these activities. No business model seems to  underpin the entire implementation 
strategy. 
To answer the research question about the effect of the implementation strategies, we 
reviewed the research designs that were used to measure their effects. In general, quasi-
experimental designs (before and after and time series designs) underpin the research 
activities. Implementation outcomes are usually measured in a before-and-after design, 
where they do not concern antibiotic use, and therefore provide little insight into temporal 
changes in implementation results or adherence. HCWs are the main target group in the 
research designs. It is unclear who these designs seek to manage (researchers, HCWs, 
management) in their execution or whether a project manager is responsible for this. 
Trained nurses or infection control teams are sometimes used. In most cases quantitative 
instruments are used to measure the effects on knowledge and behaviour (questionnaires, 
self-reporting of behaviour, material use, and hand hygiene) and on a reduction in MRSA 
and antibiotic doses (lab statistics). The effects on cost/benefits were sometimes measured, 
addressing utilizations such as reduced length of stay. In general the outcomes are 
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promising. However, the extent to which the outcomes are related to the implementation 
strategies is not clear, except for the routine screenings and reduced MRSA rates. The 
outcomes on cost-savings are especially hard to analyse. It remains unclear what is measured, 
how it is measured and to what purpose. Long-term effects are almost never addressed.  
Due to several shortcomings in research designs, the overall impact of the implementation 
strategies could not be measured sufficiently. Shortcomings in the research designs 
include, for example, the one-sided focus on HCWs. We know from prior research 
(Verhoeven et al., 2009) and from behaviour change models that not only is a multifaceted 
strategy needed to change safety behaviour, but that a multi-perspective stakeholder view 
(HCWs, infection experts, patients, the safety policy of the management of the 
organization) is necessary to obtain insight into the cost/benefits of the implementation 
strategy and to discuss the long-term implications of the strategy for the organization and 
workflow (Kukafka et al., 2003). This requires a theory or innovation-driven approach 
that grounds the implementation strategy, enabling an assessment of which activities are 
successful for whom (patient, HCWs, management) and what the interaction effects of the 
different components of the strategy are.  
Another shortcoming concerns the chosen study designs. Authors of the included studies 
refer to the difficulties in matching control and intervention groups, the high rates of drop-
outs and the low volume of included respondents, and confounding factors that cannot be 
excluded. These shortcomings are well-known impediments related to RCTs and the self-
reported behaviours. In fact, these shortcomings cannot be avoided due to the study of real-
time behaviours and contextual factors that influence these behaviours. Therefore, these 
factors should not be regarded as nuisances, as the authors do; they are the key issues that 
are important in implementation studies aimed at changing culture and behaviour. For 
example, some authors reported problems in implementing the activities due to a lack of 
resources (a result of the economic downturn) to manage the implementation and problems 
with measuring the effects of each component of the implementation strategy due to 
financial constraints. A lack of transparent funding models and lack of management support 
made the participation of different institutes or wards in the research projects problematic, 
resulting in only small pilot projects being carried out. These financial barriers should not be 
reported as shortcomings; rather, these factors should be determined by the key 
stakeholders and considered as critical factors for changing behaviour and the culture of 
safety in hospitals or other institutions.  
In addition, some authors reported a lack of commitment on the part of nursing personnel to 
participate in the implementation projects. It appeared that some personnel were uncertain 
about the implications of several measures. For example, they were concerned that patients 
would not feel as clean after being washed with wipes instead of soap and water. The level 
of commitment of HCWs and management is one of the main conditions for success in 
programmes for innovation or change. The impediments indicate that the implementation 
strategies are expert-driven rather than stakeholder-centred. Changing safety behaviour in 
hospitals is first and foremost a cultural problem of management and staff, which requires 
that implementation strategies should address that level. 
How to improve the implementation strategies? Given the fact that the implementation 
strategies influenced the attitude and knowledge of HCWs in a positive way, that intentions 
to behave safely increased, and that MRSA rates decreased in several studies, the question is 
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strategy and to discuss the long-term implications of the strategy for the organization and 
workflow (Kukafka et al., 2003). This requires a theory or innovation-driven approach 
that grounds the implementation strategy, enabling an assessment of which activities are 
successful for whom (patient, HCWs, management) and what the interaction effects of the 
different components of the strategy are.  
Another shortcoming concerns the chosen study designs. Authors of the included studies 
refer to the difficulties in matching control and intervention groups, the high rates of drop-
outs and the low volume of included respondents, and confounding factors that cannot be 
excluded. These shortcomings are well-known impediments related to RCTs and the self-
reported behaviours. In fact, these shortcomings cannot be avoided due to the study of real-
time behaviours and contextual factors that influence these behaviours. Therefore, these 
factors should not be regarded as nuisances, as the authors do; they are the key issues that 
are important in implementation studies aimed at changing culture and behaviour. For 
example, some authors reported problems in implementing the activities due to a lack of 
resources (a result of the economic downturn) to manage the implementation and problems 
with measuring the effects of each component of the implementation strategy due to 
financial constraints. A lack of transparent funding models and lack of management support 
made the participation of different institutes or wards in the research projects problematic, 
resulting in only small pilot projects being carried out. These financial barriers should not be 
reported as shortcomings; rather, these factors should be determined by the key 
stakeholders and considered as critical factors for changing behaviour and the culture of 
safety in hospitals or other institutions.  
In addition, some authors reported a lack of commitment on the part of nursing personnel to 
participate in the implementation projects. It appeared that some personnel were uncertain 
about the implications of several measures. For example, they were concerned that patients 
would not feel as clean after being washed with wipes instead of soap and water. The level 
of commitment of HCWs and management is one of the main conditions for success in 
programmes for innovation or change. The impediments indicate that the implementation 
strategies are expert-driven rather than stakeholder-centred. Changing safety behaviour in 
hospitals is first and foremost a cultural problem of management and staff, which requires 
that implementation strategies should address that level. 
How to improve the implementation strategies? Given the fact that the implementation 
strategies influenced the attitude and knowledge of HCWs in a positive way, that intentions 
to behave safely increased, and that MRSA rates decreased in several studies, the question is 
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how to boost the impact of the implementation strategies. Education-inspection-feedback 
rounds could be one way to do this. 
Based on prior experience in infection management control and on information gathered 
from other studies of innovation management (Cain & Mittman, 2002; Rogers, 2003), we 
argue that the participation of staff and management is crucial to the development and 
implementation of interventions, to increase applicability, accountability and ownership and 
to create a fit between the proposed activities and the culture of the organization (Van 
Gemert et al., in press). In addition, both positive and negative incentives are needed to 
encourage staff to do the right things at the right times. Change agents and demonstration of 
best practices will improve the incorporation of safety behaviour. To enhance the 
transparency of the implementation programme and strategies, communication of results or 
key factors for success should be available to staff. Communication should include insights 
into results related to infection management (prevalence and incidence rates of MRSA, 
identification of increasing/decreasing trends), the business model underpinning the 
programme (resources, investments, additional costs) and benchmarking (how are we doing 
and what are others doing?). It is also important to demonstrate to the management and 
staff that the investment costs of the intervention can be less than the costs of not adopting 
an MRSA-infection control programme.  
Another point of attention is the use of media to implement the strategies. Even though 
evidence of the usefulness and effectiveness of computerized decision support or reminders 
exists (Grimshaw et al., 2004), it is not often used. We found that in ten studies DVDs, 
PowerPoint presentations, educational programmes available online or on CD-ROM, and 
electronic alerts or reminders were used. This is rather remarkable in our Internet-driven 
world. Web-based communications systems in particular can increase staff knowledge and 
provide access to accurate, adequate and easy to understand information (Kreps & 
Neuhauser, 2010). In prior and on-going research projects aimed at cross-border infection 
control (MRSA-net; EurSafety Health-net) we developed stakeholder-driven, web-based 
communication systems, based on national infection control standards, to support staff and 
patient behaviours (see for example Verhoeven et al., 2009). This resulted in fewer errors, 
time savings and also appropriate behaviour by HCWs.  
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1. Introduction 
Infection control education has been a core component of infection control programs since 
they were established (Scheckler et al., 1998; Department of Health and Ageing, 2004) and 
remains a constant feature in the modern healthcare context. Education is a pivotal strategy 
used to address problems identified through surveillance of infection or to improve 
infection control practice.(Dubbert et al, 1990; Scheckler et al, 1998; Turner et al, 1999). It is clear 
that simple educational efforts are of minimal benefit and that while a number of 
interventions may achieve a short-term effect, few have a measurable, prolonged effect 
(Larson, 1997). Research efforts relating to infection control education as a control measure; 
have focused on evaluating the effectiveness of a variety of strategies (Kim et al, 2001). 
While debate continues regarding the extent and quality of infection control education as 
a component of professional curricula, it is a requisite element of the orientation process 
in each healthcare facility. This process ensures that all members of the healthcare team 
are provided with basic infection control education and training on entry to the healthcare 
organization. Basic infection control information such as standard and additional 
precautions, safe use and disposal of sharps, waste segregation and minimization and 
staff health issues such as vaccination should be imparted through continuing education. 
Research efforts relating to infection control education as a control measure; have focused 
on evaluating the effectiveness of a variety of strategies (Kim et al., 2001). Studies often 
describe the effects of educational initiatives in combination with dissemination of data 
derived from surveillance initiatives such as practice audits (Goetz et al., 1999 and 
Chandra and Milind, 2001). 
Establishing appropriate Infection control staffing levels for hospitals should be considered 
as a priority in every health care setting (Hoffman, 1997). Multiple logistic regression 
analysis found that larger hospitals (OR, 1.6; 95% CI, 1.2-2.0; P = .003) and teaching hospitals 
(OR, 3.7 95% CI, 1.2- 11.8; P = .02) were associated with the presence of VRE. Hospitals were 
less likely to have VRE when infection control staff frequently contacted physicians and 
nurses for reports of new infections (OR, 0.5; 95% CI, 0.3- 0.7; P = .02) and there were in-
service programs for updating nursing and ancillary staff on current infection control 
practices. Prevention of hospital associated infection remains biggest challenge for health 
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care providers in the developed countries where there are adequate resources and trained 
staff. We can envisage the hard-fought task of countries like India with minimum resources 
and non-availability of trained infection control personnel. It is almost impossible to have 
1.5 infection control practicing nurses for every 200 beds. Most of the Indian hospitals are 
not even near to the recommended staffing criteria.  
All health care professionals are responsible for ensuring that they consistently deliver high 
quality clinically effective care and protect their patient from the risk of infection. To do this 
they need clinical credibility, leadership skills, ability to participate and lead relevant 
practices and whole range of skills associated with implementation of infection control 
programs. This ability may be enhanced though continuing education. It was observed that 
infection control practice and ongoing primary surveillance at unit level is the most 
challenging task and almost impossible with present staffing model. 
The Purpose of the study is to empower selected core group nurses with participatory 
training on hospital infection control with a view to train other nurses in hospital. Thus 
providing facilities for ongoing training program for sustained improvement in infection 
control practice. 
This study addresses the following questions regarding improving infection control nursing 
education and practices in the Indian setting; 
1. Why educational programs on hospital infection control are a Herculean task to 
implement? 
2. How to develop an effective and sustainable hospital infection control educational 
program to empower the nurses working in a selected hospital? 
3. Will nurses on ward develop ownership and awareness of infection control activities? 
4. How does the culture of the clinical environment influence infection control practice? 
Present study is conducted in several hospitals like private multi-specialty ,rural suburban 
and government settings of Udupi and Dhakshina Kannada district of Karnataka, India. 
2. Methodology 
The main strategy of the participatory training was needs-driven, internally and determined 
exercises to facilitate this, the approaches included were; 
1. Developing human resources by empowering them with the knowledge required to 
perform infection control practices and transfer this knowledge to other nurses working 
with them without any extra effort and cost so that individual participants, the 
organization and the research project would benefit. 
2. Inspiring participants, so that they are motivated to use creativity in developing 
participatory approaches and techniques. 
According to Rao et al.,(1997), participation is closely linked to power and Knowledge. 
Sources of power and the distinction between dominant knowledge and popular knowledge 
are important to understand to contextualize participation. Power in the society is exercised 
through knowledge. The culture of silence associated with powerlessness is essentially related to lack 
of articulation and domination of dominant knowledge over people's knowledge. This is possible by 
building each individual participant’s communication, leadership, small group teaching and 
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facilitating skills and finally developing professional approach towards prevention of 
Hospital associated infections.  
The paradigm shift associated with participation, essentially means, providing space and 
articulation for popular knowledge, practices and analysis. This helps the powerless to 
exercise their control over knowledge generation, distribution and will be able to control 
knowledge and power, there by demystifying dominant knowledge. According to Kiessling, 
(2003) participation is also seen as an integral part of empowerment process. Thus 
participation is part of empowerment strategy. Continuous professional development also 
includes learning from others. The word participation stands for the action or state of taking 
part with others in an activity’. The fundamental basis of all participatory learning methods 
is that learners are active participants instead of passive listeners or readers. 
The present study of participatory education will empower the nurses by building their 
capacity and to transmit their current knowledge and skill to prevent infection in low 
resource settings. During participation the nurses will be exposed to in interactive 
education, participatory seminars, workshops and other nursing education activities. In 
their true sense, participatory approaches are important tools to promote practice change, 
develop the capacity for collective action and reflection, and ensure that people involved are 
in the decision making process especially in Low resource setting and to enhance power to 
alter professional practice (Sudhaker, 2005; Kiessling, 2003; Upendranadh,1997; Brigham and 
Foster; Hodson, 1991) When adults participate in learning activities, they bring many years of 
experiences with them. They view new material through the lens of these experiences (Baird, 
Schneier and Laird, 1983). As adults continue to acquire newer knowledge and skills, they 
must integrate new learning with prior learning. When contradictions or dilemmas result, 
perceptions based on prior learning must be re-examined. Individuals can choose to reject 
the contradictory new information or revise their previous views. Transformative learning 
occurs when adjustments to prior learning are made (Cranton, 1996; Pilling-Cormick, 
1997).There are two goals in the experiential learning process. One is to learn the specifics of 
a particular subject matter. The other is to learn about one’s own strengths and weaknesses 
as a learner. This understanding of learning strengths and weaknesses helps in the back-
home application of what has been learned and provides a framework for continuing 
learning on the job. Day-to-day experience becomes a focus for testing and exploring new 
ideas. Learning is no longer special activity reserved for the classroom, but becomes an 
integral and explicit part of work itself. (Justice and Jamieson, 1999) To incorporate this 
researcher developed learners handbook based on the need assessment and extensive 
literature review and validated this with experts  
The present study was conducted in different phases; 
Phase I-Survey for need assessment was conducted using survey questionnaire (28 items) 
for 700 nurses from rural suburban, referral and government hospitals. 
One of the most important influences in the development of Participatory research has been 
the work of Paulo Freire. Freire linked the process of knowing with that of learning, through 
an ongoing cycle of reflection and action (praxis). This learning process stimulates the 
growth of critical thinking, which raises critical awareness in learners of the world about 
them. Alongside Freire's ideas came a parallel development, that of the phenomenologist 
who held experience as a legitimate source of knowledge. Thus, experience was added to 
reflection and action, as factors that could influence practice. 
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In phaseII-40 nurses from different setting were elected as observers they were given to 
observe infection control practices Randomly selected participants were called for 
discussion and they were given pretest using Demographic Proforma and Knowledge 
Questionnaire (alpha 0.81) and observed for their infection control practices at their unit by 
the observers using observation checklist (r=0.9) Upon completing the pretest the learners 
handbook on Hospital infection control for nurses along with the video(CD) was given to 
them to study before attending the training program, core group nurses were participated in 
2 days participatory infection control training using different participatory teaching and 
learning activity, organized by the participants themselves. Posttest was given to this core 
group nurses 1 month and 3 month after the training. During Phase III-Each of the Core 
group nurses trained 10 trainee group nurses from their respective units (400 trainee 
nurses). Pretest and posttest were given to this group at 1week interval. Phase IV-The FGD 
sessions were conducted at 3, 6 and 9 month at 3 months interval to assess the impact of 
training to improve their infection control practice. Phase V-The core group nurses also 
encouraged to involve infection control related practice improvement in their area with the 
help of their network they are encourage to share their successes and failures and get peer 
support during their FGD sessions. Opinion survey on administrators /supervisors (40) 
collected to evaluate the impact of the program in clinical area. Total sample size was 1284. 
The first step of the intervention was involving core group nurses to identify the gap 
between current and expected infection control practice and encourage them to raise 
awareness from what was called “Unconsciously incompetent to consciously competent“ among 
all core group members to decrease the gap using their own techniques, accessible and 
available to them in their own areas. The core group nurses were encouraged to involve 
with infection control related practice improvement along with training of other nurses. 
These core group nurses were formed a network and shared their problem and progress and 
tried to find the solutions to overcome some challenges along with researcher and some 
nursing administrative staff. They shared small success stories and ideas to solve infection 
control related problems in their work place and also the frustrations and anger towards 
their inability to correct most of the infection control practice related challenges.  
This forum also gave them a sense of belongingness, and enhanced their capacity to 
communicate. The network of core group nurses helped them to share their knowledge and 
education materials and also helped their participation in infection control activities like 
surveillance and reporting at unit level .The gaps were found out using focus group 
discussion and analysis. The FGD was repeated every 3 months to follow up the impact of 
participatory infection control education and their actions to improve infection control 
related clinical practice. 
3. Results 
 Learning need assent analysis of the nurses on infection control training 
Majority selected teaching methods like group discussion (83.38) demonstration (79.31), 
video (79.31) self study (77.03) and only16.61% selected lecture as their preferred mode of 
teaching and learning. There were 100% agreement with the topics like Infection 
transmission in the health care setting, Misconception about disease transmission, 
Importance of following infection control, Methods of infection control ,Standard 
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precautions Hand washing and use of gloves, Disinfections, Aseptic technique management 
of sharps sterilization and waste management.  
Knowledge and practice of staff nurses on hospital infection control 
i. Core group nurses 
The mean post-test -1 (45.55) and post test-2 (49.20) knowledge score are higher than the 
mean pre-test scores (23.40) of core group nurses who underwent participatory training 
program on infection control. The mean post-test -1 (24.75) and post test-2 (25.32) practice 
score are higher than the mean pre-test scores (16.87) of core group nurses who underwent 
participatory training program on infection control. 
ii. Trainee group 
The mean post-test (41.01) knowledge score are higher than the mean pretest scores (23.96). 
The mean post-test (25.05) practice score are higher than the mean pre-test scores (19.66) of 
trainee group nurses who underwent participatory training program on infection control by 
core group nurses. 
Effectiveness of participatory training program 
 Core group nurses 
A repeated measures one-way ANOVA revealed that there were significant differences in 
the knowledge of core group nurses participated in the participatory infection control F 
(1,39) = 483.89 p < .001, was a relatively significant effect size (Eta-squared = 0.92). Post Hoc 
LSD comparisons revealed that all three means were significantly different from each other. 
The practice of core group nurses were significantly different between the three times of 
measurement, F (1,39) = 151.628, p < .001, was a relatively significant effect size (Eta-squared 
= 0,60). Post Hoc LSD comparisons revealed that all three means were significantly different 
from each other.  
 Trainee group of nurses 
There was a significant increase in knowledge (t (353)= 17.05)and the practice(t (353)= 20.20) 
of trainee group who have undergone the participatory infection control training program 
by core group nurses. Their knowledge is independent of their age(0.85), education2.85, 
exposure to previous teaching (0.61) and their years of experience3.35.Their practice is also 
independent of the age(1.82), education(3.38), exposure to previous teaching (0.35)and their 
years of experience(0.52). 
Clinical practice improvement 
Quantitative enquiry has limitations to go in-depth for questions like; how significantly 
this program helps to improve infection control practice in the health care delivery 
system. To understand the impact of participatory infection control education, researcher 
aimed to reflect the opinions and experiences of the core group nurses using qualitative 
enquiry, which relies on inductive reasoning to interpret and structure the meanings that 
can be derived from the focus group discussion data. According to Bero, et al.,( 1998) it is 
evident that no single solutions will address all barriers at many levels of health care 
delivery system. 
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Fig. 1. Infection control nursing practice improvement model. Part of the theoretical 
framework was based on a strategy to change practice by Langley et al.,(1996) Institute for 
Healthcare Improvement, Boston  
Based on the findings of Bordley, et al.,(2001) it was considered that clinical practice 
improvement method was bound to be effective in changing clinical practice to overcome 
the barriers that keep health care professionals from changing their practice and to reduce 
external pressures to change, such as increased workload and lack of time. The researcher 
utilized this model to guide the infection control practice improvement of the nurses 
working in the selected areas. Fundamental components for clinical practice management: 
1. Developing the knowledge and skills for understanding human performance, for minimizing and 
dealing with error. 
2. The application of methods to identify measure and analyze problems with care delivery. 
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3. Action upon that information to improve both the individual and the systemic aspects of care 
delivery (infection control nursing). 
The researcher also analyzed the clinical practice improvement from the participatory 
infection control training. The results from FGD(Focus group dissuasion)II and III showed 
the changes in determinants of themes regarding improving infection control nursing 
practice were; 
 Education at all levels- Increased awareness, Interested to share and monitor others 
practice, improved recognition, Sharing ideas, Peer support, improved communication 
and network 
 Individual factors- Increased awareness, Interest to share and monitor others practices, 
Recognition, Sharing ideas, Peer support, confident, and improved communication. 
 Improved participants practice , self knowledge and practice, ability to self learn, and 
the ability to transfer knowledge to other colleagues. 
 Improved self esteem, belongingness to group and power to bring change, more 
assertiveness, confidence to change infection control related situation and awareness 
,systematic problem solving to improve infection control related practice  
 Observation /communication of observation will create awareness for a short time, this 
initial awareness and practice, may help to bring the change up to certain level. 
Opinionaire from the key personnel after 1 year and 6moths of the participatory infection 
control training shows that majority of the key personnel opined that they had clear 
expectation of the infection control training program(22) and following participation in the 
program, they find their staffs performance on infection control practices is improved (23), 
this training helped them to communicate more effectively regarding infection control 
issues(25), increased their staff’s involvement in infection control education and 
surveillance(20). Finally majority opined that their staff is effective member as they meet 
their expectations to prevent hospital associated infection in their respective units (24). 
The core objective of the present study is to establish a sustained infection control education 
program for nurses in Indian settings. The results of the present study show that the core 
group nurses who participated in the participatory infection control training acted as change 
agent and were successful to enhance educational communication like procedural 
explanations sharing ideas ,communication to face infection control related problems, 
decrease negative talks and also established a network to face education related problems. 
Clinical improvement process has also been considered more generally as a series of steps 
to help health workers and managers identify and solve problems of inadequate 
performance. Thus, this process shows where specific interventions fit into the larger 
process of managing health workers and health systems. Many of the core group nurses 
felt that they had improved infection control related clinical practice in their area. The 
group was able to identify specific issues, and instances where they felt infection control 
practice had been improved. For example improvement in hand washing, aseptic 
practices, and decrease in sharp injury, HAI rates and also improved infection control 
education at all level. This was attributed to the influence of the core group nurses, who 
had ensured that all staff understood key infection control practice. In addition, some of 
the core group nurses had produced education material, low cost materials/devises to 
improve infection control practice. The numerous examples suggest that the core group 
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nurses have improved the quality of infection control practice. Importantly they appear to 
be confident in their ability to improve infection control practice. This led to influence 
others and empowerment, with the ultimate impact of improving quality of infection 
control nursing practice within the clinical area. 
4. Conclusions 
The following conclusions were made based on the study findings; 
 Why educational programs on hospital infection control are a Herculean task to 
implement? 
The present result showed that the core group nurses not only became change agent to 
cover the entire nurses’ infection control education but also other staff like technical and 
housekeeping and also supported the educational program for doctors. They established 
continuing sustainable educational network without any additional cost. They developed 
indigenous materials and devises to improve infection control related practice. Their 
communication skills also improved and in one of the hospital the core group nurses are 
also instrumental in developing reporting network (e -surveillance). 
Through participatory training mode, it is possible to train the core group nurses to have 
self-help by educating and empowering them and also provide education to their 
colleagues. Participatory training may be more effective than the other methods of 
education delivery, in terms of cost of mass training, sustainability and acceptance by 
nurses, thus empowering them to practice infection control. 
A self-learning approach by participatory learning helps to develop facilitation of skills, and 
decision-making abilities, to increase self confidence and self-respect, and thus reduces 
dependency on others. This research based effort of using participatory infection control 
training to improve infection control related clinical practice aims to lead to improvements 
in the quality of care. 
The present study showed that the participatory education on hospital infection control was effective 
in enabling participants to improve their knowledge and practice of infection control. It also 
facilitated their capacity to train others as change agents thereby improve the clinical practice to 
reduce infection in the hospital. The participatory training concept appears to offer one approach to 
organizations who can successfully overcome some of the barriers in implementing infection control 
theory into practice. However further studies are required to identify if development and 
empowerment influenced the clinical outcome (patient outcome). 
 How to develop an effective and sustainable hospital infection control educational 
program to empower the nurses working in a selected hospital? 
Establishing infection control teams and ongoing surveillance of hospital associated 
infection is required in majority of the Indian hospitals.The focus group discussion revealed 
that nurses in this study accomplished significant increase in knowledge of Hospital 
Associated Infection and were able to find solutions for the problems themselves and 
change their practices.  
The experiences that nurses gained during this research project can be utilized as an ongoing process 
to introduce clinical practice improvement programs in the organization as a whole. Team effort in 
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which the most appropriate and best-positioned people are involved in a process of participatory 
learning can help to bring the practice improvement. The findings can be shared with other 
organizations that in turn can set up their own educational programs. This experience also helped to 
sustain practice improvement. 
 Will nurses on ward develop ownership and awareness of infection Control activities? 
This is concluded by the responses of key personnel. Majority opined that their staffs are 
effective members as they meet their expectations to prevent hospital associated infection in 
their respective unit. By attending and teaching infection control classes, helping others to 
improve practice and participating in surveillance and reporting, they are able to achieve 
infection control related clinical improvement. 
The result of the present study showed that there is continuing infection control education 
program run by the core group nurses and other nurses who participated in the training. This 
ongoing training is conducted on voluntary basis. The nurses also participate in surveillance and 
reporting activities. 
 How does the culture of the clinical environment influence infection control practice? 
Further, the findings of this study demonstrate that when infection control issues are not 
embedded in the clinical culture and infection control principles are not entrenched in 
clinical practice they are considered separately during care activities and easily displaced by 
other imperatives. Zimmerman and Peta-Anne, (2007) studied the current infection control 
advice applicable in low- and middle-income countries. Infection control guidelines 
designed for high-income countries are being utilized by Low and middle income countries, 
with varying degrees of success mainly because of physical, environmental, and 
socioeconomic factors. There is a lack of published studies exploring the implementation of 
comprehensive infection control advice and programs, including the minimal advice, which 
is designed specifically for resource-limited settings. They also concluded that this must be 
done in collaboration with those same health care workers who belong to low and middle 
income group countries. Equally, because of finance and health priorities, health care 
facilities should choose those interventions most relevant to the needs of their population 
and workers to prevent infection transmission. 
Therefore, it is important to develop a positive and collaborative workplace and system 
culture; specifically, seek to identify the most appropriate players for each change priority 
and explicitly support them to learn how to function effectively as a team. Successful work-
place cultures talk more about “why don’t we?” and less about “why don’t they” (Ancheril, 
2004) the present study experience helped the core group nurses to stretch and push the 
professional culture congenial to infection control related clinical practice improvement . 
The present study demonstrates that delivery of the programme based on participatory learning, led 
to confidence in the role, a belief in the importance of infection control and a feeling of legitimate 
empowerment. In turn, this facilitated development of empowered practice and influence at clinical 
level. This positively influenced clinical practice as demonstrated in the study, and led to increased 
ownership and motivation of the participants as described in this study. 
The study provided an opportunity to think through realistic strategies for change in 
infection control nursing activities, especially infection control education. Whenever it is 
possible, researcher kept in touch with participants to offer encouragement and support. An 
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effort is made to meet them in their work settings. The participants also created a network 
with their colleagues to support one another in creating change in infection control related 
activities in their institutions. To date this strategy has been successful in creating awareness 
in infection control. However to create a significant change in overall practice is still 
challenging and it is indisputably a collaborative effort. Most clinical practice improvement 
situations require that context-specific ‘knowledge’ be produced within the situation, in a 
time-bound manner. The literature in this area also points out that some of the more 
relevant human phenomena are not at all amenable to external observation, Most of these 
approaches seem to focus on creating (or improving) the situation-specific knowledge’ that 
would improve the problem situation(Dash,1999). 
Encouraging and allowing people to define their own problems, solve such problems in 
groups, share experiences, have critical and constructive dialogue, reflect on their own 
behavior and actions, adopt the inquisitive and critical mind-set, articulate positively effects 
change for the better, and making them change agents in the process and use their own 
‘local knowledge’, be helpful towards each other. Such awareness and interaction in 
combination with the organizational support helps to bring about the required clinical 
practice improvement. 
In the present study the information gathered during participatory infection control ranges 
from passive information providing to self mobilization. The results of FGD connote 
participant’s involvement, decision making and implementing in the infection control 
program. It has also created an opportunity to interact with each other and generate ideas to 
improve infection control knowledge and practice. 
There is no such thing as neutral education ... education either facilitates the integration of 
generations into the logic of the present system and brings conformity to it, or it becomes 
the 'practice of freedom', the means by which men and women deal critically and 
creatively with reality and discover how to participate in the transformation of their 
world -Freire,1972. 
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1. Introduction 
Progressively gaining importance, “Infection control” is an important subject in dentistry, 
on which many researches have been performed in recent years. Both dentists’ and the 
societies’ sensibility rapidly enhances the amount of efforts made in creating a “perfect” 
infection control.  
Dental team workers are members of a “high risk” group when dealing with patients in 
terms of cross infections. When the part of the body dentists mainly work on and the 
procedures performed are taken into account, contamination via blood and saliva can be 
clearly identified as a high risk. It should be kept in mind that other body fluids can also act 
as contamination risk factors.  
For an infection to emerge, microorganisms of adequate count and a disease causing 
potential must contaminate the host thru a proper path. These contamination paths are 
specified (Esen 2007); 
 Body fluids’ direct contact with the wound site during operation, 
 Injuries of the skin and the mucosa with sharp objects. 
 Body fluids’ and contaminated materials’ contact with eyes.  
 Aerosols arise during the operation with air turbined and ultrasonic devices. 
Contamination via droplet infection 
 Surgical smoke formed during electro-cautery or laser applications.  
2. Infectious diseases of concern in dentistry  
A number of infectious diseases can and should be of concern in dental procedures.  
2.1 Viral infections 
Herpes Simplex Virus, one of the most common types of Herpes Virus family. Among major 
signs of the primary infection are fewer, malaise lymphadenopathy and ulcerative 
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gingivostomatitis. Recurrent infections in the form of herpes labialis can also occur. A 
herpes simplex virus infection of the fingers (herpetic whitlow) is usually caused by direct 
contact with a herpetic lesion or infected saliva (Malik 2008).  
Transmission occurs by direct contact of the affected part of the skin. Mucosa lesions and 
secretions can also be responsible for the transmission. Lesion in general is characterized by 
vesicles and sequent crusting. When the processor symptoms are present, acyclovir can be 
used for treatment or at least avoiding the worsening of the symptoms. Wearing gloves 
when treating patients with Herpes lesions provides adequate protection for the clinician. 
Varicella Zoster Virus, causative agent of both chickenpox (primary disease) shingles 
(secondary disease) caused by the reactivation of the latent virus residing in sensory ganglia. 
Mild form is chickenpox mainly encountered in children. Shingles on the other hand can be 
very painful. 
Chickenpox is considered highly contagious and spreads via-airborne route. The non-
immune dental staff may contact the disease via inhalation of aerosols from a patient who is 
incubating the disease. Even though masks and gloves offer some level of protection they 
are usually not adequate for absolute protection of the healthcare professionals.  
Epstein-Barr Virus causes infectious mononucleosis and can remain latent in epithelial 
tissues. Can be transmitted by skin contact or blood and the virus is present in saliva, thus 
members of the dental team are considered in the low risk group of EBV infection. 
Human Herpes Virus 6 (HHV6), A relatively new member of the Herpes Family. Generalized 
rash is encountered frequently in patients. The virus is present in the saliva but medical or 
dental staff is considered as members of the low-risk group. 
Influenza, Rhino and Adenoviruses, Commonly cause respiratory tract infections. 
Transmission route is droplet infection members of the dental team are at risk of these 
infections but wearing masks and gloves offer adequate amount of protection. 
Rubella (German Measles) is a toga virus capable of affecting developing foetus causing 
cataract, deafness etc. Route of transmission is droplets. Female members of the dental team 
should be warned of possible dangers because at risk are non-immune females of 
childbearing age. Combined vaccine applications of MMR should be administered to the 
members of the dental staff. 
Coxsackie Virus, causative agent of herpangina and hand-foot and mouth disease. 
Considered as significant in dentistry due to presence of oral lesions and possibility of 
spreading in dental office. The virus is present in saliva and can pread via direct contact or 
aerosols. Gloves and masks offer adequate protection. 
Human T-Lymphotropic Virus, is a retrovirus and plays a key role adult T Cell Leukemia 
and spastic paraparesis. Route of transmission is blood, sexual transmission and IV drug 
use. In dental practice, can spread via sharp instruments oriented injuries. 
Hepatitis B Virus (HBV), A DNA virus causative of acute hepatitis. Hepatitis B surface 
antigen (HbsAg) is identified by serological tests as the main indicator of active infection. 
HbeAg on the other hand indicates continuing activity of the virus present in the liver and 
its higher levels correlates with higher levels of infectivity. 
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The routes of transmission are, sexual intercourse, blood transfusion, contaminated material 
injuries and perinatal way. 
All members of the dental team should be vaccinated against Hepatitis B and maintain this 
vaccination schedule.  
Hepatitis C Virus (HCV), is a RNA virus, causative of non-A and non-B Hepatitis. Route of 
transmission is similar to HBV. Following the primary infection, which is usually 
asymptomatic, majority of the infected individuals become persistent carriers of the virus 
and there is a long-term risk of chronic liver disease with cirrhosis and hepatocellular 
carcinoma. 
Human Immunodeficiency Virus (HIV), is a RNA retrovirus and is capable of infecting 
various cellular components of the immune system, T-Helper cells in particular. Route of 
transmission is similar to HBV, through sexual intercourse, blood borne and perinatal ways. 
HIV infections have oral manifestations, which can be helpful for the diagnosis of the 
disease. Among these oral manifestations are; 
 Oral Candidiasis 
 Oral Hairy Leukoplakia 
 Oral Necrotising Ulcerative gingivitis 
 Oral Kaposi’s Sarcoma       
2.2 Bacterial infections 
Tuberculosis, caused by M. Tuberculosis is transmitted by inhalation, ingestion and 
inoculation. Cervical lymphadenitis and pulmonary infections are usually encountered. 
Immunization with BCG vaccine adequately covers dental team members. Gloves and 
masks on the side must be utilized. It should be kept in mind that M. Tuberculosis is highly 
resistant to chemicals and heat and disinfection protocols should be strictly followed. 
Legionellosis caused by Gram-negative bacteria, which usually reside in warm and stagnant 
water reservoirs. Is capable of causing life threatening pneumonias in elder people? Since 
the organism is water-borne, it can easily be transmitted via aerosols formed during routine 
dental procedures. There have been reports about Legionella proliferations in dental unit 
water systems, thus systems, which remain unused for long periods of time should be 
regularly checked for legionella presence. The members of the dental team should be 
informed about the long term risk of legionellosis.  
Syphilis, caused by T.pallidum. wearing gloves offer adequate protection. 
3. Personal protection methods 
Dental team professionals must adapt a series of precautions in order to avoid these 
infections.  
The priority in infection control in dentistry is laid on the enhancement of awareness levels 
of dentists and other team members on infection control and personal protection techniques. 
An education emphasizing the importance of sensibility in this subject undoubtedly is the 
first and the most important step of precautions (Atac & Turgut 2007).  
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Personal protection techniques comprise of a series of applications that aim to reduce 
contaminations risks. It is not a realistic option to check all patients in terms of contagious 
diseases and dental professionals are exposed to these sorts of risks countless times 
everyday. Thus the main principle in infection control is to treat every patient as if he/she is 
an infected patient and to apply standard protection techniques properly is a “must” in a 
perfect infection control (Kulekci 2000). 
3.1 Routine procedure 
A proper medical and dental history should be obtained for all patients at the first visit and 
updated regularly. On the form, inclusion of patient views about the place cleanliness where 
they had received medical and dental treatment is useful.  
The history and examination may not reveal asymptomatic infectious disease. This means 
operator must obey the same infection control rules for all patients.  
3.2 Immunization 
Dentists and other dental team workers who are members of “the high risk group” must be 
vaccinated against Hepatitis B by means of personal protection (Kohn 2003). 3 doses of 
vaccination is required. Vaccination must be started in ten days after onset of practice and 
must be carried on during practice. Individuals who have been vaccinated before the onset of 
their practice must check their levels of immunity sufficiency against Hepatitis B (Thomas 
2008). All dental health care personnel are also strongly urged to receive the following 
vaccinations: influenza, measles (live-virus), mumps (live-virus), rubella (live-virus), and 
varicella-zoster (live-virus). Besides, women who have pregnancy uncertainty are strongly 
recommended to be vaccinated against rubella (Molinari 2005). Vaccination against influenza 
may also be beneficial for professionals of dental health who are under risk of contamination 
with droplet infections in terms of close working distance with patients. Updates of Centre for 
Disease Control (CDC) must be checked and paid attention in this subject.  
3.3 Hand hygiene 
Providing and maintaining a certain level of hand hygiene is of great importance in 
protection techniques. All member of the dental team must adapt the habit of maintaining 
providing hand hygiene. The idea and the practice of washing the hands with antiseptics 
date back to 19th century. In 1846, Semmelweis reported a lower rate of infection and 
mortality in obstetric clinics performed by students and physicians who have the habit of 
washing hands with chlorine when compared with midwifes who had lower levels of hand 
washing habits (Semmelweis 1983). 
In 1961, the U.S. Public Health Service produced a training film that demonstrated hand 
washing techniques recommended for use by health-care workers (HCWs)(Coppage 1961). 
At the time, recommendations directed that personnel wash their hands with soap and 
water for 1–2 minutes before and after patient contact. Rinsing hands with an antiseptic 
agent was believed to be less effective than hand washing and was recommended only in 
emergencies or in areas where sinks were unavailable (Boyce & Pittet 2002). CDC published 
a “how to” guideline for washing hands in 1975 and 1985 and according to these 
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publications hands must be washed with antimicrobial soaps before and after invasive 
procedures performed on patients. At times when washing hands is not an option, 
application of water-free antiseptics is recommended.  
 
Fig. 1. Hands should be washed before and after all procedure. 
It should be kept in mind that using gloves is not an alternative to washing hands. For routine 
procedures other than surgical ones, normal or antibacterial soaps are appropriate (Kohn 
2004). When an obvious stain is not present, alcohol-containing (% 60-95 ethanol or 
isopropanol) hand cleaning agents can be utilized (Garner & Favero 1986; Steere & Mallison 
1975). And also, alcohol-containing agents are very affective and preferable between the 
procedures when hand washing facility located far away from the dental unit. Cold water 
must be of choice when washing hands de to the fact that exposure of the skin to hot water 
repeatedly may increase the risk of dermatitis. Application of liquid soaps when washing 
hands for a minimum duration of 15 seconds and disposable paper towels for drying hands is 
recommended (Figure 1). Reducing numbers of pathogen microorganisms in hand washing 
before surgical procedures is of great importance. This is why application of antibacterial 
soaps and a detailed cleaning (arms, nails etc.) followed with alcohol containing liquids are 
recommended (Esen 2007). Despite the fact that antibacterial effects of alcohol containing 
cleansers arise rapidly, they do not last long and for a longer effect, antiseptics such as 
trichlosane, quarterner amonnium compounds, chlorehexidine and octenidine must be 
included (Boyce & Pittet 2002). Rings, watches and other accessories must be taken off before 
surgical hand washing and no nail polishes or other artificial (acrylics) must be present (Kohn 
2004). After the washing, hands must be dried with sterile towels and other surfaces must not 
be contacted until wearing sterile gloves. Following the procedure, after taking the gloves off, 
it is highly recommended to wash hands once again with regular soaps. 
3.4 Single use (disposable) items 
Equipment described by manufacturer as “single use”, should be preferred and used 
whenever possible. “Single use” means that a device can be used on a patient during one 
treatment session and then discarded (Thomas 2008). These items are local anaesthetic 
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needles and cartridges, scalpel blades, suction tubes, matrix bands, impression trays, 
surgery burs, patient gown, working area covers.     
3.5 Barrier techniques 
Dental team members must utilize personal protective equipment during applications in 
order to protect themselves and avoid cross infections. Hardships and limitations when 
using these equipment must be known and valued and when using new ones, detailed 
information about these protects must be gained. Guidelines for using these products must 
be kept under record and updated under contemporary data. 
3.5.1 Masks, eyewear and face shields 
Contact of blood and saliva of patients with dentists’ eyes and airways and contamination 
with aerosols formed during dental procedures is inevitable if proper precautions are not 
taken. A mask and a protective eyewear must be used during all applications (Figure 2, 
Figure 3). 
 
Fig. 2. Protective eyewear should be worn during the procedure 
Even though masks were first thought to be used by patient, today masks are mostly 
utilized for healthcare professionals. Dental masks must have the capacity to block 95% of 
all bacteria of 3-5 µm diameter and other particles (Esen 2007; Thomas 2008). If the masks 
get wet when dealing with a patient, they must be changed or thoroughly cleaned before 
using them for another patient’s application.  
Sides and upper edges of the protective eyewear must adapt the face well and provide 
protection against all kinds of infection agents (Thomas 2008). Face shields are more 
practical then protective glasses for dentists who also have to wear medical glasses and also 
a lower level of misting is experienced when using. However, wearing and keeping them at 
place appear to be troublesome which is why they are more often avoided by clinicians 
(Bebermayer 2005; Esen 2007). 
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3.5.2 Gloves 
Gloves were first used in medical procedures by William Halstead a century ago for 
avoiding nurses’ hands from harsh antiseptics (Randers-Pehrson 1960). Identification of 
diseases and their contamination routes resulting from viruses such as Hepatitis B and HIV, 
using gloves has been more and more popular in recent years (Field 1997).  The Expert 
Group on Hepatitis in Dentistry suggested the use of non-sterile gloves for the first time in 
1979, when dealing with patients infected with Hepatitis B and as HIV on the side spread 
around the world, non-sterile gloves have been concluded to be used for all patients 
routinely (Burke & Wilson 1989; EGHD 1979).  
During all kinds of procedure in dentistry, it is impossible to avoid contact of hands with 
blood and saliva. This is why all clinicians must wear protective hand gloves before they 
perform any kind of procedure on their patients. It is strongly recommended for dental 
professionals to use protective gloves both in America and all over Europe (Field 1994; 
Molinari 2005). Gloves are mainly produced of latex or vinyl and aside from the non-sterile 
ones, which are appropriate for regular dental procedures, less permeable sterile ones for 
surgical approaches offered in sterile packs are also available on the market. However, due 
to the fact that using sterile gloves during routine dental procedures increase costs and seen 
as an economical burden, clinicians most commonly prefer non-sterile ones instead. 
 
Fig. 3. Gloves must be worn during the operation by all working team. 
A separate pair of gloves must be used for every patient and contact with surfaces when 
with gloves must be avoided to prevent cross infections. Not only the dentist but also other 
members of the dental team must put on gloves during dental procedures. When cleaning 
dental appliances and instruments more durable gloves than regular non-sterile ones must 
be utilized to prevent injuries. 
Gloves are powdered to make them easier to put on. However, the powder present inside 
the gloves are reported to cause skin irritations (Field 1997). Wilson and Garach further 
reported that this powder could cause starch granulomas on surgical sites among which oral 
cavity is mentioned (Wilson & Garach 1981). Powder-free gloves are produced and available 
in the market today and they should be used when such reactions are experienced. 
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needles and cartridges, scalpel blades, suction tubes, matrix bands, impression trays, 
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Allergies and contact dermatitis due to latex can be encountered in some people. Dental 
team members should be warned about this subject. Allergic symptoms may include local 
ones such as itching, redness, rash, dryness, fissures/cracking, hyperkeratosis and swelling 
and at times, systemic ones such as sneezing, wheezing, urticarial and red watered eyes can 
emerge. In such a situation latex gloves should be avoided and a medical consultation 
should be obtained. Latex-free gloves are also available for allergic individuals. 
3.5.3 Protective clothing 
Protective clothing should be utilized instead of daily clothing (Figure 4). Whenever the 
clinician is to deal with patients with contagious diseases, he/she should prefer long-
sleeved protective clothing. This way, contact of pathogens with skin can be avoided. In case 
the clothing gets wet, they should be changed immediately with new ones and should be 
taken off when the clinician is to leave the operation area. 
 
Fig. 4. Protective clothing should be utilized instead of daily clothing. 
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3.5.4 Operation room protection 
a. Floor 
 The floor covering should be impervious and non-slip. Carpeting must be avoided. 
 The floor covering should be seam free; where seams are present, they should be 
sealed. 
 The junctions between floor and wall and the floor and cabinetry should cove or be 
sealed to prevent inaccessible areas where cleaning might be difficult (BDA 2003). 
b. Work Surface 
 Work surfaces should be easy to clean and disinfection. 
 Work surface joins should be sealed to retention of contaminated matter. 
 All work surface junctions should be rounded or coved to aid cleaning (BDA 2003).   
3.6 Post-exposure protocol 
In case skin gets injured with contaminated instruments or open wounds come in contact 
with body fluids of the patient, procedure should be imeediately intercepted and injured 
area should be rinsed with ample amount of soap and water and mucosa if involved, water 
should be used for flushing. If another member of the dental team gets injured, he/she 
should inform the dentist. According to Control Disease Center (CDC)’s recommendations, 
following injuries with contaminated material or contact with certain body fluids; 
 Injury’s date and time  
 How and with what sort of instrument injury occurred,  
 With which body fluid exposure occurred 
 Details about the exposure source (information regarding the presence of any 
contagious disease) 
 Detailed medical information of the injured, 
 Precautions followed before and during the injury should be recorded in detail (CDC 
2009).  
If an injury with contaminated materials utilized in HIV, HBV or HCV infected patients 
occurs, patient’s detailed medical history should be questioned and tested should be carried 
out for certain markers if required. CDC’s post-exposure management publication regarding 
this subject should be referred as the guideline and necessary precautions should be taken 
(CDC 2001).    
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In the late 1990s and early part of the 21st century, alcohol-based hand rubs started to gain 
popularity. Today, alcohol-based hand rubs are widely used for infection control in clinical 
practice. However, many healthcare workers complain about unacceptable skin irritation 
caused by alcohol-based hand rubs. In spite of the complaint, when the irritant effect of 
alcohol on the skin has been evaluated, most authors found low toxicity (Boyce et al., 2000; 
de Haan et al., 1996; Lübbe et al., 2001; Winnefeld et al., 2000). 
Kownatzki has pointed out that the skin irritation of healthcare workers is not simply 
caused by alcohol antisepsis but by combined damage resulting from the alcohol antisepsis 
dissolving lipids in the stratum corneum, the removal of lipids from the skin surface by 
detergent washing, and the skin becoming over-hydrated from wearing gloves. 
To reduce the adverse effects of alcohol-based hand rubs, it is known that adding emollients 
or humectants is efficacious (Many studies are reviewed in Boyce & Pittet, 2002). 
By contrast, addition of a certain type of chemical compound such as cationic antiseptics 
may cause irritation (Tsuji et al., 1993). 
Thus, so-called “alcohol-based hand rubs” include wide variations of alcohol formulations. 
When we discuss the skin irritancy of alcohol-based hand rubs, we need to note the 
formulation of each testing sample and the type and concentrations of the alcohols, 
emollients, and antiseptic compounds contained. 
To evaluate the skin irritancy of alcohol-based hand rubs in human, animal experiments 
such as Draize rabbit tests are quite useful. However, using experimental animals requires 
special techniques and facilities, and also have problem in animal protection. 
Hence, alternatives to animal experiments have been developed in last decades. To predict 
the skin irritancy in human, in vitro skin irritation tests using three-dimensional human skin 
models are quite useful. The EU has accepted the in vitro skin irritation test using a human 
skin model as stand-alone test to determine the skin irritation potential of a substance 
(OECD TG 439). However, the in vitro skin irritation tests using human skin models cannot 
be used for high alcohol-content solutions, such as alcohol-based hand rubs. To overcome 
this problem, the author has developed a novel in vitro evaluation method named “Skin 
model blowing method (SMBM)” (Yamamoto et al., 2010). 
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The first objective of this review is to summarize the structure and barrier function of the 
skin, the mechanism and evaluation methods of skin irritation, and the irritancy of alcohol-
based hand rubs. The second objective is to implement the novel in vitro evaluation method 
“SMBM” for assessing the skin irritation caused by alcohol-based hand rubs, and show the 
evaluation results of some of the alcohol-based hand rubs used in Japan. 
2. Structure and barrier function of the skin 
2.1 Structure of the skin 
The skin is the largest human organ and consists of two main layers: epidermis and dermis 
(Fig.1). One major task of the skin is to protect the organism from water loss and 
mechanical, chemical, microbial, and physical influences. The protective properties are 
provided by the outermost layer of the skin, the epidermis. The epidermis is approximately 
100 to 150 micrometers thick, has no blood flow and includes the superficial layer known as 
the stratum corneum (Fig.2). 
 
Fig. 1. Histological structure of the human skin1 
The stratum corneum consists of slabs of flat, platelike dead cells called corneocytes. The 
corneocytes, which are anucleated cells derived from keratinocytes, have no viable function 
and are called "dead" cells. They are continuously being sloughed off and then replaced in 
cycles of 3 to 4 weeks. The cells are pushed up from the living layer just lying below. The 
corneocytes are embedded in the intercellular lipid matrix, thus the structure of the stratum 
corneum can be roughly described by a “brick and mortar” model (Elias, 1983).  
                                                 
1. U.S. National Cancer Institute, In: Anatomy of the Skin, Available from 
http://training.seer.cancer.gov/melanoma/anatomy/ 
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2.2 Barrier function of the skin 
The major factor that keeps the skin moist and pliable is the presence of intercellular lipids. 
These form a lamellar (stacked bilayers) structure surrounding the corneocytes and 
incorporate water into the stratum corneum. The lipids are derived from lamellar granules, 
which are released into extracellular spaces from degrading cells in the granular cell layer; 
and the membranes of these cells also release lipids, including cholesterol, free fatty acids 
and sphingolipids. Ceramide, a type of sphingolipid, is mainly responsible for generating 
the stacked lipid structures that trap water molecules in their hydrophilic region. 
These lamellar lipids surround the corneocytes and form a semi-permeable barrier that 
prevents water and natural moisturizing factors (NMF) from moving out from the surface 
layers of the skin. 
Epidermis Stratum Corneum
Keratin (Brick)
Intercellular lipid with 
lamellar structure (Mortar)






Fig. 2. Schematic diagrams of the epidermis and stratum corneum based on the “brick and 
mortar” model (Elias, 1983) 
2.3 Measurement of the skin barrier function 
2.3.1 Transepidermal water loss (TEWL) 
The measurement of transepidermal water loss (TEWL) is an important non-invasive 
method for assessing the barrier function of the stratum corneum. As a consequence, TEWL 
has been found to be a very useful index for studying skin irritation induced by various 
physical and chemical effects. Exposure of the skin to chemicals (detergents) and physical 
conditions (occlusion and stripping) generally results in an increase of TEWL (Barel & 
Clarys, 1995). 
Several TEWL measuring instruments such as Evaporimeter EP-2 (ServoMed, Sweden), 
Tewameter TM 300 (Courage+Khazaka electronic GmbH, Germany) and VapoMeter (Delfin 
Technologies, Finland) are commercially available. Evaporimeter and Tewameter are based 
on the open chamber system with two humidity and temperature sensors for measuring the 
water evaporation gradient at the surface of the skin. 
By contrast, VapoMeter is based on the closed chamber system, and is easier to use than 
the open chamber device. However, its tendency to become saturated under high water 
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Fig. 2. Schematic diagrams of the epidermis and stratum corneum based on the “brick and 
mortar” model (Elias, 1983) 
2.3 Measurement of the skin barrier function 
2.3.1 Transepidermal water loss (TEWL) 
The measurement of transepidermal water loss (TEWL) is an important non-invasive 
method for assessing the barrier function of the stratum corneum. As a consequence, TEWL 
has been found to be a very useful index for studying skin irritation induced by various 
physical and chemical effects. Exposure of the skin to chemicals (detergents) and physical 
conditions (occlusion and stripping) generally results in an increase of TEWL (Barel & 
Clarys, 1995). 
Several TEWL measuring instruments such as Evaporimeter EP-2 (ServoMed, Sweden), 
Tewameter TM 300 (Courage+Khazaka electronic GmbH, Germany) and VapoMeter (Delfin 
Technologies, Finland) are commercially available. Evaporimeter and Tewameter are based 
on the open chamber system with two humidity and temperature sensors for measuring the 
water evaporation gradient at the surface of the skin. 
By contrast, VapoMeter is based on the closed chamber system, and is easier to use than 
the open chamber device. However, its tendency to become saturated under high water 
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loss conditions could be a disadvantage when assessing dynamic TEWL (Cohen et al., 
2009). Tewameter is able to detect significantly smaller differences than VapoMeter (de 
Paepe et al., 2005). 
2.3.2 Electrical characteristics of skin surface 
Deterioration of the skin barrier function leads to reduced hydration levels of the skin 
surface. To determine the hydration level of the skin surface, Corneometer CM 825 
(Courage+Khazaka electronic GmbH, Germany) and SKICON-200EX (I.B.S Co., Ltd., Japan) 
are widely used. Corneometer CM 825 measures the changes in the dielectric constant 
caused by skin surface hydration by measuring changes in capacitance with a precision 
capacitor. SKICON-200EX measures high frequency conductance of the skin, which is 
sensitively correlated to the skin surface water content. 
3. Mechanism of skin irritation 
3.1 Inflammatory response 
Foreign materials (e.g., micro-organisms, surfactants, etc.) that have penetrated the stratum 
corneum barrier encounter living epidermal cells. Interactions with keratinocyte surface 
molecules or membrane lipids activate the cells. Cytokines are released, emitting signals 
requesting assistance to blood vessels and white blood cells. Activation of Langerhans cells 
initiates an immune response, which is particularly effective when a given foreign material 
is encountered repeatedly. When these responses exceed a certain level, inflammatory 
symptoms are elicited (Gallin et al., 1992). 
1. Destruction of the lipid lamellar structure
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Fig. 3. Diagrams of structurally altered stratum corneum. Due to the deterioration of the 
barrier function (enhanced permeability) of epidermis, irritants can penetrate through the 
stratum corneum. 
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3.2 Hand hygiene and skin barrier function 
The mechanism of skin barrier damage in healthcare workers was summarized by 
Kownatzki (Kownatzki, 2003). The main concern in hygiene-dependent risks to the skin’s 
health is damage to the lipid barrier. The lipid barrier is jeopardized on three occasions: 
when the lipid lamellar structure is destroyed, the intercellular lipid is lost, and the skin is 
over-hydrated. In healthcare settings, these phenomena usually occur in a concerted 
situation of alcohol antisepsis, detergent cleaning, and glove work. 
Destruction of the lipid lamellar structure 
Antiseptic alcohols, which are organic solvents, are capable of dissolving stratum corneum 
lipids and destroying the barrier. Alcohol remaining on the skin evaporates leaving the 
lipids on the skin, but the lipids do not reassume the original structure and arrangement of 
the barrier and do lose the sealing function. 
Loss of intercellular lipids 
Detergents clean surfaces by removing lipids, together with any adhering contaminants. 
Sebum lipids on the skin surface, which are encountered and emulsified first by detergents, 
may provide protection for the underlying barrier lipids. Repeated detergent washes and 
progressive removal of surface lipids reduce the lipid-dependent cleaning efficiency and 
allow the detergent molecules to penetrate deep in the stratum corneum. In individuals with 
less supply of sebum lipids, this occurs more quickly. 
Over-hydration 
There is a high rate of hand problems among professions whose hands have frequent 
contact with water or wet objects such as food workers and hair dressers. Also the gloves 
worn by healthcare workers create a wet environment as they do not allow the sweat to 
evaporate. Extended water exposure leads to extensive disruption of stratum corneum 
intercellular lipid lamellae. The hydration induces disruption of the intercellular lipid 
lamellae, forms large pools of water in the intercellular space and creates corneocyte 
separations (Warner et al., 2003). 
4. In vivo and in vitro evaluation of skin irritation 
Human patch testing is commonly used to evaluate the skin irritation caused by a 
substance. Animal and in vitro testing is also utilized to predict the skin irritancy in human. 
4.1 Human testing (single-application patch test) 
Widely used method for assessing skin irritation include single-application patch testing, 
cumulative irritation test, chamber scarification test and immersion tests (Levin & 
Maibach, 2004). Especially, many variations of single-application patch test have been 
developed. Testing is often performed on undiseased skin (Skog, 1960) of the dorsal upper 
arm or back. The required test area is small, and up to ten materials can be tested 
simultaneously and compared. A reference irritant substance is often included to interpret 
variability in test responses. In general, screening of new materials involves open 
application on the back or dorsal upper arm for a short time (30 min to 1 hr) to minimize 
potential adverse events in the subjects. 
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potential adverse events in the subjects. 
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The National Academy of Sciences (National Academy of Sciences and Committee for the 
Revision of NAS Publication 1138, 1977) recommended a 4-hr single-application patch test 
protocol for routine testing of skin irritation in humans. In general, patches are occluded 
onto the dorsal upper arm or back skin of patients. The degree of occlusion varies 
according to the type of occlusive device; the Hilltop or Duhring chambers or an occlusive 
tape will enhance percutaneous penetration as compared to a non-occlusive tape or cotton 
bandage (Patil et al., 1996). Potentially volatile materials should always be tested with a 
non-occlusive tape. 
Exposure time to the putative irritant varies greatly, and is often customized by the 
investigator. Volatile chemicals are generally applied for 30 min to 1 hr while some 
chemicals have been applied for more than 24 hr. 
Following patch removal, the skin is rinsed with water to remove the residue. Skin 
responses are evaluated 30 min to 1 hr following patch removal in order to allow hydration 
and pressure effects of the patch to subside. Another evaluation is performed 24 hr 
following the patch removal. The animal Draize scale is used to analyze test results (see 
Table 1). The Draize scale does not include papular, vesicular, or bullous responses; and 
other scales have been developed to address these needs. 
Single-application patch tests generally heal within one week. Depigmentation at the test 
site results in some subjects. 
 
Erythema  
 No erythema 0 
 Slight erythema 1 
 Well-defined erythema 2 
 Moderate or severe erythema 3 
 Severe erythema or slight eschar formation (injuries in depth) 4 
Edema  
 No edema 0 
 Very slight edema 1 
 Slight edema (well-defined edges) 2 
 Moderate edema (raised >1 mm) 3 
 Severe edema (raised >1 mm and extending beyond the area of 4 
Table 1. Draize scoring system 
4.2 Animal testing (Draize rabbit test) 
In order to evaluate the skin irritation, Draize rabbit test, guinea pig immersion test and 
mouse ear test are utilized as animal models. Especially, the Draize scores are most 
accurate when compared to related compounds with a record of human exposure (Levin 
& Maibach, 2004). 
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The Draize rabbit test was developed in 1944, and has since been adopted in the US Federal 
Hazardous Substance Act (Patrick & Maibach, 1989). The test involves two (1 square inch) 
test sites on the dorsal skin of six albino rabbits. One site is abraded (through use of a 
hypodermic needle across the rabbit skin) and the other site remains intact. The stratum 
corneum is broken on the abraded site, without loss of blood. The undiluted “irritant” 
materials (0.5 g for solids or 0.5 ml for liquids) are placed on a patch and applied to the test 
sites. They are secured with two layers of surgical gauze (1 square inch) and tape. The 
animal is wrapped in cloth so that the patches are secure for a 24-hr period. Assessment of 
erythema and edema, utilizing the scale noted in Table 1, takes place 24 hr and 72 hr 
following patch application. Severe reactions are again assessed on days 7 or 14. 
Radiolabeled tracers or biochemical techniques to monitor skin healing is also utilized by 
some investigators. Other investigators supplement with histological evaluation of skin 
tissue (Mezei et al., 1966; Murphy et al., 1979). 
The Draize test ultimately quantifies irritation with the primary irritation index (PII), which 
averages the erythema and edema scores of each test site and then adds the averages 
together. Materials producing a PII of <2 are considered nonirritating, 2–5 mildly irritating, 
and >5 severely irritating and require precautionary labelling. Subsequent studies have 
demonstrated that the PII is somewhat subjective because the scoring of erythema and 
edema require clinical judgment (Patil et al., 1998). 
Main critics of the Draize test oppose the harsh treatment of animals. They argue that the 
Draize test is unreliable at distinguishing between mild and moderate irritants. Furthermore, 
they believe the Draize is not an accurate predictor of skin irritancy as it does not include 
vesiculation, severe eschar formation or ulceration in evaluating the PII. Finally, they argue 
that the Draize procedure is not reproducible (Weil & Scala, 1971) and they question its 
relevance with regard to human experience (Edwards, 1972; Nixon et al., 1975; Shillaker et al., 
1989). Proponents of the Draize test point out that the test is somewhat inaccurate but it 
generally overpredicts the severity of skin damage produced by chemicals, and thereby errs on 
the side of safety for the consumer (Patil et al., 1996). This topic is still being hotly debated. For 
the meantime, the Draize assays are recommended by regulatory bodies. 
4.3 In vitro testing (human skin models) 
4.3.1 Overview of human skin models 
Animal experiments such as Draize rabbit tests are quite useful for determining the skin 
irritancy in human. However, using experimental animals requires special techniques and 
facilities, and also have problem in animal protection. Three-dimensional human skin 
models and cultured human skin models, which have been proposed for therapeutic 
purpose of a full thickness skin defect resulting from burn or trauma, can be used to replace 
animal-based irritative studies. The human skin models have been developed during the 
last decades (Green et al., 1979; Bell et al., 1981; Asselineau et al., 1985). The first skin model 
was proposed by Green et al. in 1979, who made an artificial epidermis from human 
epidermal keratinocytes. This type of human skin model is called “reconstructed human 
epidermis (RhE)”. The skin model consisting of dermis and epidermis which resembled the 
real human skin was reported by Bell et al. in 1981. Various human skin models have been 
developed thereafter and are commercially available today (Table 2). 
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Product Name Structure Manufacturer 
EpiDerm Epidermis MatTek Corp. 
EpiDermFT Epidermis on dermis MatTek Corp. 
EPISKIN Epidermis on collagen gel SkinEthic Laboratories 
SkinEthic RHE Epidermis SkinEthic Laboratories 
EST-1000 Epidermis CellSystems Biotechnologie Vertrieb GmbH 
TESTSKIN Epidermis on dermis with collagen gel TOYOBO Co., Ltd. 
Vitrolife-Skin Epidermis on dermis with collagen sponge GUNZE Ltd. 
LabCyte EPI-MODEL Epidermis Japan Tissue Engineering Co., Ltd. 
Table 2. Commercially available human skin models 
Underside of a hanging
cell culture insert  
 
Fig. 4. An example of human skin model (LabCyte EPI-MODEL 24).2 (A) Appearance of the 
skin model in hanging cell culture insert in 24-well microplate. (B) Histological cross-
sectional view of the skin model with H&E staining. Epidermal cells were located on a 
microporous membrane. 
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4.3.2 In vitro evaluation of skin irritation by using human skin models 
To evaluate and predict the skin irritancy in human, in vitro skin irritation tests using human 
skin models have been developed. During the development processes, appropriate 
endpoints for skin irritancy evaluation have been determined. Triglia et al. compared four 
endpoints on their dermal model: 1) cell viability determination with neutral red (NR), 2) 
cell viability determination with 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium 
bromide (MTT), 3) release of prostaglandine E2 (PGE2), and 4) release of lactate 
dehydrogenase (LDH) (Triglia et al., 1991). They tested 13 chemicals, but there were no 
significant differences among the results of the four endpoints. Morota et al. compared six 
endpoints: 1) cell viability with MTT, 2) cell viability with NR, 3) release of PGE2, 4) LDH, 5) 
interleukin-1α (IL-1α), and 6) interleukin-8 (IL-8) (Morota et al., 1999). They concluded that 
cell viability assays revealed good correlations with animal testing (Draize score of skin 
irritancy) and were advantageous to the other endpoints as they were easier to use and less 
costly. Recently, the EU has accepted the in vitro skin irritation test using RhE as stand-alone 
test to determine the skin irritation potential of a substance (OECD TG 439). In this 
guideline, cell viability assay with MTT is adopted. 
However, in vitro skin irritation tests using human skin models have some limitations. For 
example, they cannot be used for samples containing high concentrations of ethanol. It is 
because most skin models are more sensitive to alcohols than the skin in vivo. Instead of the 
low irritation scores demonstrated in Draize rabbit skin tests, ethanol showed high toxicity in 
human skin model tests. In a dose-response test, higher concentration of ethanol resulted in 
lower cell viability (Genno et al., 1998; Li et al., 1991). It was found that ethanol concentrations 
above 30% affected the skin model, but had minimal effects on the rabbit skin. 
Cytotoxicity of ethanol in human skin models are affected not only by the concentration of 
ethanol but also by the time of exposure. From the time course change of cytotoxicity test, it 
was shown that cell viability was not affected by short time exposure to ethanol (Nagasawa 
et al., 2002). Cell viability was found to be negligible when the skin was exposed to 76.9–81.4 
vol% of ethanol for a period shorter than 1 minute (Yamamoto et al., 2010). 
5. Irritancy and antimicrobial activity of alcohol-based hand rubs 
Most alcohol-based hand rubs contain either ethanol, isopropanol or n-propanol, or a 
combination of two of them. Assessments of alcohol effects on the skin have involved 
evaluating the effects of individual alcohol at various concentrations, combinations of two 
or more alcohols, and alcohol solutions containing thickening agents, foaming agents, 
and/or small amounts of antiseptics. 
5.1 Irritancy of alcohol 
Most irritancy assessments of alcohol have shown that alcohols are little toxic to the skin 
(Boyce et al., 2000; de Haan et al., 1996; Lübbe et al., 2001; Winnefeld et al., 2000). However, 
many healthcare workers complain about unacceptable skin irritation caused by alcohol-
based hand rubs. Even in the Guideline for Hand Hygiene in Healthcare Settings of the 
Centers for Disease Control (Boyce et al., 2002), skin tolerability of alcohol-based hand rubs 
is stated as potentially problematic: ‘Although alcohols are among the safest antiseptics 
available, they can cause dryness and irritation’. 
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According to the well-designed patch testing with alcohols and sodium lauryl sulphate 
(SLS) as a model detergent, it was found that alcohols lead to only minor skin barrier 
changes and cause no changes in erythema independent of the concentration tested (Löffler 
et al., 2007). Compared to alcohols, the detergent SLS induced a much stronger barrier 
disruption and a pronounced skin hydration decrease. 
Kownatzki has pointed out that the skin irritation of healthcare workers is not simply 
caused by alcohol antisepsis but by combined damage resulting from the alcohol antisepsis 
dissolving stratum corneum lipids, the removal of lipids from the skin surface by detergent 
washing, and the skin becoming over-hydrated from wearing gloves. 
5.2 Basic formulation of alcohol-based hand rubs 
Antimicrobial activity of alcohols results from their ability to denature proteins. Alcohol 
solutions containing 60–80% alcohol are most effective, with higher concentrations being 
less potent (Price, 1938; Harrington & Walker, 1903). This paradox results from the fact that 
proteins are not denatured easily in the absence of water (Larson & Morton, 1991). The 
alcohol content of solutions may be expressed as a percentage by weight, which is not 
affected by temperature or other variables, or as a percentage by volume, which may be 
affected by temperature, specific gravity and reaction concentration. For example, 70% 
alcohol by weight is equivalent to 76.8% by volume if prepared at 15ºC, and 80.5% if 
prepared at 25ºC (Price, 1938). In the Japanese Pharmacopoeia, ethanol solution for 
disinfection is defined as the concentration of 76.9–81.4% by volume. 
5.3 Gel and foam formulations 
Alcohol-based hand rubs intended for use in hospitals are available as low viscosity 
rinses, gels, and foams. For example, thickening agents such as polyacrylic acid or 
cellulose derivatives are commonly formulated in alcohol gels to increase the viscosity of 
alcohol solutions. 
Limited data are available regarding the relative efficacy of various formulations. One field 
trial demonstrated that an ethanol gel was slightly more effective than a comparable ethanol 
solution in reducing bacterial counts on the hands of healthcare workers (Ojajärvi, 1991). 
However, a more recent study indicated that rinses reduced more bacterial counts on the 
hands than the gels tested (Kramer et al., 2002). Further studies are warranted to determine 
the relative efficacy of alcohol-based rinses and gels in reducing transmission of healthcare-
associated pathogens. 
In prospective trials, alcohol-based gels containing humectants caused significantly less skin 
irritation and dryness than the soaps or antimicrobial detergents tested (Boyce et al., 2000; 
Newman & Seitz, 1990). 
5.4 Antiseptics formulation 
Some alcohol-based hand rubs contain antiseptics in order to provide persistent (residual) 
activity. Addition of antiseptics (e.g., chlorhexidine or quaternary ammonium compounds) 
to alcohol-based formulations can result in persistent activity (Rotter, 1999). 
Chlorhexidine, a cationic bisbiguanide, was developed in the United Kingdom in the early 
1950s. It is effective against grampositive bacteria and has substantial residual activity. 
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Chlorhexidine base is barely soluble in water, and thus the water-soluble digluconate form 
(CHG) is widely used. Addition of low concentrations (0.5–1%) of chlorhexidine to alcohol-
based preparations results in significantly greater residual activity than alcohol alone (Aly & 
Maibach, 1979; Lowbury et al., 1974).  
Quaternary ammonium compounds are composed of a nitrogen atom linked directly to four 
alkyl groups, which may vary considerably in their structure and complexity (Merianos, 
1991). Among this large group of compounds, alkyl benzalkonium chlorides (BAC) are the 
most widely used as antiseptics. 
In Japan, alcohol-based hand rubs containing CHG or BAC are widely used in healthcare 
settings. For example, WELPAS (0.2% w/v BAC, 70% ethanol solution) and WELLUP 
(0.2% w/v CHG, 70% ethanol solution) are recommended for hand hygiene in the 
Guideline for the prevention of healthcare-associated infection in urological practice in 
Japan (Hamasuna et al., 2011). 
Compared with CHG, BAC shows stronger activity to various microorganisms (Jono et al., 
1985; Shimizu et al., 2002). However, alcohol-based hand rubs containing CHG are less 
irritative to the skin than those containing BAC (Tsuji et al., 1993). The skin irritancy level of 
alcohol-based hand rubs containing antiseptics correlates with the irritancy of the antiseptic 
compound contained (Tsuji et al., 1996). 
It is known that alcohols may enhance skin permeation. For example, the enhancement 
ability of ethanol is maximized at the concentration of 50–70% (Kim et al., 1996; 
Watkinson et al., 2009). Hence the irritancy of antiseptic compounds may be amplified in 
alcohols-based hand rubs. 
6. Reduction of skin irritancy 
In prospective trials, alcohol-based hand rubs containing humectants caused significantly 
less skin irritation and dryness than the soaps or antimicrobial detergents tested. These 
results suggest that addition of humectants can minimize the skin irritation and dryness. 
6.1 Humectants 
Most alcohols-based hand rub formulations contain humectants (or emollients). The drying 
effect of alcohol can be reduced or eliminated by adding 1%–3% glycerol or other skin-
conditioning agents (Many studies are reviewed in Boyce & Pittet, 2002). Moreover, in 
several recent prospective trials, alcohol-based rinses or gels containing emollients caused 
substantially less skin irritation and dryness than the soaps or antimicrobial detergents 
tested (Winnefeld et al., 2000; Boyce et al., 2000; Larson et al., 2001a, 2001b). 
These studies, which were conducted in clinical settings, used various subjective and 
objective methods for assessing skin irritation and dryness. Further studies are warranted to 
know whether products with different formulations would yield similar results or not. 
6.2 Skin barrier stabilizers 
Lamellar structures of intercellular lipid in the stratum corneum are quite important to 
maintain the barrier property of the skin. It is known that some kind of compounds can 
stabilize the lamellar structures. 
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Ceramides are characteristic components of intercellular lipids in the stratum corneum. The 
lamellar structures of intercellular lipids are stabilized by long-chain ceramides. Alcohol-
based hand rubs containing synthetic pseudo-ceramide are less likely to roughen the skin of 
the hands in comparison with hand rubs containing no emollient (Tsuboi et al., 2006). 
MPC polymers (Lipidure®) 
MPC polymers are novel phospholipid-like synthetic polymers composed of 2-
methacryloyloxyethyl phosphorylcholine (MPC). They are biomimetic materials which have 
excellent biocompatiblity as its structure closely resembles that of cell membrane 
phospholipids (Iwasaki & Ishihara, 2005). Recently, unique functions of the MPC polymers 
have been reported.  
MPC homo-polymer can protect the barrier property of the stratum corneum by preventing 
the intercellular lipid bilayer (ILB) structure from being disrupted by extensive skin 
hydration (Lee, 2004). It helps maintain the barrier property of the skin by preventing 
disruption of the ILB structure, and functions as a barrier-like membrane to prevent toxic 
substances from penetrating into the skin. 
The effects of MPC/n-butyl methacrylate (BMA) co-polymer on the water barrier function 
and water-holding capacity of the stratum corneum were examined by measuring 
transepidermal water loss (TEWL) and electrical conductance of the skin surface (Kanekura 
et al., 2002). The MPC/BMA co-polymer reduced TEWL in laboratory mice significantly 
compared with the control. Human skin treated with this polymer showed significantly 
























Fig. 5. Water content in the stratum corneum of hairless mice. A 100 µL solution (80% 
ethanol or 80% ethanol + 2% MPC/BMA co-polymer) was applied on the back skin of 
hairless mice twice a day for 10 days. (Figure modified from Andoh et al., 2008) 
The skincare function of the MPC/BMA co-polymer was also determined by Andoh. As 
shown in Fig. 5, both the control and the ethanol solution containing MPC/BMA co-
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polymer showed the same tendency. By contrast, applying ethanol solution without 
MPC/BMA co-polymer decreased the water content of the stratum corneum. In addition, 
the presence or absence of MPC/BMA co-polymer had no relation to the bactericidal 
activity of the ethanol solutions (Andoh et al., 2008). 
Recently, the unique function of MPC/stearyl methacrylate (SMA) co-polymer has been 
reported. It was found that the MPC/SMA co-polymer forms a self-assembled mosaic 
lamellar structure, which is structurally similar to ILB, by simple drying process. It is 
considered that the MPC/SMA co-polymer has a potential to act as an artificial intercellular 
lipid for damaged skin (Yamamoto et al., 2007).  
Commercially available MPC polymers for skincare products are shown in Table 3. 
Chemical Structure Product Name
MPC* homo-polymer Lipidure®-HM 
MPC/BMA** co-polymer Lipidure-PMB® 
MPC/SMA*** co-polymer Lipidure®-S 
Polyol solution of MPC/SMA co-polymer Lipidure®-NR 
Note: *MPC: 2-methacryloyloxyethyl phosphorylcholine. **BMA: n-Butyl methacrylate. ***SMA: Stearyl 
methacrylate. 
Table 3. Commercially available MPC polymers for skincare products3 
7. In vitro evaluation of skin irritation caused by alcohol-based hand rubs 
Animal experiments are quite useful for estimating the skin irritation potential in human. 
However, using experimental animals requires special techniques and facilities, and also has 
problem in animal protection. Thus development of an alternative to animal experiments is 
important not only from the viewpoint of ethical aspects but also for efficient research and 
development. The in vitro reconstructed human epidermis (RhE) has been applied for 
evaluating the skin irritancy of various substances. However, RhE has not been used for the 
evaluation of alcohol-based hand rubs because of the high skin permeability and cytotoxicity 
of alcohols. Recently, the author has developed a novel in vitro experimental method named 
“Skin model blowing method” (SMBM), which mimics the actual usage of alcohol-based hand 
rubs: putting on, spreading, rubbing into the skin, and drying. The skin irritation potential of 
alcohol-based hand rubs could be estimated by using SMBM. In this section, details of SMBM 
and evaluation results of some of alcohol-based hand rubs used in Japan are described. 
7.1 Development of in vitro evaluation method using RhE 
7.1.1 Experimental 
Alcohol-based hand rubs used in this study 
The alcohol-based hand rubs used in this study are summarized in Table 4. 
                                                 
3. http://www.nof.co.jp/business/life/lipidure/english/ 
Lipidure and Lipidure-PMB are registered trademarks of NOF Corporation in the U.S., and are 
registered trademarks or trademarks in other countries. All other product names are registered 
trademarks or trademarks of each company. 
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Code Product Name Antiseptics** Supplier*** 
a Ethanol for disinfection* - Kozakai 
b ISODINE PALM PVP-I 0.5% Meiji 
c WELLUP CHG 0.2% Maruishi 
d WELPAS BAC 0.2% Maruishi 
Note: *Complying with the Japanese Pharmacopoeia (76.9–81.4 vol% of ethanol). **Antiseptics: 
Povidone iodine (PVP-I), Chlorhexidine gluconate (CHG), Benzalkonium chloride (BAC). ***Supplier: 
Kozakai Pharmaceutical Co., Ltd., Meiji Seika Pharma, Ltd., Maruishi Pharmaceutical Co., Ltd. 
Table 4. Alcohol-based hand rubs (76.9–81.4 vol% of ethanol) used for studies 
Reconstructed human epidermis (RhE) 
The RhE kit LabCyte EPI-MODEL was purchased from Japan Tissue Engineering Co., Ltd. 
Blowing equipment 
Blowing equipment consisting of an air pump (exhaust volume: 1.3 L/min), tube and 4-
channel nozzle (VACUBOY adapter, Integra Bioscience AG) was assembled in house. 
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Fig. 6. Testing protocol and the blowing equipment. (A) Schematic illustration of testing 
protocol named "Skin model blowing method". (B) Blowing equipment consisting of an air 
pump (exhaust volume: 1.3 L/min), tube and 4-channel nozzle. The 4-channel nozzle 
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In vitro evaluation of skin irritancy, “Skin model blowing method” (SMBM) 
Ten μL each of alcohol-based hand rub was applied to the surface of RhE, and blow-dried 
within 1 minute by using blowing equipment. This operation was repeated 5 times. As a 
control, only blow-drying was applied. After the operation, the RhE was incubated in an 
assay medium for 24 hr at 37°C in 5% CO2 atmosphere. Then the RhE were further 
incubated in a MTT medium (0.5 mg of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H 
tetrazolium bromide in assay medium) for 3 hr at 37°C in 5% CO2 atmosphere. Living cells 
were dyed with purple formazan. The dyed RhE was put into microtube; then 200 µL of 
isopropyl alcohol was added to extract purple formazan. The extracts were measured for the 
absorbance at 570 nm (reference wavelength 650 nm) using a microplate reader (SpectraMax 
250, Molecular Devices). Three RhE were used per group (n=3). 
Comparative analysis between in vivo and in vitro experiments 
The cell viability values obtained from SMBM and the integrated scores of irritation index of 
skin in rabbit (Tsuji et al., 1993) was compared. The integrate scores of primary irritation 
index were a: 1.2, b: 1.7, c: 5.7, and d: 58.3. The integrate scores of cumulative irritation index 
were a: 7.0, b: 6.5, c: 22.5, and d: 104.0. 
Statistical analysis 
Values were represented in means ± SD. Experimental groups were compared with the control 
using Student’s t-test. P < 0.05 and P < 0.01 were taken to be the level of statistical significance. 
7.1.2 Results 
In vitro evaluation of skin irritancy by SMBM 
The cell viability of the RhE exposed to alcohol-based hand rub was determined by MTT-
assay. The order of cell viability was as follows: Ethanol for disinfection = ISODINE 
PALM > WELLUP > WELPAS (Fig. 7). The RhE exposed to ISODINE PALM was stained 






























*  (P =0.032)
** (P =0.004)
 
Fig. 7. Cell viability determined by MTT-assay; a: ethanol for disinfection, b: ISODINE PALM, c: 
WELLUP, d: WELPAS. The cell viability of RhE exposed to alcohol-based hand rub is expressed 
as a percentage relative to untreated one (negative control). Data are presented as means ± SD 
(n=3). *P < 0.05 and **P < 0.01 compared with ethanol for disinfection. 
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Fig. 7. Cell viability determined by MTT-assay; a: ethanol for disinfection, b: ISODINE PALM, c: 
WELLUP, d: WELPAS. The cell viability of RhE exposed to alcohol-based hand rub is expressed 
as a percentage relative to untreated one (negative control). Data are presented as means ± SD 
(n=3). *P < 0.05 and **P < 0.01 compared with ethanol for disinfection. 
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Comparative analysis between in vivo and in vitro experiments 
The cell viabilities obtained from SMBM (this study) and the skin irritation index obtained 
from Draize rabbit tests (previous study: Tsuji et al., 1993) were examined. Fig. 8 shows a 
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Fig. 8. Comparative analysis of in vivo and in vitro experiments. (A) Correlation of integrated 
score of primary irritation index of skin in rabbit and mean cell viability. (B) Correlation of 
integrated score of cumulative irritation index of skin in rabbit and mean cell viability. 
7.1.3 Discussion 
As already mentioned in Section 5.4, alcohols may enhance skin permeation, thus the 
irritancy of alcohol-based hand rubs containing antiseptics should be evaluated for the 
whole formulation, not for each component. In this study, a novel in vitro experimental 
method named SMBM was developed. SMBM mimics the actual usage of alcohol-based 
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hand rubs: putting on, spreading, rubbing into the skin and drying. As described in 
Section 4.3.2, cytotoxicity of ethanol in RhE is negligible for exposure shorter than 1 
minute (Yamamoto et al., 2010). The results of the SMBM showed that the method can 
evaluate the overall irritation potential of the whole formulation of alcohol-based hand 
rubs containing antiseptics. 
From the comparative analysis between in vivo and in vitro experiments, it was found that 
there was a high correlation between cell viability and skin irritation index. Therefore, SMBS 
is effective for quantitatively estimating the skin irritation potential of alcohol-based hand 
rubs containing antiseptics. 
7.2 Evaluation of alcohol-based hand rubs containing cationic antiseptics by SMBM 
7.2.1 Experimental 
Alcohol-based hand rubs containing cationic antiseptics used in this study 
The alcohol-based hand rubs used in this study are summarized in Table 5. 
Code Product Name Antiseptics Other components Supplier* 
A Hibiscohol A CHG 0.2% Diisobutyl adipate, Allantoin, PEG glyceryl cocoate Saraya 
B WELLUP CHG 0.2% Isopropyl myristate, 4 Non-disclosed components Maruishi 
C WELLUP Hand Lotion 0.5% CHG 0.5% 
HM-HPMC**, 1,3-Butylene glycol, 
Glycyrrhetinic acid, Diisopropyl 
adipate, Glycerine fatty acid ester, 
Buffering agent 
Maruishi 
D WELPAS BAC 0.2% 
Propylene glycol, Isopropyl 
myristate, 4 Non-disclosed 
components 
Maruishi 
E RABINET BAC 0.2% 
Urea, Glycerin, Tocopherol acetate, 
Allantoin, PCA ethyl cocoyl 
arginate 
Kenei 
F Puremist BAC 0.2% 
Lipidure-PMB®***, Isopropyl 





Note: *Supplier: Saraya Co., Ltd., Maruishi Pharmaceutical Co., Ltd., Kenei Pharmaceutical Co., Ltd., 
Johnson & Johnson K.K. **HM-HPMC: Hydrophobically-modified hydroxypropyl methylcellulose. 
***Lipidure-PMB®: Poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate). 
Table 5. Alcohol-based hand rubs (76.9–81.4 vol% of ethanol) containing cationic antiseptics 
Other materials and methods 
Reconstructed human epidermis (RhE) and blowing equipment were prepared; and in vitro 
evaluation of skin irritancy and statistical analysis were carried out as previously described 
in Section 7.1.1. 
 
Infection Control – Updates 
 
154 
Comparative analysis between in vivo and in vitro experiments 
The cell viabilities obtained from SMBM (this study) and the skin irritation index obtained 
from Draize rabbit tests (previous study: Tsuji et al., 1993) were examined. Fig. 8 shows a 
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Fig. 8. Comparative analysis of in vivo and in vitro experiments. (A) Correlation of integrated 
score of primary irritation index of skin in rabbit and mean cell viability. (B) Correlation of 
integrated score of cumulative irritation index of skin in rabbit and mean cell viability. 
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The mean cell viability of the 0.5% CHG formulation was slightly lower than that of 0.2% 
CHG formulations, but there were no significant differences in statistical analysis. On the 
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Fig. 9. Means ± SD of cell viability of commercially available alcohol-based hand rubs 
determined by using SMBM 
7.2.3 Discussion 
Tested samples containing 0.2% or 0.5% CHG showed 64–72% cell viability, and therefore, 
their skin irritation potential was likely to be mild. The difference in CHG concentration did 
not significantly affect cell viability. 
By contrast, in the case of BAC, the cell viability differed depending on formulation 
although the BAC concentration was the same. Of these, code F (Puremist) showed 
especially high cell viability (73% of cell viability). It was suggested that some 
components other than BAC may have reduced the skin irritation potential. Since 
isopropyl myristate and glycerin are also formulated in the other products (code D and E), 
they were unlikely to be the factor regulating the phenomenon. It is noteworthy that 
Lipidure-PMB® (MPC/BMA co-polymer) is contained in Puremist. As already mentioned 
in Section 6.2, MPC polymers stabilize the skin barrier. The results of this study suggest 
that the MPC polymers are possibly capable of reducing the cytotoxicity of alcohol-based 
hand rubs containing antiseptics. 
8. Conclusion 
In this review, the author summarized the structure and barrier function of the skin, the 
mechanism and evaluation methods of skin irritation, and the irritancy of alcohol-based 
hand rubs. It also described a novel in vitro evaluation method for assessing the skin 
irritation caused by alcohol-based hand rubs. The newly developed in vitro evaluation 
method “SMBM” has several advantages including 1) replacing animal experiments, 2) 
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enabling multiple substances to be tested at once, 3) easy quantitative estimation because it 
is based on simple cytotoxicity test. The author believes that this new approach is quite 
efficient and useful for developing less irritating alcohol-based hand rub products. 
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1. Introduction 
The emergence of clinical infection due to methicillin resistant Staphylococcus aureus (MRSA) 
with decreased susceptibility to vancomycin and the frequent isolations in some countries of 
multidrug-resistant (resistant to three or more classes of antimicrobials), extensively drug 
resistant (resistant to all but one or two classes) or even pandrug-resistant (resistant to all 
available classes) Gram negative nosocomial pathogens are causing great concern 
worldwide. In an era of increasing antimicrobial resistance many recent studies have 
focused on the heteroresistance phenomenon that is considered to be a precursor stage, 
which may or may not lead to the emergence of a resistant strain. 
The term heteroresistance has been mostly used to describe hetero-vancomycin intermediate 
Staphylococcus aureus (hVISA) that spontaneously produces VISA cells within its cell 
population at a frequency of 10-6 or above (Neoh et al., 2008). In a broader sense though, 
heteroresistance may be understood as mixed populations of drug-resistant and drug-
sensitive cells in a single clinical specimen or isolate where the proportion of resistant 
organisms may not be explicable by the natural “background” mutation rate alone (Rinder, 
2001); and even more precisely, heteroresistance can be defined as resistance to certain 
antibiotics expressed by a subset of a microbial population that is generally considered to be 
susceptible to these antibiotics according to traditional in-vitro susceptibility testing (Falagas 
et al., 2008). The frequency of these resistant organisms is about one sub-clone in every 105–
106 colonies, which roughly equals the normal rate of mutation. 
2. Heteroresistance in Staphylococcus aureus 
S. aureus is the species in which the phenomenon has been reported more often and studied 
more in detail. Heteroresistance to methicillin (Ryffel et al., 1994) and oxacillin (Cimolai et 
al., 1997; H. Liu et al., 1990; Wannet, 2002) is dependent on the mecA gene that codes for a 
lower-affinity penicillin-binding protein conferring strain-specific variable resistance from 
borderline to elevated resistance to beta-lactam antibiotics. It has been shown that in 
addition to this resistance, chromosomal mutations not related to mecA may generate a small 
proportion of highly methicillin-resistant subclones (Strandén et al., 1996). 
The first reports of VISA (Hiramatsu et al., 1997a) and hVISA (Hiramatsu et al., 1997b) were 
made from Japanese hospitals in 1997 and inspired further research because vancomycin has 
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heteroresistant to vancomycin and it is used since then as a control strain in different 
methodologies for the detection of vancomycin heteroresistance in MRSA. Several later studies 
from various parts of the world (Borg et al., 2005; Chesneau et al., 2000; Howe et al., 1999; M.N. 
Kim et al., 2002; Marchese et al., 2000; Reverdy et al., 2001; Wang et al., 2004) have proved that 
heteroresistance to vancomycin among MRSA was maybe ignored or underestimated but not 
absent. Furthermore, since early VISA isolates in the USA were resistant to teicoplanin too 
(Appelbaum, 2007), and reduced susceptibility (Park et al., 2000) or heterogeneous resistance 
(Nunes et al., 2007) to this drug were also reported, the term glycopeptide-intermediate S. 
aureus (GISA) has been added to indicate a broader resistance profile. 
Reduced vancomycin susceptibility of hVISA and VISA strains is not linked to the vanA gene, 
which causes the high-level vancomycin resistance of certain enterococcal species and has been 
found rarely in vancomycin-resistant MRSA (VRSA) (Cui et al., 2006; Howden et al., 2008) but 
is rather a consequence of several phenotypic changes (Rong & Leonard, 2010). Among those 
suggested, the thickened bacterial cell wall is the most frequently observed (Kim et al., 2000). 
This cell wall change could probably explain also the cross-heteroresistance between 
vancomycin and daptomycin- a relatively large molecule that has to access relevant binding 
regions on the bacterial cell membrane in order to act (Sakoulas et al., 2006). 
3. Heteroresistance among Gram negative nosocomial pathogens 
Carbapenems are the most effective antimicrobial agents against Gram negative bacteria. 
Furthermore, they are stable to the hydrolytic activity of extended spectrum beta-lactamases 
and therefore they have been used widely for treating infections caused by multidrug resistant 
isolates. The extended use however of these compounds has led to the emergence of 
carbapenem resistance mechanisms mainly in members of the Enterobacteriaceae family, in 
Pseudomonas aeruginosa and Acinetobacter baumanii. Carbapenem heteroresistance among A. 
baumanii strains has been reported in a preliminary (Pournaras et al., 2005) and a complete 
study (Ikonomidis et al., 2009) from Greece where Pournaras et al. found also meropenem 
heteroresistant subpopulations in six apparently meropenem-susceptible, carbapenemase 
(KPC)-producing Klebsiella pneumoniae (KPC-KP) clinical isolates (Pournaras et al., 2010). 
Colistin is among the last-resort therapy for treating infections caused by carbapenem 
resistant pathogens but resistance to this drug is emerging in multidrug-resistant Gram 
negative bacteria (Kontopoulou et al., 2010). Heteroresistance to colistin was initially 
described among clinical A. baumannii (Li et al., 2006; C.H. Tan et al., 2007; Yau et al., 2009) 
and Enterobacter cloacae isolates (Lo-Ten-Foe et al., 2007). Intrestingly, in A. baumannii, this 
heteroresistance was documented to be related to previous colistin therapy (Hawley et al., 
2008). Heteroresistance to colistin has been reported in K. pneumoniae isolates collected from 
16 medical centers in various countries (Poudial et al., 2008) and among carbapenemase-
producing K. pneumoniae (KPC or VIM-1) regardless prior colistin therapy in a Greek 
hospital where resistant rates to colistin in carbapenemase-producing K. pneumoniae rose 
from 0% in 2007 to 24.3% in 2009 (Meletis et al., 2011). 
4. Heteroresistance in other species 
Heteroresistance to glycopeptides is not limited in S. aureus but has been described for 
Enterococcus faecium (Alam et al., 2001; Qu et al., 2009) and coagulase-negative staphylococci 





warneri (Nunes et al., 2006; Wong et al., 1999). Heteroresistance to penicillin has been 
reported in Streptococcus pneumoniae (Morand & Muhlemann, 2007), heteroresistance to 
fluconazole and other azoles in Cryptococcus neoformans (Mondon et al., 1999; Yamazumi et 
al., 2003) while metronidazole heteroresistance in Gardnerella vaginalis has been blamed for 
therapeutic failures (Altrichter et al., 1994). 
The heteroresistance phenomenon is present even in clinical tuberculosis. It is not rare and 
not restricted to a particular resistance gene, but is obscured by cultivation as well as by 
some, culture-independent resistance prediction tests (Rinder et al., 2001). In fact, 
heteroresistant subpopulations are frequent in Mycobacterium tuberculosis although they 
seem to be well hidden. This observation may be explained by studies showing that 
acquisition of resistance results in an- at least temporary- decrease in growth rate (Billington 
et al., 1999; Gillespie et al., 2001). 
It will be very interesting to find out if heteroresistance exists even among other species or 
concerns more antimicrobial agents. It is conceivable that there is more to be found and 
further research may provide new insight in this field. 
5. Detection methods 
Detection of heteroresistance is difficult and labor-intensive. Disc diffusion method or 
commercial automated systems may fail to detect most heteroresistant isolates (Lo-Ten-Foe 
et al., 2007; Tenover, 1999), and E-test results depend on the medium used (T.Y. Tan & Ng., 
2007). Gradient plates, Disc-agar Method, E-test GRD (Glycopeptide Resistance Detection), 
Vancomycin-containig plates and E-test Macrodilution have all been explored for the 
detection of hGISA and GISA staphylococci but Population Analyses Profiles remains to 
date the most reliable method to detect heteroresistant subpopulations in Gram positive as 
well as in Gram negative bacteria. Growth of resistant subcolonies within a clear E-test 
inhibition zone and Population Screening Plates can be used for screening purposes, 
therefore, these two techniques are also described in this chapter. 
Various studies used Population Analysis Profiles-Area Under the Curve (PAP-AUC) 
(Wooton et al., 2001) as the gold standard in order to evaluate the sensitivity and 
specificity of some of the other methods. Walsh et al. evaluated seven methods in 2001 
among which, E-test Macrodilution appeared to perform better (sensitivity 96%, 
specificity 97%) for the detection of Staphylococcus strains with reduced susceptibilities to 
vancomycin (SRSV) (a term that contains both GISA and hGISA) (Walsh et al., 2001). In 
2007, Wootton et al. performed a large-scale multicenter study involving 3 different 
methods of GISA and hGISA detection (brain-heart infusion agar with 6 mg/L 
vancomycin (BHIA6V), Mueller-Hinton agar with 5 mg/L teicoplanin (MHA5T), and E-
test Macrodilution. Among them, BHIA6V had a very low sensitivity for hGISA (11.47%) 
whereas MHA5T and E-test Macrodilution performed both well. MHA5T though, gave 
twice as many false-positive results compared to E-test Macrodilution which moreover, 
resulted in significantly less variation between laboratories (Wooton et al., 2007). In 2011, 
Satola et al. evaluated the E-test Macrodilution method, E-test GRD and BHI screen agar 
plates containing 4 mg/L vancomycin and 16 g/L casein using 0.5 and 2.0 McFarland 
inocula. E-test Macrodilution was 57% sensitive and 96% specific, E-test GRD was 57% 
sensitive and 97% specific, and BHI screen agar was 90% sensitive and 95% specific with a 
0.5 McFarland inoculum and 100% sensitive and 68% specific with a 2.0 McFarland 
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inoculums (Satola et al., 2011). In the same year, van Hal et al. screened 458 MRSA 
bloodstream isolates to determine the most accurate testing strategy to detect the presence 
of heteroresistance. Compared to PAP-AUC, the sensitivities and specificities of E-test 
Macrodilution, E-test GRD, vancomycin broth microdilution (using a MIC cutoff of ≥ 2 
mg/L), and standard vancomycin E-test (using a MIC cutoff of ≥ 2 mg/L) were 89 and 
55%, 71 and 94%, 82 and 97%, and 71 and 94%, respectively (van Hal et al., 2011). 
Research for the most effective method to detect SRSV is still going on but reports of 
heteroresistance even among other clinically important species worldwide highlight the 
need for the development of a reliable and easy-to-use susceptibility testing method that can 
be used in the everyday laboratory practice. 
5.1 Population analysis profiles 
Step 1: Prepare agar plates containing varied antibiotic concentrations, for example 0, 0.5, 1, 
2, 3, 4, 5, 6, 8… mg/L. 
Step 2: Culture bacteria overnight in tryptone soya broth (TSB). 
Step 3: Prepare a cell suspension of approximately 108 CFU/ml (OD 0.3 at 578 nm or 2:3 
dilution of a 0.5 McFarland suspension). 
Step 4: Make 10-fold serial dilutions of the cell suspension and spread 50μl from each 
dilution onto a complete series of antibiotic-containing plates. (Fig. 1) 
 





Step 5: Incubate at 35-37 oC for 48h. 
Step 6: Count the number of colonies grown on each plate (Table 1). 
  Drug concentration (mg/L) 
  0,5 1 2 3 4 5 6 8 
 10
8         
107         
106         
105         
104         
103         
102         
Table 1. Colony counting table. 
Step 7: Plot the colony counts on a semi-logarithmic graph with colony counts on the 
vertical axis and drug concentration on the horizontal axis (Fig 2). 
Step 8: Calculate the frequency of resistant subpopulations at the highest drug concentration 
by dividing the number of colonies grown on an antibiotic containing plate by the colony 
counts from the same bacterial inoculum plated onto antibiotic-free plates. 
Step 9: Determine the MIC of the resistant subpopulations and reassess it after serial daily 
subcultures on antibiotic-free medium for 7-14 days in order to evaluate whether the 
resistance is stable. 
  
    Drug concentration (mg/L) 
Fig. 2. Colony counts plotting of eight K. pneumoniae strains tested for heteroresistance to 
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5.2 Modified population analysis profiles-AUC (area under the curve) 
Modified PAP-AUC was proposed by Wooton et al. for the detection of heteroresistance to 
vancomycin among S. aureus strains and is considered to date the gold standard for hGISA 
detection (Wooton et al., 2001). It is based upon the calculation of the ratio of the test strain’s 
AUC divided by the corresponding Mu 3 AUC. After 24h incubation in TSB, cultures are 
diluted in saline to 10-3 and 10-6 and plated onto BHIA plates containing 0.5, 1, 2, 2.5 and 4 
mg/L vancomycin. Colonies are counted after 48h incubation at 37 oC and the viable count 
is plotted against vancomycin concentration. The AUC of the study strain and Mu 3 are 
calculated and their ratio is evaluated as follows: <0.9, GSSA; 0.9-1.29, hGISA; ≥ 1.3, GISA 
(Wooton et al., 2005). 
5.3 Gradient plates 
Step 1: Culture Mu 3 and test strains overnight in TSB. 
Step 2: Pour 25 ml of BHIA containing 4 mg/L vancomycin in a 10 cm square Petri dish at 
an angle of 12o and keep solidified for 30 min in room temperature (Fig. 3). 
Step 3: Overlay 25 ml of BHIA and leave to set horizontally. Keep the solidified agar at room 
temperature for 120 min. 
Step 4: Adjust each culture to a turbidity equal to 0.5 McFarland and streak the Mu 3 and 
test strains onto the gradient agar plate with a cotton swab. 
Step 5: Measure the growth distance of the bacteria after 48h incubation at 37 oC and divide 
it with the distance grown by Mu 3 on the same plate. A ratio of ≥ 1 denotes an hGISA 
(Wooton et al., 2001). 
 






5.4 E-test macrodilution 
Bolmström et al. proposed that the use of a dense inoculum, rich medium and a 48h 
incubation period can optimize the detection of VISA and hVISA (Bolmström et al., 1999). 
Step 1: Spread 250 μl of a 2 McFarland suspension onto BHI agar plates and put one 
vancomycin and one teicoplanin E-test for each strain (Fig. 4). 
Step 2: Incubate at 35-37 oC for 48h. 
Step 3: Interpretation (hVISA when vancomycin MIC and teicoplanin MIC ≥ 8 or when 
teicoplanin MIC ≥ 12 and vancomycin MIC <4). 
 
 
Fig. 4. E-test Macrodilution. Photo courtesy of Dr. Tzampaz Egki. 
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5.5 Disc-agar method 
The disc-agar method has been used to demonstrate both the presence of potential 
intermediate vancomycin resistant staphylococci and staphylococci with heteroresistance to 
vancomycin on the same plate. It is based upon the observation that beta-lactam antibiotics 
(Aritaka et al., 2001; Y.S. Kim et al., 2003) and higher salinity can induce the phenotypic 
expression of vancomycin resistance and for this purpose aztreonam is preferred over other 
beta-lactam antibiotics because it has no inhibitory effect on Gram positive bacteria (Fig. 5).  
Wong et al. performed a preliminary study of the disc-agar method using different beta-
lactams including penicillins, oxacillin, cephalosporin and carbapenems. Although 
sometimes sattelitism could be seen around other beta-lactam discs, the results were less 
consistent than they were with aztreonam, and some strains had a large zone of inhibition 
around the disc (Wong et al., 1999). 
 
Fig. 5. Bacterial growth around aztreonam disc. Photo courtesy of Dr. Tzampaz Egki. 
Step 1: Prepare vancomycin-salt agar plates by incorporating 4 mg/L vancomycin and 4% 
NaCl into MHA. 
Step 2: Make a 1 McFarland bacterial suspension. 
Step 3: Inoculate with a sterile cotton swab and place a 30 μg aztreonam disc 5 minutes 
afterwards. 
Step 4: Incubate at 37 oC for 48h. 
Step 5: Suspect heteroresistance if bacterial growth is observed around the disc. The colonies 
may be homogeneous or heterogeneous in size (Fig. 6). 
Note: In any case further testing by population analysis profiles is recommended for the 






Fig. 6. Different size colonies around aztreonam disc. Photo courtesy of Dr. Tzampaz Egki. 
5.6 E-test GRD (glycopeptide resistance detection) 
The E-test GRD strip consists of a double-sided gradient of vancomycin and teicoplanin on a 
calibrated plastic strip. This double-sided predetermined gradient of vancomycin and 
teicoplanin is used exclusively for the detection of GISA or hGISA phenotypes. 
Strains that give a positive E-test GRD result (vancomycin or teicoplanin ≥ 8) should be send to 
a reference laboratory for further investigation by population analysis profiles (Fig. 7 and 8). 
Note: The endpoints read from the E-test GRD strips should not be regarded as true MICs, 
but rather as modified results with interpretive cutoffs defined for the phenotypic detection 
of glycopeptides resistance phenotypes in S. aureus (Yusof et al., 2007). 
Step 1: Determine the MIC of the study strain. 
Step 2: Use standard inoculum (0.5 McFarland) onto Mueller Hinton + 5% blood agar plates 
and add the GRD strip. Ensure that the whole length of the strip is in complete contact with 
the agar surface. If necessary, remove air pockets by pressing gently on the strip with 
forceps, always moving from the lowest concentration upwards. Small bubbles under the 
strip will not affect the results. 
Note: Once applied, the strip cannot be moved because the antibiotic is instantaneously 
released into the agar. 
Step 3: Incubation at 35-37 oC for 24 and 48h. 
Step 4: Results interpretation according to manufacturer’s instructions (GISA: positive E-test 
GRD and vancomycin MIC ≥ 4 mg/L, hGISA: positive E-test GRD and vancomycin MIC < 4 
mg/L). When mutant colonies are present in the inhibition eclipse, read the result where 
these colonies are completely inhibited.  
 
Infection Control – Updates 
 
170 
5.5 Disc-agar method 
The disc-agar method has been used to demonstrate both the presence of potential 
intermediate vancomycin resistant staphylococci and staphylococci with heteroresistance to 
vancomycin on the same plate. It is based upon the observation that beta-lactam antibiotics 
(Aritaka et al., 2001; Y.S. Kim et al., 2003) and higher salinity can induce the phenotypic 
expression of vancomycin resistance and for this purpose aztreonam is preferred over other 
beta-lactam antibiotics because it has no inhibitory effect on Gram positive bacteria (Fig. 5).  
Wong et al. performed a preliminary study of the disc-agar method using different beta-
lactams including penicillins, oxacillin, cephalosporin and carbapenems. Although 
sometimes sattelitism could be seen around other beta-lactam discs, the results were less 
consistent than they were with aztreonam, and some strains had a large zone of inhibition 
around the disc (Wong et al., 1999). 
 
Fig. 5. Bacterial growth around aztreonam disc. Photo courtesy of Dr. Tzampaz Egki. 
Step 1: Prepare vancomycin-salt agar plates by incorporating 4 mg/L vancomycin and 4% 
NaCl into MHA. 
Step 2: Make a 1 McFarland bacterial suspension. 
Step 3: Inoculate with a sterile cotton swab and place a 30 μg aztreonam disc 5 minutes 
afterwards. 
Step 4: Incubate at 37 oC for 48h. 
Step 5: Suspect heteroresistance if bacterial growth is observed around the disc. The colonies 
may be homogeneous or heterogeneous in size (Fig. 6). 
Note: In any case further testing by population analysis profiles is recommended for the 






Fig. 6. Different size colonies around aztreonam disc. Photo courtesy of Dr. Tzampaz Egki. 
5.6 E-test GRD (glycopeptide resistance detection) 
The E-test GRD strip consists of a double-sided gradient of vancomycin and teicoplanin on a 
calibrated plastic strip. This double-sided predetermined gradient of vancomycin and 
teicoplanin is used exclusively for the detection of GISA or hGISA phenotypes. 
Strains that give a positive E-test GRD result (vancomycin or teicoplanin ≥ 8) should be send to 
a reference laboratory for further investigation by population analysis profiles (Fig. 7 and 8). 
Note: The endpoints read from the E-test GRD strips should not be regarded as true MICs, 
but rather as modified results with interpretive cutoffs defined for the phenotypic detection 
of glycopeptides resistance phenotypes in S. aureus (Yusof et al., 2007). 
Step 1: Determine the MIC of the study strain. 
Step 2: Use standard inoculum (0.5 McFarland) onto Mueller Hinton + 5% blood agar plates 
and add the GRD strip. Ensure that the whole length of the strip is in complete contact with 
the agar surface. If necessary, remove air pockets by pressing gently on the strip with 
forceps, always moving from the lowest concentration upwards. Small bubbles under the 
strip will not affect the results. 
Note: Once applied, the strip cannot be moved because the antibiotic is instantaneously 
released into the agar. 
Step 3: Incubation at 35-37 oC for 24 and 48h. 
Step 4: Results interpretation according to manufacturer’s instructions (GISA: positive E-test 
GRD and vancomycin MIC ≥ 4 mg/L, hGISA: positive E-test GRD and vancomycin MIC < 4 
mg/L). When mutant colonies are present in the inhibition eclipse, read the result where 
these colonies are completely inhibited.  
 
Infection Control – Updates 
 
172 
Note: Although the procedure is straightforward, proper use of the test requires the judgment 
of skilled personnel trained in microbiology and antimicrobial susceptibility testing. 
 
Fig. 7. Negative E-test GRD. Photo courtesy of Dr. Tzampaz Egki. 
 





5.7 Standard E-test 
The presence of resistant subcolonies within a clear inhibition zone (Fig. 9) can potentially 




Fig. 9. Subpopulations grown within the inhibition zone. Photo courtesy of Dr. Tzampaz Egki. 
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5.8 Population screening plates 
Screening for potential vancomycin resistance can be performed using BHIA plates with 4 
mg/L vancomycin. 10 μl of a bacterial suspension from an overnight culture adjusted to 0.5 
McFarland standard is spread on the plate and bacterial growth after incubation at 37 oC for 24 
and 48h is observed. Growth at 24h may be deemed to be of the GISA phenotype and growth 
occurring between 24 and 48h may be deemed to be an hGISA strain (Walsh et al., 2001). 
6. Conclusion 
Many studies have tried to associate hGISA with failure of vancomycin therapy but this is 
still up for debate as results are controversial (van Hal & Paterson, 2011; C. Liu & 
Chambers., 2003; Neoh et al., 2007; Rong & Leonard, 2010). A further research problem is 
that such studies are difficult to perform because of the serious nature and high mortality 
rate among patients infected by MRSA. 
 
Fig. 10. Meletis, G 2011, 'Natural evolution to drug resistance due to heteroresistance', in 





However, heteroresistance could very possibly be a tool for natural evolution to drug 
resistance, since it provides bacteria with an opportunity to explore the possibility of growth 
in the presence of antibiotics (Morand & Muhlemann, 2007). The resistant subpopulations 
may proliferate readily in the absence of competition by the inhibited susceptible cells, 
thereby giving rise to a new resistant population (Falagas et al., 2008). On the other hand, 
the emergence of resistant strains in vitro may not necessarily have therapeutic implications 
(Johnson, 1998) mainly because acquisition of resistance in some cases may be accompanied 
by loss of virulence (Fig. 10). 
Nevertheless, heteroresistant strains have been deemed to be responsible for treatment 
failures (Moore et al., 2003; Wong et al., 1999) and difficulties to detect heteroresistant 
isolates could already be contributing to a hidden spread of these strains within hospital 
facilities (Falagas et al., 2008). Therefore, more research is needed to determine the true 
clinical impact of heteroresistance and its role in the development of fully-resistant bacterial 
populations. 
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1. Introduction 
The discovery of penicillin, the Magic bullet in 1928 and its clinical use in 1941 led the 
people to think that mankind has won the war against microbes. With a short span of 
seventy years, antimicrobial discovery from Penicillin to Tigecycline, mankind is facing the 
problem with some hospital strains resistant to almost all antimicrobials, and is busy in 
writing the obituary for antimicrobials. 
Infact, the rising trend of developing resistance to multiple antibiotics in microbes, leading 
to therapeutic failure is a serious problem of global magnitude. P.aeruginosa, Methicillin 
Resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococci(VRE), 
Glycopeptide Intermediate Staphylococcus aureus (GISA), Glycopeptide Resistant 
Staphylococcus aureus (GRSA), Acinetobacter baumani, Stenotrophomonas maltophila etc. 
need special attention as they are commonly isolated from Health Care Associated 
Infections(HAI) and belong to Multidrug resistant Organism (MDRO) i.e. they are resistant 
to one or more classes of antibiotics (Harrison & Lederberg, 1998). P. aeruginosa is 
responsible for 10-15% of nosocomial infections worldwide. The β-lactam group of 
antibiotics which include Penicillins, Cephalosporins, Monobactams and Carbapenems are 
mainly used to treat infections caused by Gram negative bacteria. The widespread use of 
antibiotics put tremendous selective pressure on bacteria which develop new mechanisms to 
escape the lethal action of the antibiotics. These infections are difficult to treat because of 
emergence of newer β-lactamases such as Extended Spectum β-lactamases (ESBL), AmpCβ-
lactamases and Carbapenemases. The β-lactamases inactivate β-lactam antibiotics by 
cleaving the structural β-lactam ring. Failure to detect these enzymes producing strains has 
contributed to their uncontrolled spread in Health Care setup and therapeutic failure. 
Major mechanisms causing resistance to the β-lactam antibiotics in P.aeruginosa are the 
production of β-lactamases, reduced outer membrane permeability and altered affinity of 
targetPenicillin binding proteins. (Washington et al, 2006; Pitt, 1990). 
1.1 Classification of β-lactamases 
β-lactamase can be classified according to Functional or Bush Jacoby Mederious classification ( 
Bush et al, 1995), into group 1, 2a, 2be, 2br, 2c, 2d, 2e, 2f and according to molecular or Ambler 
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classification (Ambler, 1980) into Ambler class A,B,C and D. Detection of β-lactamase 
production has been achieved in the past by measuring the production of penicilloic acid, 
which is produced when benzyl penicillin is hydrolysed. The acid production can be detected 
by acidometric method, iodometric method and chromogenic cephalosporin (nitrocephin) 
method (Miles & Amyes, 2008). The first plasmid mediated β-lactamase was described in early 
1960. The TEM1 enzyme was named after the patient Temoniera from whom it was originally 
found in isolated strains of E.coli, (Medeiros, 1984) whereas β-lactamase SHV-1 (Sulphydryl 
variable) is chromosomally encoded in most isolates of Klebsiella pneumoniae but is usually 
plsmid mediated in E.coli (Tz-ouvelekis, 1999). 
1.1.1 Extended spectrum β-lactamases (ESBL) 
ESBLs were first reported in 1983 in Klebsiella pneumoniae from Germany. Typically ESBLs 
are mutant plasmid mediated β-lactamases derived from older broad-spectrum β-
lactamases. The mutations alter the amino acid configuration around active site of β-
lactamases (Thomson, 2001). The first ESBL to be described in 1983 was actually TEM3 ( 
Soughakoff et al, 1980) and now over 130 additional TEMs have been isolated. ESBLs have 
an extended substrate profile that cause hydrolysis of cephalosporins, penicillins and 
aztreonam and are inhibited by β-lactamase inhibitors, such as clavulanate, tazobactam and 
sulbactam. ESBLs are commonly produced by Klebsiella species and Escherichia coli; but 
also occur in other Gram negative bacteria, including Enterobacter, Salmonella, Proteus, 
Serratia marcescens, Pseudomonas aeruginosa, Burkholderia, Acinetobacter species, etc. 
1.1.2 AmpC β-lactamases 
Molecular class C or AmpC primarily hydrolyses cephems (cephalosporins and 
cephamycins) but also hydrolyze penicillins and aztreonam. These enzymes are resistant to 
the currently available β-lactamase inhibitors such as clavulanate, tazobactam and 
sulbactam ( Philippon et al, 2002). With rare exceptions, the hydrolysis of cephamycins, such 
as cefotetan and cefoxitin, is a property that can help to distinguish AmpCs from ESBLs. 
Genes encoding inducible chromosomal AmpC β-lactamases are part of the genomes of 
many Gram negative bacteria specially P.aeruginosa. High level production of AmpC may 
cause resistance to the first, second and third-generation cephalosporins and cephamycins, 
penicillins and β-lactamase inhibitor combination. Higher level AmpC production may 
occur as a consequence of mutation or when the organism is exposed to an inducing agent. 
Cephamycins (e.g. cefoxitin and cefotetan ), ampicillin, and carbapenem are good inducer ( 
Moland et al, 2008). AmpC β-lactamases producing organisms are on rise and leads to 
therapeutic failure if 3rd Generation cephalosporins are given empirically or not tested in the 
laboratory for AmpC β-lactamases production ( Basak et al, 2009). The chromosomally 
mediated AmpC β-lactamases are only inducible. 
1.1.3 Carbapenemases 
These include β-lactamases which cause carbapenem hydrolysis, with elevated carbapenem 
MICs and they belonged to molecular classes A, B and D. Molecular classes A, C and D 
include the β-lactamases with serine at their active site, whereas class B β-lactamases are all 
metalloenzymes with an active site zinc ( Queenan & Bush, 2007). 
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Metallobetalactamases – They belong to molecular class B β-lactamases, and have 3 
characteristics –  
1. Hydrolyze carbapenems 
2. Resistant to clinically used β-lactamase inhibitors and 
3. Inhibited by EDTA, a metal ion chelator. 
Other MBL inhibitors used are 2-mercaptoethanol, sodium mercapto acetic acid (SMA), 2-
mercaptopropionic acid, copper chloride and ferric chloride (Arkawa et al, 2000). MBLs have a 
broad substrate spectrum and in addition to carbapenems, they can hydrolyze cephalosporin 
and penicillins but cannot hydrolyse aztreonam. Interestingly, not all of the MBLs readily 
hydrolyze nitrocefin. The first MBL detected were chromosomally encoded and was detected 
in Bacillus cereus ( Lim et al, 1988). Since then there has been a dramatic increase in detection 
and spread of acquired or transferable families of these MBLs. There are 5 major families of 
acquired MBLs (IMP, VIM, SPM, GIM and SIM) ( Toleman et al, 2007). In 1990, IMP-1, the 1st 
MBL encoded on plasmid, was discovered in Japan ( Watanabe et al, 1991). The MBLs are 
located on integrons and are incorporated as gene cassettes.When these integrons become 
associated with plasmids or transposons, transfer between bacteria is facilitated.  
Classification of MBLS 
MBLS are classified into 3 subclasses—B1,B2 and B3. Subclass B1 and B3 are divided by 
aminoacid homology, bind 2 zinc atoms for optimal hydrolysis and have broad hydrolysis 
spectrum. Subclass B2 are inhibited when a second zinc atom is bound and preferentially 
hydrolyse carbapenem ( Free et al, 2005).  
Molecular class A carbapenemase – Class A serine carbapenemases belong to functional 
group 2f include chromosomally encoded NMC( not metalloenzyme carbapenemase), IMI 
(Imipenem hydrolyzing β-lactamase) and SME(Serratia marscenscens enzyme) and plasmid 
mediated KPC (Klebsiella pneumoniae carbapenemase) and GES/IBC(integron borne 
cephalosporinase) ( Queenan & Bush, 2007). All have the ability to hydrolyse carbapenems, 
cephalosporins, penicillins and aztreonem and all are inhibited by clavulanate and 
tazobactam. The chromosomal class A carbapenemase are infrequently found and can be 
induced by imipenem and cefoxitin. The KPC ( Klebsiella pneumoniae carbapenemase) 
producing strains are found in Klebsiella pneumoniae, Enterobacter species, Salmonella 
species and other Enterobacteriaceae ( Hossain et al, 2004; Miriagou et al, 2003). 
Class D Serine carbapenemases: The OXA (Oxacillin hydrolysing) β-lactamase with 
carbapenemase activity was detected by Patow et al in 1993 and the enzyme was purified 
from Acinetobacter baumani (Queenan & Bush, 2007). They have been also found in 
Enterobacteriaceae and P.aeruginosa and were described as penicillinase capable of 
hydrolyzing oxacillin and cloxacillin ( Bush & Sykes, 1987; Naas & Nordmann, 1999). They 
were poorly inhibited by clavulanic acid and EDTA and were designated as ARI-1 
(Acinetobacter Resistant to Imipenem) and reside on large plasmid. The OXA 
carbopenemases have hydrolytic activity against penicillins, some cephalosporins and 
imipenem. The widespread use of reserved antibiotics such as β-lactam /β-lactamases 
inhibitor combinations, monobactams and carbapenem has caused persistent exposure of 
bacterial strains to a multitude of β-lactam leading to overproduction of β-lactamases 
(Goossens et al, 2004; Manoharan et al, 2010; Lee et al, 2003). Consequently the emergence of 
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carbapenem resistance is a world-wide public health concern since carbabapenems are used 
as last resort to treat serious infections caused by ESBL producing organisms. 
Approximately 40% strains of P.aeruginosa are resistant to anti-pseudomonal drugs 
including carbapenems. Therefore, early detection of of ESBL, AmpC β-lactamase & MBL 
producing P. aeruginosa strains is of crucial importance for prevention of their inter and 
intra hospital dissemination.  
1.2 Aims and objectives 
The present study was undertaken with the aim to study Pseudomonas aeruginosa with 
special reference to β-lactamase production isolated in the Department of Microbiology, 
Jawaharlal Nehru Medical College, Wardha ( M. S.), India. 
1.2.1 To fulfill the aim the following objectives were taken 
 To study the prevalence of Extended Spectrum β-lactamases (ESBL), Amp C β-
lactamases, Metallobetalactamases (MBL) producing Pseudomonas aeruginosa strains, 
isolated from different clinical samples of patients attending the Hospital 
 To study the antibiotic susceptibility profile of Extended Spectrum β-lactamases (ESBL), 
Amp C β-lactamases and Metallobetalactamases (MBL) producing Pseudomonas 
aeruginosa strains isolated. 
2. Material and methods 
The study was conducted from 1st September 2008 to August 2010 (2 year period). A total 
number of 250 P.aeruginosa strains were isolated from different clinical samples e.g. urine, 
pus and wound swab, blood, catheter tips, endotracheal tube secretions, different body 
fluids etc. received from indoor as well as outdoor patients departments (IPD &OPD) of our 
hospital, which is a tertiary care hospital in a rural set-up. P.aeruginosa strains were 
characterized according to conventional identification tests. P.aeruginosa ATCC 27853 were 
used as positive control for all conventional tests. All antibiotic disks and culture media 
used in the study were procured from HiMedia laboratories Pvt. Limited, India. Ethylene 
Diamine Tetraacetic acid (EDTA) and 3-amino phenylboronic acid (APB) were procured 
from Sigma-Alderich. 
2.1 Antibiotic susceptibility testing 
All 250 P.aeruginosa strains were subjected to antibiotic susceptibility testing to different 
antimicrobial agents using Mueller-Hinton agar plates by Kirby-Bauer disk diffusion method 
according to CLSI guidelines (CLSI Document M2-A9, 2006). Using sterile swab, lawn culture 
of the test strain (turbidity adjusted to 0.5 McFarland standard) was made on Mueller Hinton 
Agar plate. With all aseptic precaution, the antibiotic disks were put on that inoculated plate. 
Six antibiotic disks were put on a 90mm diameter plate. The antibiotic sensitivity tests were 
put for aminoglycosides such as amikacin (Ak-30µg), netilimicin (Nt-30µg); cephalosporin 
such as ceftazidime(Ca-30µg), cefepime(Cpm-30µg); fluoroquinolones i.e. ciprofloxacin(Cf- 
5µg); monobactams i.e. aztreonam (Ao-30 µg); carbapenems such as imipenem(I-10µg), 
meropenem(Mr-10µg); piperacillin/tazobactam (Pt-100/10µg ), ceftazidime/clavulanic acid 
(Cac-30µg /10 µg) and polymyxin B (Pb-300µg) etc. (Fig. 1) 
 




Fig. 1. Antibiotic susceptibility test. 
Detection of newer β-lactamases 
Though several methods both phenotypic and genotypic have been described for detection of 
newer β-lactamases, we restricted our study only to phenotypic methods. There is no CLSI 
guideline given for detection of ESBL, AmpC β-lactamases ans MBL producing P.aeruginosa.  
2.1.1 Detection of extended spectrum β-lactamases (ESBL) 
Screening test: ESBL production was detected by reduced susceptibility to Ceftazidime, 
Cefotaxime.  
Confirmatory tests: As per Clinical and Laboratory Standard Institute (CLSI) guidelines 
for Enterobacteriaceae (Waynepa CLSI, 2008; Storenburg, 2003), we used the same 
combined disk method as confirmatory test for Pseudomonas aeruginosa also, as the 
principle remains the same.  
1. Combined Disk Method (Carter et al, 2000)  
Broth cultures of test strains were adjusted to McFarland 0.5 standard and used to 
inoculate Mueller Hinton agar plates with a sterile swab. Commercialized disks 
containing ceftazidime (Ca) 30 µg and ceftazidime plus clavulanate (Cac) 30µg plus 
10µg respectively were used in this method. An increase in diameter of ≥5mm with 
ceftazidime plus clavulanate (Cac) disk as compared to ceftazidime(Ca) disk alone was 
considered positive for ESBL detection. All 250 P. aeruginosa strains were also tested 
using piperacillin (Pc)100 µg & piperacillin-tazobactam (Pt) 100 µg plus 10 µg 
respectively in combination. 
2. E test ESBL strip (Washington et al, 2006) 
The E-test ESBL confirmatory test strips are based on the CLSI dilution method. The 
strip has concentration gradients of ceftazidime (TZ) 0.5 to 32 µg/ml on one half and 
ceftazidime 0.064 to 4 µg/ml plus 4 µg/ml clavulanic acid (TZL) on another half . The 
ESBL E-test was performed and interpreted using test strains and Quality Control 
strains according to the manufacturerer’s instructions. In this method lawn culture of 
test strain was done on a Mueller Hinton agar plate. With a sterile forceps the ESBL E-
test strip was placed onto the inoculated plate. After overnight incubation at 37°C, the 
zone of inhibition was read from two halves of the strip. MIC ratio of 
ceftazidime/ceftazidime clavulanic acid (TZ/TZL) ≥ 8 or deformation of ellipse or 
phantom zone present was considered as positive for ESBL production.  
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2.1.2 Detection of Amp C β-lactamases  
For detection of AmpC class of β-lactamases, no satisfactory technique has been established 
till date as per CLSI guidelines. Induction of C β-lactamase synthesis was Amp based on the 
disc approximation assay using several inducer substrate combinations.  
Screening test: Several inducer/substrate combinations disks like Cefoxitin/Piperacillin, 
Imipenem/Ceftazidime,Imipenem/Cefotaxime, Imipenem/Cefoxitin, Imipenem/Piperacillin 
-Tazobactum were used as described by Dunne and Hardin et al. Imipenem and cefoxitin were 
used as inducers of AmpC β-lactamases (Dunne & Hardin, 2005). 
Interpretation: Strains were considered inducible if a positive test was obtained with any of 
the inducer/substrate combinations. A test was considered positive if the zone of inhibition 
was reduced by ≥2 mm on the induced side of the substrate disc or even blunting of substrate 
zone of inhibition adjacent to inducer disc. Also, if the zone of inhibition produced by 
ceftazidime/ceftazidime-clavulanic acid (Cac) disk was ≥2mm less than the zone produced by 
a ceftazidime (Ca) disk, the strain was considered to be inducible Amp C positive. Similarly, 
same criteria was used for piperacillin & piperacillin/tazobactam (Pc/Pt) disks.  
Confirmatory test: Disk potetiation(DP) test and Double disk synergy test (DDST) using 3-
aminophenylboronic acid (APB) (100mg/ml dissolved in DMSO) (Yagi et al, 2005). An 
increase in zone size of ≥5mm around the Ceftazidime- APB disk compared to ceftazidime 
only disk was recorded as a positive result for disk potentiation test. In DDST, the presence 
of change in the shape of growth inhibitory zone around ceftazidime or cefotaxime disk 
through the interaction with the 3- Aminophenyl boronic acid containing disk was 
interpreted as positive for AmpC production. 
2.1.3 Detection of metallobetalactamases (MBL) 
All imipenem resistant strains were screened for Carbapenemase activity by Classical Hodge 
Test and Modified Hodge Test (MHT) (Lee et al, 2001a; 2003b). Pseudomonas aeruginosa 
strains which were positive by Classsical Hodge Test(IHT) and Modified Hodge Test (MHT) 
were tested for metallobetalactamase (MBL) production by Imipenem/EDTA double disk 
synergy test (Lee et al, 2001)and disk potentiation test or imipenem-EDTA combined disk test 
(Yong et al, 2002) using Di-potassium EDTA (10µl of 0.5 M). 
Imipenem-EDTA double disk synergy test (DDST) ( Lee et al, 2001) 
The IMP-EDTA double disk synergy test was performed for detection of 
metallobetalactamases. Test strains i.e. Pseudomonas aeruginosa (turbidity adjusted to 0.5 
McFarland standard ) were inoculated on to Mueller Hinton agar plate. After drying, a 10μg 
Imipenem disk and a blank sterile filter paper disk (6mm in diameter, Whartman filter paper 
no.2) were placed 10mm apart from edge to edge. 10 μl of 50mM zinc sulfate solution was 
added to the 10 μg imipenem disk. Then, 10μl of 0.5 M EDTA(Sigma, USA) solution was 
applied to the blank filter paper disk. As disodium-EDTA is difficult to be solubilised in sterile 
water, we had used dipotassium-EDTA which is easily soluble in sterile water. Enhancement 
of the zone of inhibition towards the EDTA disk was interpreted as a positive result. 
Disk Potentiation test or Imipenem-EDTA combined disk test (Young et al, 2002) 
The test was performed for detection of metallobetalactamases. Test strains (turbidity 
adjusted to 0.5 McFarland standard ) were inoculated on to Mueller Hinton agar plate. Two 
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imipenem disk (10 µg) were placed on the plate wide apart and 10 μl of 50mM zinc sulphate 
solution was added to each of the imipenem disks. Then 10µl of 0.5 M EDTA solution was 
added to one of the disk to obtain the desired concentration. The inhibition zones of the 
imipenem and imipenem-EDTA disks were compared after 16-18 hours of incubation at 
35°C. If the increase in inhibition zone with the Imipenem and EDTA disk was ≥7 mm than 
the imipenem disk alone, it was considered as MBL positive.  
The MBL producing strains were further confirmed by using MBL – E test strip (AB 
bioMerieux) (Walsh et al, 2002). 
MIC ratio of Imipenem /Imipenem-EDTA (IP/IPI) of ≥8 or deformations of ellipse or 
phantom zone indicate MBL production by MBL E-test.  
2.2 Observations and results 
Maximum 204(81.6%) P.aeruginosa strains were isolated from Indoor Patient Department 
(IPD). No newer β-lactamase producing strains were isolated from patients attending Out 
Patient Department 
 
Fig. 2. Isolation of Pseudomonas aeruginosa strains from OPD, IPD and ICU patients.  
Fig. 3 shows 165 (66%) P.aeruginosa strains were ESBL, AmpC β-lactamases and MBL 
producers. 
 
Fig. 3. Prevalence of newer β-lactamases producing P. aeruginosa strains (n=250). 
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No. Percentage No. Percentage No. Percentage 
n=250 100 40 105 42 28 11.2 
Table 1. Prevalence of ESBL, AmpC β-lactamase and MBL producing P. aeruginosa (n=250) 
Amongst the 100 ESBL (Fig. 4) and 105 Amp C β-lactamase producers (Fig. 5 & 6), 68 (27.2%) 
P. aeruginosa strains had produced both ESBL as well as AmpC β-lactamases. 28 (11.2%) P. 
aeruginosa strains were Metallobetalactamase (MBL) producers.  
 
Fig. 4. Detection of ESBL( Combined disk method ) 
Detection of AmpC β-lactamases (Figure 5&6) 
 
Fig. 5. Inducer-substrate combination disk test. 
Fig. 7 shows amongst 100 ESBL and 105 AmpC β-lactamase producers 68 (41.2%) strains had 
produced both ESBL as well as AmpC β-lactamases. There was no strain which produced all 
the 3 types of β-lactamases. Similarly, no strain produced ESBL or AmpC β-lactamase along 
with MBL.  
 




Fig. 6. DDST & DP test using 3-Aminophenyl-boronic acid (3-APB). 
 
Fig. 7. Incidence of different newer β-lactamases producing P.aeruginosa strains(n=165) 
Table 2 shows that out of 250 P. aeruginosa strains studied, 31 (12.4 %)were imipenem 
resistant and 28 (11.2 %) were metallobetalactamase (MBL) producers. 31 imipenem 
resistant strains were screened for carbapenem hydrolysis by Classical Hodge test (HT) & 
modified Hodge test (MHT). Amongst these 31 imipenem resistant P. aeruginosa strains, 28 
(90.3%) were positive for Classical Hodge test (HT) & modified Hodge test (MHT) for 
carbapenem hydrolysis and these 28 strains were also positive for metallobetalactamase 
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These 28 strains were also confirmed for metallobetalactamase (MBL) production by using 
MBL E-test strip (AB bioMerieux). MBL E-test (Fig. 9) shows MIC ratio of imipenem IP/ 
imipenem-EDTA IPI for test strain P. aeruginosa as 16/1 i.e. 16 and MBL E-test positive. The 
phantom zone shown in Fig. 9 is another criteria for MBL E-test positivity. MBL E-tests done 
for those 28 P. aeruginosa strains showed that the MIC ratio of imipenem / imipenem-
EDTA i.e. IP/IPI were > 8 such as 16/1 for 9 strains, 24/1.5 for 3 strains, 32/1 for 5 strains, 
48/1 for 8 strains, 64/1 for 2 strains and 128/1 for 1 strain.  
Confirmation of MBL by E-test : Figure 8 & 9 
 
Fig. 8. Quality control: P.aeruginosa ATCC 27853 (MBL E test negative). 
 
Fig. 9. MBL E-test (positive). 
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Fig. 10 shows from ICU 6 (14.3%) strains produced both ESBL and AmpC β-lactamases 
whereas 9(21.4%) strains produced MBL. 
 
 




*others include throat swab, vaginal swab, ear swab, bronchial wash, tip of catheter & drain fluid.  
Fig. 11. Isolation of β-lactamases producing P.aeruginosa strains from different clinical 
specimens. 
In the present study, maximum P.aeruginosa strains isolated from pus and wound swab, 73 
(29.2%) followed by 60(24%) from urine. The fig. 11 shows 26(49%) P.aeruginosa strains 
isolated from sputum sample were both ESBL and AmpC β-lactamase producer. 50% 
P.aeruginosa strains isolated from endotracheal tube secretions were MBL producers. 
Though no MBL producing strains were isolated from blood culture.  
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Fig. 12 shows maximum 36.2% strains isolated from Medicine ward produced both ESBL 
and AmpC β-lactamase. From surgery ward maximum 10(35.7%) strains were MBL 
producers. No MBL producing P.aeruginosa strains were isolated from Neonatal Intensive 
Care Unit(NICU) and 3(20%) strains were only ESBL producers. 
 
 
Fig. 12. Isolation of β-lactamases producing P. aeruginosa strains from different clinical 
specialities  
Fig. 13 shows that P.aeruginosa strains showed a high degree of resistance to cefepime (90.4%), 
cefoxitine(91.6%) and ceftazidime(67.2%). However effective antimicrobial agents were found 
to be polymyxin B (100%), Imipenem(87.6%) and piperacillin-tazobactum (86%) sensitive. 
 
 
Fig. 13. Antibiotic susceptibility profile of P. aeruginosa strains (n=250)  
Fig. 14 shows most effective antimicrobial agent against ESBL andAmpC β-lactamase 
producing P.aeruginosa strains were Imipenem(100%) and Polymyxin-B(100%). However, 
sensitivity of ESBL and AmpC β-lactamase producers to piperacillin-tazobactam were 100% 
and 82.8% respectively. 
 




Fig. 14. Antibiotic susceptibility profile of ESBL & Amp C β-lactamases producing 
P.aeruginosa strains  
Fig.15 shows all(100%) MBL positive isolates were sensitive to polymyxin-B. 1(3.7%) each 
MBL producing strain was sensitive to Amikacin and Netilmicin respectively. But no MBL 
producing strain was susceptible to Aztreonam. 
 
Fig. 15. Antibiotic susceptibility profile of MBL & non-MBL P. aeruginosa strains  
2.3 Discussion 
Pseudomonas aeruginosa is one of the most important microorganisms which causes 
problems clinically as a result of its high resistance to antimicrobial agents and is therfore a 
particularly dangerous & dreaded bug. Despite the discovery of ESBL, Amp C β-lactamases 
and MBL at least a decade ago, there remains a low level of awareness of their importance 
and many clinical laboratories have problems in detecting ESBL& Amp C β-lactamases. 
Failure to detect these enzymes has contributed to their uncontrolled spread and commonly 
to therapeutic failures. 
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Detection problems arise especially with organisms that produce an inducible Amp C β-
lactamases, as clavulanate can induce high level production of Amp C , which may obscure 
recognition of ESBLs ( Moland et al, 2008). According to Clinical & Laboratory Standards 
(CLSI) interpretive definations, ESBLs do not always increase MICs to levels characterized 
as resistant ( Livermore, 2002). Not only that ESBL producing organisms may give false 
sensitive zones in routine disk diffusion test. The number of infections caused by Amp C β-
lactamases producing P. aeruginosa is on rise and poses a threat to patients due to 
therapeutic failure if they remain undetected ( Arora & Bal, 2005). Metallobetalactamase 
(MBL) producing P.aeruginosa is an emerging threat and a cause of concern for treating 
physicians as it can hydrolyze carbapenems which are given as a last resort to the patient 
having infection with ESBL and AmpC β-lactamase producing P.aeruginosa. The MBLs 
have become more notorious as therapeutically available inhibitors are not available and for 
their potential for rapid and generalized dissemination to different other Gram negative 
bacilli. Hence, accurate identification of MBL producing strains are very urgently needed. 
Though PCR gives specific and accurate results, it’s use is limited to few laboratories 
because of it’s high cost and different types of ESBLs, AmpCβ-lactamases and 
metallobetalactamases (MBLs) present worldwide ( Moland et al, 2008b). 
In the present study 81.6% P.aeruginosa strains were isolated from IPD patients Algun et al 
from Turkey in 2004 reported isolation of P. aeruginosa 61% from IPD patients. Basak et al 
in 2009 reported 89.3% isolation from IPD and 10.7% from ICU from our hospital.  
In the present study, co-existence of MBL producing P. aeruginosa was not observed along 
with ESBL & Amp C producers. Saha et al in 2010 reported 86% strains producing both MBL 
and Amp C β-lactamases while only one strain was observed to produce both ESBL and 
MBL. In the present study 68(27.2%) strains were both ESBL & Amp C β-lactamases 
producers amongst 250 P. aeruginosa strains studied. 
6(22.2%) MBL producing strains were isolated from Medicine ICU. Sarkar et al in 2006 
reported 36.4% of imipenem resistance in nosocomially infected patients with P. aeruginosa. 
In present study, we found 15 (35.7%) P. aeruginosa from NICU and all were from blood 
cultures of neonates and all were imipenem sensitive. Only 3 (20%) of these were found to 
be positive for ESBL production. Arkawa et al, 2000 recommended testing ceftazidime-
resistant isolates for MBL production because in their study some MBL producing Gram 
negative bacilli were inhibited by low concentration of imipenem and they were difficult to 
detect. But Lee et al, 2001 reported that in their study, not a single MBL-producing isolates 
were detected among imipenem susceptible isolates. 
In Japan, Sugino et al, 2001 used only carbapenem non-susceptible isolates for screening of 
MBL. Hence we also used carbapenem resistant isolates for detection of MBL. Though 
Arkawa et al, 2000 and other authors have done DDST & Disc potentiation test with 
ceftazidime and EDTA, in our study we used imipenem and EDTA for DDST & Disc 
potentiation test. As in our study, even in non MBL producing P.aeruginosa strains, the 
ceftazidime resistance was quite high (69.8%). The MBL producing strains may also have 
another ceftazidime resistance mechanism (Lee et al, 2003b). With such type of strains, 
DDSTs using an imipenem disc can show positive results for MBL but a ceftazidime disc can 
not; just as a cefepime disc but not a ceftazidime disc can detect extended spectrum β-
lactamase (ESBL) production in Amp-C β-lactamase producing strains. 
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Though Franklin et al, 2006 have reported that 87% of their MBL producing 
Enteobacteriaceae isolates had >30mm of zone with aztreonam, we did not find any MBL 
producing P.aeruginosa strain to be susceptible to aztreonam. This can only be explained by 
the fact that there are presence of some other mechanisms for aztreonam resistance in P. 
aeruginosa strains isolated. 
Aggarwal et al in 2008 found that polymyxin B was the most effective antibiotic recording 
0% resistance, similar was the finding of our study. In our study we found 67.2% resistance 
against ceftazidime which was quite high and corelated well with the study of Behra et al in 
2008 who had reported 70% resistance to ceftazidime. 
3. Conclusion  
Microbial drug resistance is now a global problem due to newer β-lactamases produced by 
Gram-negative bacteria including Pseudomonas aeruginosa. E-test and Polymerase chain 
reaction (PCR) can be used for accurate detection of newer β-lactamases , but both are costly 
and require expertise and cannot be done routinely.  
Hence to conclude, for detection of ESBL, combined disk method using 
piperacillin/piperacillin-tazobactam (Pc/Pt), for detection of Amp C β-lactamases 
confirmatorty Disk potentiation test using 3-aminophenylboronic acid and for detection of 
MBL producing P. aeruginosa disk potentiation test using imipenem-EDTA should be done 
by all clinical Microbiolgy laboratories to prevent its dissemination and also for a good 
therapeutic outcome as these tests are economical, easy to perform and quite specific. 
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Detection problems arise especially with organisms that produce an inducible Amp C β-
lactamases, as clavulanate can induce high level production of Amp C , which may obscure 
recognition of ESBLs ( Moland et al, 2008). According to Clinical & Laboratory Standards 
(CLSI) interpretive definations, ESBLs do not always increase MICs to levels characterized 
as resistant ( Livermore, 2002). Not only that ESBL producing organisms may give false 
sensitive zones in routine disk diffusion test. The number of infections caused by Amp C β-
lactamases producing P. aeruginosa is on rise and poses a threat to patients due to 
therapeutic failure if they remain undetected ( Arora & Bal, 2005). Metallobetalactamase 
(MBL) producing P.aeruginosa is an emerging threat and a cause of concern for treating 
physicians as it can hydrolyze carbapenems which are given as a last resort to the patient 
having infection with ESBL and AmpC β-lactamase producing P.aeruginosa. The MBLs 
have become more notorious as therapeutically available inhibitors are not available and for 
their potential for rapid and generalized dissemination to different other Gram negative 
bacilli. Hence, accurate identification of MBL producing strains are very urgently needed. 
Though PCR gives specific and accurate results, it’s use is limited to few laboratories 
because of it’s high cost and different types of ESBLs, AmpCβ-lactamases and 
metallobetalactamases (MBLs) present worldwide ( Moland et al, 2008b). 
In the present study 81.6% P.aeruginosa strains were isolated from IPD patients Algun et al 
from Turkey in 2004 reported isolation of P. aeruginosa 61% from IPD patients. Basak et al 
in 2009 reported 89.3% isolation from IPD and 10.7% from ICU from our hospital.  
In the present study, co-existence of MBL producing P. aeruginosa was not observed along 
with ESBL & Amp C producers. Saha et al in 2010 reported 86% strains producing both MBL 
and Amp C β-lactamases while only one strain was observed to produce both ESBL and 
MBL. In the present study 68(27.2%) strains were both ESBL & Amp C β-lactamases 
producers amongst 250 P. aeruginosa strains studied. 
6(22.2%) MBL producing strains were isolated from Medicine ICU. Sarkar et al in 2006 
reported 36.4% of imipenem resistance in nosocomially infected patients with P. aeruginosa. 
In present study, we found 15 (35.7%) P. aeruginosa from NICU and all were from blood 
cultures of neonates and all were imipenem sensitive. Only 3 (20%) of these were found to 
be positive for ESBL production. Arkawa et al, 2000 recommended testing ceftazidime-
resistant isolates for MBL production because in their study some MBL producing Gram 
negative bacilli were inhibited by low concentration of imipenem and they were difficult to 
detect. But Lee et al, 2001 reported that in their study, not a single MBL-producing isolates 
were detected among imipenem susceptible isolates. 
In Japan, Sugino et al, 2001 used only carbapenem non-susceptible isolates for screening of 
MBL. Hence we also used carbapenem resistant isolates for detection of MBL. Though 
Arkawa et al, 2000 and other authors have done DDST & Disc potentiation test with 
ceftazidime and EDTA, in our study we used imipenem and EDTA for DDST & Disc 
potentiation test. As in our study, even in non MBL producing P.aeruginosa strains, the 
ceftazidime resistance was quite high (69.8%). The MBL producing strains may also have 
another ceftazidime resistance mechanism (Lee et al, 2003b). With such type of strains, 
DDSTs using an imipenem disc can show positive results for MBL but a ceftazidime disc can 
not; just as a cefepime disc but not a ceftazidime disc can detect extended spectrum β-
lactamase (ESBL) production in Amp-C β-lactamase producing strains. 
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Though Franklin et al, 2006 have reported that 87% of their MBL producing 
Enteobacteriaceae isolates had >30mm of zone with aztreonam, we did not find any MBL 
producing P.aeruginosa strain to be susceptible to aztreonam. This can only be explained by 
the fact that there are presence of some other mechanisms for aztreonam resistance in P. 
aeruginosa strains isolated. 
Aggarwal et al in 2008 found that polymyxin B was the most effective antibiotic recording 
0% resistance, similar was the finding of our study. In our study we found 67.2% resistance 
against ceftazidime which was quite high and corelated well with the study of Behra et al in 
2008 who had reported 70% resistance to ceftazidime. 
3. Conclusion  
Microbial drug resistance is now a global problem due to newer β-lactamases produced by 
Gram-negative bacteria including Pseudomonas aeruginosa. E-test and Polymerase chain 
reaction (PCR) can be used for accurate detection of newer β-lactamases , but both are costly 
and require expertise and cannot be done routinely.  
Hence to conclude, for detection of ESBL, combined disk method using 
piperacillin/piperacillin-tazobactam (Pc/Pt), for detection of Amp C β-lactamases 
confirmatorty Disk potentiation test using 3-aminophenylboronic acid and for detection of 
MBL producing P. aeruginosa disk potentiation test using imipenem-EDTA should be done 
by all clinical Microbiolgy laboratories to prevent its dissemination and also for a good 
therapeutic outcome as these tests are economical, easy to perform and quite specific. 
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